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Abstract: 
 
Skeletal muscle mass is vitally important for the maintenance of health and quality of 
life into old age, with a plethora of disorders and diseases linked to the loss of this 
tissue. As a consequence, molecular biologists have extensively investigated both 
atrophying and hypertrophying skeletal muscle, in order to understand the molecular 
pathways that are induced to evoke both loss and growth of skeletal muscle. Despite 
huge progressions in the field, a full understanding of the molecular mechanisms that 
orchestrate growth and loss in skeletal muscle, remain elusive. In this regard, 
epigenetics, referring to alterations in gene expression via structural modifications of 
DNA without fundamental alterations of the DNA code, have recently become a 
promising area of research, specifically for its role in modulating genetic expression. 
However, the field of skeletal muscle epigenetics is in its infancy, and as such, there 
is currently a distinct paucity of research investigating this biological phenomenon. 
Herein, a genomic approach was utilised to examine the role DNA methylation plays 
in modulating the response, at both a genetic and phenotypic level, of mammalian 
skeletal muscle. The methodological and analytical approaches utilised in this thesis 
identify a number of important, novel and impactful findings. Firstly, it is identified 
that DNA methylation displays a distinct inverse relationship with gene expression 
during both muscular atrophy and hypertrophy, these findings are furthered by work 
identifying that DNA methylation alterations may precede functional changes in gene 
expression during skeletal muscle hypertrophy. This thesis also elucidated that 
skeletal muscle possesses an epigenetic memory that creates an enhanced adaptive 
response to resistance load induced hypertrophy, when the same stimulus was 
previously encountered. Finally, in human subjects, a number of novel and previously 
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unstudied gene transcripts were identified that display significantly positive 
correlations with changes in skeletal muscle mass, as evoked by resistance training.  
 
The data in this thesis demonstrates an important role for DNA methylation in 
regulating skeletal muscle mass during periods of both muscle atrophy and 
hypertrophy, respectively. The work presented here may allow for further work to be 
conducted, expanding our understanding of epigenetics in skeletal muscle and best 
facilitating the development of therapeutics that may alleviate the detrimental effects 
observed during periods of skeletal muscle atrophy.   
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NR2F6 Nuclear receptor subfamily 2 group f member 6 
NUB1 Negative regulator of ubiquitin like proteins 1 
NUP205 Nucleoporin 205 
ODF2 Outer dense fibre of sperm tails 2 
P38 MAPK P38 mitogen activated protein kinase  
P70-S6 Kinase-1 P70S6K 
PAPD7 Poly(A) RNA polymerase D7 
Pax 7 Paired box protein 
PDK4 Pyruvate dehydrogenase lipoamide kinase isozyme 4 
PGC1-a Peroxisome proliferator activated receptor gamma co-activator 
1-alpha 
PI3K Phosphoinositide 3-kinase 
PLA2G16 Phospholipase A2 group XVI 
POLR2a DNA-directed RNA polymerase II subunit RPB1  
PTH1R Parathyroid hormone 1 receptor 
qRT-PCR Quantitative reverse transcription polymerase chain reaction 
RN18s 18s ribosomal RNA 
RNA Ribonucleic acid 
RPIIb RNA polymerase II subunit B 
RPL13a Ribosomal protein L13a 
RPL35a Ribosomal protein L35a 
RSU1 Ras suppressor protein 1 
rt-qRT-PCR Real time qRT-PCR 
RUNX1 Runt related transcription factor 1 
SAH S-adenosyl homocysteine 
SAM S-adenosyl methionine 
SD Standard deviation 
SEM Standard error of the mean 
SETD3 SET domain containing 3 
SIN3a SIN3 transcriptional regulator family protein member A 
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STAG1 Cohesin subunit SA-1 
STIM1 Stromal interaction molecule 1 
T2D Type II diabetes 
TA Tibialis anterior 
TAC Transcriptome analysis console 
TET1 Ten-eleven translocation methylcytosine dioxygenase 1 
TFAM Mitochondrial transcription factor A 
TM6SF1 Transmembrane 6 superfamily member 1 
TNF-a Tumour necrosis factor alpha 
TOR Target of rapamycin 
TRAF1 TNF receptor associated factor 1 
TRD Transcriptional repressor Domain 
Trim63 Tripartite motif containing 63 
TSC Tuberous sclerosis complex 
TSS Transcriptional start site 
TTX Tetrodotoxin  
UBR5 Ubiquitin protein ligase E3 component N-recognin 5 
UNC45a Protein unc-45 homolog A 
URT Untranslated region 
VPS34 Phosphatidylinositol 3-kinase VPS34 
WNT7b WNT family member 7b 
ZFP2 Zinc finger protein 2 
ZNF56 Zinc finger protein 56 
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Chapter 1:  
	
	
	
Introduction 
 
 
 
 
	
	
	
	
	
	
	
	
Portions of the introduction of this thesis have been utilised in a literature review 
published in the peer-reviewed journal, Aging Cell: 
 
Sharples, A. P., Stewart, C. E., Seaborne, R. A. (2016). Does skeletal muscle have 
an ‘epi’-memory? The role of epigenetics in nutritional programming, metabolic 
disease, aging and exercise. Aging Cell, 15, 603-616.	
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1.1 General Introduction 
Skeletal muscle is the largest and most abundant tissue in the mammalian body, 
playing a fundamental role in locomotive performance, physiological function, 
metabolic homeostasis and maintenance of health across the organism life span. 
Despite homo-sapiens possessing almost identical genetic codes (Levy et al., 2007), 
large variations in skeletal muscle mass and functionality are observed, that may, in-
part, be due to encounters with environmental stimuli such as physiological behaviour 
(e.g. activity level) and nutrient availability (Sharples et al., 2016c). An observed 
increase in muscle mass, referred to as hypertrophy, is obtained following chronic 
periods, such as embryonic development and mammalian maturation/puberty, or 
repeated encounters with anabolic stimuli, in which the muscle is in a growth state. 
Most applicably, for example, this hypertrophic response is observed following 
resistance exercise (RE) in a fed state, where muscle protein synthesis (MPS) is 
increased orchestrating a positive net protein balance. Conversely, during periods of 
catabolism (fasting, sedentary behaviour, limb immobilization, disease states) the 
muscle decreases in size, known as atrophy, where muscle protein breakdown (MPB) 
is higher than MPS, leading to a negative net protein balance and muscle loss. One of 
the most prolific causes of atrophy, is the gradual loss in muscle observed with age, a 
condition known as sarcopenia (Narici and Maffulli, 2010). In young, healthy 
humans, muscle protein balance remains either in a state of synthesis or equilibrium, 
resulting in the sufficient development and turnover of skeletal muscle up until the 
age of ~ 40. However, for reasons that are not yet fully characterised, nor understood, 
this balance shifts towards a predominantly catabolic state with advancing age. Past 
the 4th decade, ~ 0.8% of muscle mass in humans is lost annually (Paddon-Jones and 
Rasmussen, 2009), with the rate of atrophy rising even further to 1-2% by the age of 
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50 (Hughes et al., 2001). In sedentary individuals this condition is exacerbated, with 
the onset of natural muscle atrophy occurring as early as 25 years of age, with a total 
reduction of 10% observed in skeletal muscle by the age of 40, rising to 40% by the 
age of 70 (Porter et al., 1995). Additionally, repeated exposure to acute periods of 
skeletal muscle atrophy (bed-rest, hospitalisation, injury) exacerbates the progression 
of sarcopenia, a phenomenon deemed acute sarcopenia (Wall et al., 2013a, Wall et 
al., 2013b). Collectively, this has important ramifications, as muscle mass is strongly 
linked with an increase in a number of debilitating conditions and health-impacting 
pathologies that ultimately lead to earlier life morbidity and mortality (Rennie et al., 
2010).  
 
Despite progressions in the field of molecular biology, the precise mechanisms that 
orchestrate muscle atrophy and hypertrophy are still poorly and inadequately 
described. It is of significant importance for scientists to elucidate the cause of muscle 
hypertrophy and atrophy in order to aid in the development of therapeutics that may 
help in alleviating the reduction in muscle mass during acute and chronic catabolic 
events. This may aid in the reduction of muscle loss associated pathologies and 
illnesses, and aid in promoting greater human health and quality of life into old age.  
 
With this in mind, this thesis was performed to help develop the scientific 
communities understanding of the molecular regulation of skeletal muscle atrophy 
and hypertrophy. As such, it is important to understand the current knowledge base of 
skeletal muscle adaptation during periods of anabolism and catabolism. Further, given 
that muscle perturbation is observed at a whole body, cell and gene level, the review 
of literature will briefly focus upon the adaptive response of tissue during periods of 
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atrophy and hypertrophy. It will then aim to describe known genes and proteins that 
are regularly and commonly induced in differing models of muscle atrophy and 
hypertrophy, respectively, where their role is regarded as pivotal in these cellular 
processes. Finally, given the aim of this thesis, the majority of the literature review 
will focus on our current understanding of epigenetics as a biological mechanism. It 
will then move onto describing the current opinion for the role of epigenetics in 
skeletal muscle adaptation, before identifying areas of research that warrant 
investigation in this thesis.  
 
1.2  Overview of Skeletal Muscle Structure and Response to Catabolic and 
Anabolic Stimuli  
1.2.1 Skeletal muscle structure: gross anatomy and cytoskeletal structure  
Skeletal muscle makes up a large portion (~ 40%) of the mature human body, and is 
constantly in a state of protein synthesis and degradation, equating to ~ 30-50% of 
whole-body tissue turnover. Only ~ 20% of skeletal muscle itself is made up of 
protein, with the majority of the tissues mass being comprised of water (~ 75%) and 
the remaining portion (~ 5%) made up of other biological substances such as 
carbohydrates, fats, minerals and salts (MacLaren and Morton, 2011). Skeletal muscle 
is made up of a multitude of mature single muscle cells known as myofibers that are 
arranged into bundles, which are themselves surrounded by a connective tissue known 
as the perimysium. Muscle fibers themselves contain large amounts of protein (~ 80 
%) that are responsible for the cytoskeletal structure and integrity, homeostatic 
regulation and contractile performance of the tissue (Hoppeler et al., 1973). Each 
individual muscle fibre, approximately 100 µm in diameter and up to 100 mm in 
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length, is itself made up of a further bundle of protein dense muscular structures 
referred to as myofibrils (Figure 1.1 and 1.2). Myofibrils are predominantly (~ 70-
80%) made up of the myofilament proteins actin and myosin, that when uniformly 
assembled, create a sarcomere which is the basic unit of contractile apparatus in 
mature skeletal muscle. At rest, these two myofilaments overlap and repeat along the 
myofibril structure, running in parallel with other localised myofibrils, a formation 
that gives rise to the striated appearance of skeletal muscle under microscopic analysis 
(Frontera and Ochala, 2015). A number of important organelles, macromolecular 
structures, proteins and elements are contained within, and on the periphery of, the 
sarcoplasm of skeletal muscle cells. Most notably, this includes axons, synaptic end 
bulbs, the neuromuscular junction and the sarcoplasmic reticulum, that all play a 
fundamental role in skeletal muscle contraction. Given the role of skeletal muscle 
contraction in initiating hypertrophy, via repair and regeneration processes, it is best 
to first detail the process of contraction, before proceeding.  
	
Figure 1.1. Gross anatomical structure of mature mammalian skeletal muscle. Taken 
from Kraemer et al. (2012).  
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Figure 1.2. Schematic representation of the contraction-relaxation cycle. Taken from 
Tortora and Grabowski (2003) 
 
1.2.2 The cascade of events that initiate skeletal muscle contraction 
The sarcomere is a complex biological structure that, via a cascade of reactions and 
events starting from a neural impulse arriving from the motor complex and ending 
with the sliding filament mechanism, is responsible for the contractile properties of 
mammalian skeletal muscle (Figures 1.1 and 1.2). Briefly, the action of muscular 
contraction begins with a nerve impulse generated from the motor cortex that runs 
through the nervous system to the muscle of interest. A series of events subsequently 
occur that rely on the release and binding of acetylcholine (ACh) to its receptors 
within the myofiber structure. The binding of ACh to its receptors causes a voltage-
gate ion channel to open allowing the influx of sodium and the efflux of potassium 
that renders the interior of the muscle fiber positively charged and depolarizes the 
sarcoplasmic reticulum (MacLaren and Morton, 2011). An action potential is then 
triggered via this event, that runs along the sarcolemma and into the T-tubules and 
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then propagates along the transverse tubule which allows for release and uptake of 
calcium ions, initiating the contractile apparatus. Cytosol-specific calcium causes the 
removal of the troponin-tropomyosin complex that, in basal non-contractile muscle, 
blocks the binding of myosin heads to actin receptors. Finally, in the presence of 
adenosine triphosphate (ATP), the myosin heads bind to actin receptors to form cross-
bridges, a crucial biological step that is dysregulated in a number of pathologies and 
conditions (Frontera and Ochala, 2015). ATP is subsequently broken down into ADP 
and a phosphate group, the latter of which is released, tilting the myosin head and 
sliding the actin filament across the body of the myosin filament, causing contraction. 
This process, under the continued presence of ATP, is then repeated (figure 1.2) for 
each contraction. At microscopic level damage occurs to the myofiber structures 
during contraction that require repair in order for the muscle to regenerate. The next 
section of this literature review will focus on the role that a unique form of stem cells 
plays in this repair process.  
	
1.2.3 Satellite cells and the skeletal muscle stem cell niche 
Myofibers are established during gestation and therefore, during adulthood, are a 
stable post-mitotic tissue with infrequent turnover of myonuclei. The maintenance of 
mammalian myofibers is to conserve the number, size and cross-sectional area as well 
as the integrity of the cytoskeletal structure. During day-to-day activity, minor lesions 
are adequately repaired by the myofilament structure, without the causation of cell 
death, inflammatory responses or any major morphological adaptations. For example, 
plasma membrane damage caused by day-to-day activity can be effectively repaired 
by the incorporation of local blood vesicles that can fill the damaged plasma 
membrane (Bansal et al., 2003). However, more serious damage to the myofilament 
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structure warrants a greater repair and regenerative process. The first step of muscle 
regeneration is myofiber necrosis. Necrosis initiates a cascade of events that include 
the increased influx of calcium (Ca2+) and/or increased Ca2+ release from the 
sarcoplasmic reticulum. In turn, this activates proteolysis and promotes skeletal 
muscle degeneration (Alderton and Steinhardt, 2000, Armstrong, 1990). Furthermore, 
necrosis also initiates skeletal muscle inflammation. Upon damage, two distinct sets 
of macrophages invade the tissue and secrete proinflammatory cytokines, such as 
tumour necrosis factor alpha (TNF-a) and the interleukin family member, IL-1, that 
reside within the tissue and peak at the protein level by ~ 24 hours post injury 
(Chazaud et al., 2009). Subsequently, a new population of macrophages invades and 
resides within the damaged muscle tissue. The new macrophages secrete anti-
inflammatory cytokines, such as interleukin 10 (IL-10), and reside in the damaged 
tissue until the inflammation period terminates. These macrophages are the reported 
trigger for initiating the activation, proliferation and differentiation of a set of skeletal 
muscle-specific stem cells (Cantini and Carraro, 1995, Lescaudron et al., 1999, Al-
Shanti et al., 2014). Residing beneath the basal lamina is a subset of skeletal muscle-
specific stem cells, aptly named satellite cells. Muscle precursor cells (MPC) become 
activated following autocrine, paracrine and endocrine interactions of cytokines and 
progress through the stages of myogenic differentiation, a process governed by the 
expression of two myogenic regulatory factors, myogenic factor 5 (Myf 5) and 
myogenic differentiation 1 (MyoD; a schematic overview of the myogenic 
programme is represented in figure 1.3) (Tajbakhsh et al., 1996). A crucial stage of 
this differentiation pathway is the process of division in which the activated MPCs 
will undergo either symmetric or asymmetric division (figure 1.3). Asymmetric 
division is considered a hallmark of the myogenic differentiation process due to its 
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ability to divide an MPC into two distinctly different cells with two different fates. 
This division process, shown to be largely regulated by the mitogen-activated protein 
kinase (MAPK) P38 (Bernet et al., 2014, Troy et al., 2012), produces one terminally 
differentiated myoblast that expresses both paired box protein (Pax7) and MyoD, but 
also a stem cell that does not express MyoD and which returns to the quiescent stem 
cell pool niche, thereby maintaining the progeny pool (Zammit et al., 2004). Such 
events have been extensively confirmed by explorative work, such as that by 
Rudnicki’s group (Kuang et al., 2007). Following multiple rounds of proliferation and 
entrance of the myogenic differentiation program, human satellite cells fuse to 
damaged regions of the existing tissue to help regenerate the muscle fibre. Satellite 
cells migrate and fuse to aid in repair and regeneration, with this process being 
governed by a number of myogenic regulatory factors including, and most notably, 
Myogenin and Myogenic Factor 6 (Myf6, otherwise referred to as Mrf4) (Cornelison 
et al., 2000, Cornelison and Wold, 1997).  
 
The process of skeletal muscle regeneration, the maintenance and the efficiency of 
the satellite cell pool, and the conservation of the niche in which satellite cells reside 
is integral to the morphological adaptation of muscle mass. The following series of 
sections will focus on the morphological response of skeletal muscle upon insult to 
either anabolic or catabolic stimulus. In order to do so, findings presented hereafter 
are taken and interpreted from a number of different approaches, in which different 
mammalian organisms and different experimental models are utilised, and thus, must 
be taken into consideration when interpreting these data.  
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Figure 1.3. Overview of the Satellite Cell Myogenic Differentiation Programme that 
Enables Skeletal Myofiber Repair and Regeneration. 
 
1.2.4  Physiological and Morphological Response of Skeletal Muscle During 
Hypertrophy and Atrophy Stimuli 
As previously suggested, skeletal muscle makes up a large proportion of the mature 
human bodily structure, that is dependent on the balance between synthesis and 
degradation. A multitude of factors such as nutritional behaviour, hormonal 
regulation, physical activity and disease state, alter the balance between MPS and 
MPB and therefore the structural integrity of the proteins incorporated into fibres and 
therefore the functional capacity of myofibrils.  
 
 Muscle atrophy is defined by a reduction in muscle fibre cross sectional area, length 
and total muscle mass, but not in reduction in number (Nicks et al., 1989). On the 
contrary, sarcopenia, muscle atrophy relating to the gradual loss in muscle as a result 
of the aging process, also occurs via a reduction in fibre number (Lexell et al., 1988). 
Fundamentally, skeletal muscle atrophy occurs via a shift towards a greater muscle 
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protein breakdown, either via increased MPB itself, or via concomitant reduction in 
MPS and increased MPB. This process leads to a significant reduction or 
dysregulation of skeletal muscle organelles, cytoplasm and importantly, sarcomeric 
related proteins, and thus a reduction in fibre cross-sectional area and mass (Frontera 
and Ochala, 2015). It is also to be noted that alongside a reduction in fibre cross-
sectional area and mass, a reduced functional capacity is also evident during muscle 
atrophy. For example, during bed rest periods, force, velocity and power are all 
significantly reduced in both type I and type II skeletal muscle fibres (Trappe et al., 
2004). This observation is likely due to the reduction in number of contractile units 
within the myofibril and a dysregulation in the actin-myosin cross-bridge that 
orchestrates contraction (Stevens et al., 2013). Muscle atrophy is a multi-faceted 
phenomenon that is evoked by a number of different stimuli, including age-related 
decline in muscle (sarcopenia), disease-induced muscle loss (cachexia), disuse-
induced muscle loss (e.g. bed rest or inactivity) and nutrient deprivation. To 
investigate the morphological outcomes of these stimuli, a wide-range of in-vitro and 
in-vivo models of atrophy have been used, as previously reviewed (Romanick et al., 
2013, Frontera and Ochala, 2015). Indeed, the cross-sectional area (CSA) response of 
skeletal muscle following hind-limb suspension and/or immobilisation has 
extensively been studied across species, unequivocally showing a significant atrophic 
response. For example, 7, 14, 21 and 35 days of hind limb suspension in rodent models 
induced percentage reductions of 36, 40, 45 and 63%, in type I fibres of the soleus 
muscle, respectively (Desplanches et al., 1987, Hauschka et al., 1988, Templeton et 
al., 1986, Simard et al., 1987). Classical immobilisation studies agree with these 
findings. Indeed, time course analysis of immobilised soleus muscle in mice (induced 
via plaster cast of the muscle in the shortened position) across 7, 10 and 14 days 
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induced a progressive reduction in muscle fibre CSA of 19, 25 and 39%, respectively 
(Williams and Goldspink, 1984). With similar time course findings being reported 
across multiple species, including rat (Boyes and Johnston, 1979, Nicks et al., 1989), 
guinea pig (Maier et al., 1976) and cat (Cooper, 1972), as reviewed previously 
(Appell, 1990). To examine this process in a more tightly regulated model, the 
catabolic toxin, tetrodotoxin (a toxin obtained from Tetraodontiformes species, 
function of which is described in chapter 3), has been administered into rodents and  
has been reported to induce tibialis anterior muscle mass reductions of 19% after only 
7 days (Dupont Salter et al., 2003), and 39% after 21 days of denervation (Adhihetty 
et al., 2007). The reduction in muscle mass was unequivocally confirmed by a number 
of intricate studies by Bodine et al. (2001a), where they mapped the percentile change 
in muscle mass at 3, 7 and 14 days in rodents treated via hind-limb suspension, 
immobilisation or denervation. Collectively, these findings confirm a rapid and 
maintained rate of muscle mass loss following a number of different atrophy-inducing 
stimuli. Human studies report similar findings, where after 5 and 14-days of  limb-
cast immobilisation, male subjects reported a 3.5 and 8% reduction respectively in 
muscle cross sectional area of the quadriceps in the treated limb (Dirks et al., 2014, 
Wall et al., 2013a). Similar reductions in cross sectional area have been found in 
models of unilateral knee immobilisation (14 days induced 5% reduction) (Glover et 
al., 2008) and lower limb suspension (14 days suspension induced a reduction of 
5.2%) in humans.  
 
On the contrary, muscle anabolism induces skeletal muscle hypertrophy via a shift 
towards a net positive protein balance, where MPS out-weighs breakdown. In this 
instance, a series of events take place that lead to an increase in this size and 
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abundance of myofibrillar proteins, actin and myosin, an increase in paralleled and 
uniform sarcomeres and a resulting increase in skeletal muscle fibre cross sectional 
area (Schoenfeld, 2010). The process of muscular hypertrophy is also met with the 
activation, migration and fusion of satellite cells, by which the addition of these cells 
results in an increased myonuclei number of the existing muscle fibres (Bruusgaard 
et al., 2010). It is suggested that the addition of new myonuclei to the existing 
myofiber plays a positive role in the promotion of skeletal muscle hypertrophy in 
mammals (Phillips, 2014). Nuclei possess a domain in which they regulate the activity 
of the cytoplasm within the cell, a cytoplasmic territory that is believed to be ~ 2000 
µm2 (Petrella et al., 2008). The nuclear domain theory states that an increase in muscle 
fiber cross-sectional area is met with a complementary increase in myonuclei number 
per fiber (Bazgir et al., 2017), suggesting a positive relationship between nuclei 
addition and fiber size. Despite this theory, the reliance on myonuclei for skeletal 
muscle hypertrophy and the elucidation of cause or effect of their behaviour during 
muscle fiber remodelling, has historically been controversial (Yin et al., 2013), and 
further work is required to elucidate this theory.  
 
Muscle fibre cross-sectional area is a hallmark of muscular hypertrophy, with the 
increase in fibre cross-sectional area being well documented and reviewed previously 
(Schoenfeld, 2010, Schoenfeld, 2012). For example, 8-weeks (2 session per week for 
first 4 weeks, and 3 sessions per week thereafter) of either high or intermediate 
intensity resistance exercise (RE) (4 sets of 3-5 reps of rep max or 3 sets of 9-11 reps 
of rep max) produced an increase of ~ 12.5 %, 19.5 % and 26 % in type I, type IIa and 
type IIx fibres, respectively (Campos et al., 2002). More explorative morphological 
analysis reports that in young males, 9 weeks of high-intensity leg-extensor training 
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increased quadriceps physiological cross-sectional area by 6%, fascicle penation 
angle by 5% and quadriceps femoris activation by 3%, all of which reported as 
significant (Erskine et al., 2010b). Further, these authors report a significant increase 
(31% increase in torque production compared to baseline) in quadriceps femoris 
strength by measure of maximal voluntary contraction. Indeed, the association 
between increases in skeletal muscle strength as a result of RE stimulus has been 
observed previously (Schoenfeld, 2010, Schoenfeld, 2012). Importantly, the 
relationship between increased cross-sectional area and skeletal muscle strength has 
been implied. Where, in older adults, just 6-weeks of RE significantly increased the 
cross-sectional area of the vastus lateralis by 7.4%, with significant increases in 
physiological cross-sectional area of the quadriceps muscle showing a significant 
relationship to increases in strength (Scanlon et al., 2014). Finally, and important to 
note, that strength responses of skeletal muscle to RE has been suggested to be 
associated with large inter-individual differences (Erskine et al., 2010a).  
 
Fundamentally, the balance of muscle morphology is as a result of periods of 
anabolism and catabolism that tilt the balance between protein synthesis and 
breakdown, respectively. At the molecular level, it is known that accompanying these 
periods of anabolism and catabolism is a vast, complex and multi-faceted cascade of 
events that orchestrate the signalling activity of a number of important proteins and 
pathways. The abundance (via protein translation in the ribosome) and ultimately the 
activity of these proteins (via phosphorylation, acetylation etc.) is altered only after 
changes that occur at the DNA level, via transcription of a messenger RNA (mRNA) 
molecule (or gene) in the nucleus preceding its translocation into the ribosome to 
produce the functional protein. Therefore, the next section will briefly detail the 
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current understanding for the role of gene transcription during periods of skeletal 
muscle atrophy and hypertrophy. 
 
1.3 The Adaptive Response of Mammalian Gene Expression to Orchestrate 
Adaptive Responses During Periods of Skeletal Muscle Perturbation  
While it is observed that periods of MPS or MPB orchestrate a number of distinct 
physiological and morphological adaptations at the myofiber level, the molecular 
mechanisms that support these changes lie, in-part, at a cellular level. Upon acute 
signal, such as an RE stimulus, the expression of key gene transcripts are attenuated 
or augmented compared to baseline expression levels (Perry et al., 2010). The 
commonly accepted molecular mechanisms that govern skeletal muscle adaptation 
revolve around the acute, temporal changes in gene expression that occur following 
exposure to a specific stimulus. Upon chronic and repeated exposures of the same or 
similar stimulus, regular increases or decreases in gene expression orchestrate a 
gradual adaptation in protein content and enzyme activity and result in functional 
changes and remodelling of skeletal muscle (Perry et al., 2010, Egan and Zierath, 
2013). In accordance with this, during periods of skeletal muscle anabolism and 
catabolism, a number of distinct transcript targets have been regularly cited as having 
pivotal roles in orchestrating functional changes in muscle mass. The following 
sections provide an overview of the process of gene transcription and ultimately 
translation into the protein, before discussing our current understanding of important 
genes involved in skeletal muscle growth and loss.  
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1.3.1 Transcription, translation and biology of gene expression  
Ribonucleic acid (RNA) polymerase binds to the promotor region of a gene strand 
and dissociates the nucleotide pairings, creating two open helical deoxyribonucleic 
acid strands. The RNA polymerase molecule copies the nucleotide sequence creating 
a messenger RNA (mRNA) which encodes for a specific protein of interest. The 
copying process ends when the RNA polymerase molecule reaches the termination 
region of the gene. A complex protein structure, the spliceosome, removes the mRNA 
strand of all non-coding introns and provides a 5’ and 3’ cap onto the mRNA 
sequences. The mRNA strand then travels into the cytoplasm of the skeletal muscle 
cell, where it encounters ribosomes and the initiation of protein translation will begin. 
As previously mentioned, acute environmental stimuli (such as RE) results in either 
an increase or decreased expression (from normal basal levels) in key gene transcripts. 
Upon regular and repeated exposure to similar stimuli, such as a chronic period of RE, 
the basal level of gene expression can then increase (Perry et al., 2010) in order for 
there to be a consistently higher abundance of protein to facilitate morphological 
adaptations.  
	
1.3.2 Key regulatory signalling pathways and transcripts associated with skeletal 
muscle hypertrophy 
In order to elucidate a list of candidate genes whose differential expression (upon 
hypertrophic stimulus) is commonly associated with positive changes to skeletal 
muscle mass, studies have employed and compared transcriptome wide (RNAseq 
and/or microarrays) analyses during a variety of muscular hypertrophy models. In 
contrast to those findings found in muscular atrophy models (see below), a list of gene 
targets whose gene expression is commonly up- or down-regulated during skeletal 
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muscle hypertrophy, remains somewhat elusive. Indeed, when correlative analysis 
was performed on the transcriptome of the vastus lateralis muscle tissue in both young 
and aged individuals before and following a 12-weeks RE programme (3 sessions per 
week at 3 sets of 10 reps at 70-75% 1RM; biopsies taken pre and 4h post first and last 
training session), it was identified that >660 gene transcripts correlated with changes 
in skeletal muscle size and strength (Raue et al., 2012). When young participants were 
segregated for analysis, the same authors identified that >1,100 gene transcripts that 
were differentially regulated following a single bout of REX (4h post first training 
session) and 524 gene transcripts that were significantly differentially regulated 
following the final training session (Raue et al., 2012). Similar findings of an 
extensively dysregulated transcriptome following in-vivo REX has been shown in a 
more prolonged exercise programme of 20 weeks training (Phillips et al., 2013). 
Cross-comparative analysis of muscle hypertrophy transcriptomes following models 
of muscular hypertrophy, to identify a candidate list of genes associated with muscle 
mass and strength changes, has, however, shown divergent results (Pereira et al., 
2017). Using models of post-natal growth (2 and 4 weeks old), Akt over-expression 
and over-load in extensor digitorum longus (EDL) muscle in mice, the authors failed 
to identify a list of commonly differentially regulated gene transcripts responsible for 
muscular hypertrophy (Pereira et al., 2017). Instead, through western-blot analysis of 
the same tissue, the authors conclude that all models of skeletal muscle hypertrophy 
induced an increase in mammalian target of rapamycin (mTOR) signalling, and that 
phosphorylation of the ribosomal protein S6 kinase 1 (P70S6k1/S6K1) was increased 
across all bar one time point within the models of muscular hypertrophy (Pereira et 
al., 2017). From these data analyses, the authors collectively suggest that skeletal 
muscle hypertrophy is not, per se, associated with a common set of differentially 
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regulated transcripts. Rather, the authors suggest that muscle hypertrophy stimulus 
induces activity changes to the key mTOR signalling pathway, and that translation 
(given changes in ribosomal biogenesis activity) rather than transcriptional changes 
are a hallmark of hypertrophying skeletal muscle  (Pereira et al., 2017). Further work 
is required to develop a consensus of gene transcripts that are commonly differentially 
regulated during periods of skeletal muscle hypertrophy.  
 
Despite the elusiveness of a ‘fingerprint’ profile of candidate genes that are commonly 
differentially regulated during skeletal muscle hypertrophy, a distinct cellular 
pathway has been identified (Figure 1.4). Indeed, binding of both endogenous ligands, 
insulin and insulin-like growth factor 1 (IGF-1), to their respective receptors on the 
cellular membrane initiate a cascade of events, triggering multiple down-stream 
targets, most notably phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), and 
the mammalian/mechanistic target of rapamycin complex 1 (mTORC1; Figure 1.4) 
(Bodine et al., 2001b, Rommel et al., 2001, Sandsmark et al., 2007). Following 
resistance exercise stimulus (electrically evoked isometric contraction of the 
gastrocnemius muscle of Sprague-Dawley rats), muscle specific expression of IGF-1 
significantly increased 1h and remained elevated through to 3h post REX (Kido et al., 
2016). Similar findings have also been shown in time-course analysis in human 
subjects, with multiple IGF-1 isoforms/splice variants (IGF1-ea, IGF-1Eb and IGF-
1Ec/MGF) showing significant increases in transcriptional expression following a 
maximal knee-extensor eccentric muscle protocol (Philippou et al., 2009). 
Importantly, cell signalling work suggests that IGF-1 binding to its targeted receptor 
brings about activity changes in a cascade of kinases downstream of the cellular 
membrane, that, eventually leads to an increased activity of Akt (Bodine et al., 2001b, 
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Rommel et al., 2001). Both direct and indirect targets of activated Akt include mTOR, 
P70S6K1 and 4E binding protein 1 (4eBP1), that are important proteins involved in 
translation and muscle protein synthesis (Laplante and Sabatini, 2012, Cross et al., 
1995, Nave et al., 1999, Scott and Lawrence, 1998).  
 
A paucity currently exists within the literature for a conclusive list of candidate gene 
markers that are commonly differentially regulated during periods of muscular 
hypertrophy, and the role these targets play in regulating muscle protein synthesis. On 
the contrary, cellular and molecular response of skeletal muscle during periods of 
hypertrophy has generally focussed around the activity of known kinases and protein 
complexes (figure 1.4). 
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Figure 1.4. Cell signalling pathway for activation of mammalian target of rapamycin 
complex 1 by growth factor, hormone and amino acid activation. 	
	
1.3.3 Key regulatory signalling pathways and target transcripts identified as pivotal 
in muscle atrophy 
Transcriptomic work examining the regulatory response during periods of skeletal 
muscle atrophy has received large amounts of scientific attention. Developments in 
scientific technology, assay quality, reliability and feasibility have allowed for 
increased amounts of research focussing on the transcriptomic response to atrophy, 
with a number of genes and gene pathways being elucidated (Bodine, 2013, Bodine 
et al., 2001a, Gomes et al., 2001, Lecker et al., 2004). Among the commonly identified 
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genes are transcripts relating to the ubiquitin-proteasome pathway. The alteration in 
the regulatory behaviour of these identified genes at the protein level are thought to 
bring about the destruction, degradation and loss of muscle specific components, and 
thus are commonly referred to as ‘atro-genes’ (Lecker et al., 2004).  
 
1.3.3.1 Ubiquitin-proteasome pathway inducing muscle atrophy  
The ubiquitin-proteasome pathway is responsible for removing sarcomeric related 
structures from myofibres during periods of skeletal muscle turnover, remodelling and 
atrophy. The rate limiting step in the process of ubiquitin-proteasome dependent 
muscle fibre degradation is the E3 enzymes. Over 600 E3 protein members have been 
identified (Deshaies and Joazeiro, 2009), with a small cluster of ligases being 
identified as ‘muscle-specific’ and regularly being up-regulated during periods of 
muscle atrophy. Muscle RING finger protein-1 (MuRF1) and F-box protein only 32 
(MAFbx; Figure 1.5), otherwise known as Trim63 and Fbxo32 respectively, were the 
first two E3-ubiquitin ligases two be commonly associated with a loss of muscle mass 
during periods of atrophy. Indeed, mice lacking MuRF1 and MAFbx are resistant to 
muscle atrophy induced via denervation and exposure to the corticosteroid 
dexamethasone (DMX)  (Bodine et al., 2001a, Baehr et al., 2011), and  knockdown 
of MAFbx allows fasting mice to become resistant to muscle wasting (Cong et al., 
2011). The role and expression characteristics of these two E3-ubiquitin ligases was 
unravelled in a series of intricate studies by Bodine et al. (2001a). Indeed, the authors 
unequivocally report the upregulation of these genes during periods of muscle atrophy 
evoked via denervation, DMX exposure, immobilization and unloading in rodents 
(Bodine, 2013, Bodine et al., 2001a), systematically confirming the induction of these 
two atro-genes during a number of models of muscle loss. The common up-stream 
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regulator of both MuRF1 and MAFbx is the muscle specific basic helix-loop-helix 
(bHLH) transcriptional factor and a member of the myogenic regulatory factors 
(MRFs), myogenin (MyoG; figure 1.5). Previous work has identified a regulatory link 
between MyoG induction and the increased expression and activity of the downstream 
E3 ubiquitin ligases, MuRF1 and MAFbx (Cohen et al., 2007). MyoG is a highly 
conserved muscle specific protein that is commonly associated with the coordination 
of skeletal muscle development/myogenesis or skeletal muscle regeneration, and 
specifically the differentiation/fusion of skeletal muscle cells (Le Grand and 
Rudnicki, 2007). The expression of MyoG is required for maximal activation of 
MuRF1 and MAFbx, and is therefore suggested as having a dual role in the regulation 
of muscle (Moresi et al., 2010). Forkhead box O (Foxo) is a sub complex of transcripts 
to the larger forkhead transcription factor family, whose activity has been implicated 
in apoptosis and skeletal muscle atrophy and closely linked to the E3 ubiquitin ligases 
MuRF1 and MAFbx (figure 1.5). In skeletal muscle, Akt phosphorylates the three 
known mammalian isoforms of Foxo attenuating their translocation into the nucleus 
and therefore inhibiting their contact with target genes for normal transcription 
processes (Brunet et al., 1999). This is confirmed by targeted dephosphorylation of 
Foxo isoforms that permits its nuclear entry, increasing the transcriptional expression 
of MuRF1 (Sandri et al., 2004) and the upregulation of apoptosis (Ramaswamy et al., 
2002). The importance and necessity of Foxo isoforms in producing skeletal muscle 
atrophy was demonstrated in a series of in-vitro studies examining their role in fasting, 
diabetes, uraemia and cancer related muscle atrophy (Lecker et al., 2004, Sandri et 
al., 2004, Furuyama et al., 2003).  
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A large amount of research has investigated the altered expression of a number of 
target transcripts and activity of key cellular pathways during periods of muscular 
anabolism and catabolism. Despite the vast amount of research, the precise 
mechanisms that regulate these processes are still poorly understood and inadequately 
described. Furthermore, recent breakthroughs in the field of skeletal muscle 
epigenetics has elucidated an important and as yet under-reported role for epigenetics 
in regulating gene expression involved in the regulation of muscle metabolism and 
mass. Given the aim of this thesis project, the remaining literature review sections 
will focus on our current understanding of epigenetics, its role in skeletal muscle and 
the potential role of epigenetics in skeletal muscle programming or ‘memory’.  
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Figure 1.5. Schematic representation of the cellular mechanisms induced upon 
skeletal muscle atrophy. A. Cell signalling pathways of transcripts that are known to 
play an important role in protein degeneration, as activated via TNF-alpha, 
interleukins and denervation. B. The molecular process of proteolysis via the ubiquitin 
ligases (E1, E2 and E3) and the 26S proteasome complex. Regulatory networks are 
detailed in section 1.3.3.    
 
1.4 Skeletal Muscle Epigenetics  
The study of epigenetics has rapidly developed over the last 50 years; before which it 
was a generic term referring to the development of the original fertilized zygote 
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through to the mature mammalian organism (Waddington, 1953). However, through 
scientific development, the field of epigenetics has taken a more uniform and finite 
domain. Indeed, our current understanding of epigenetics has led to the working 
definition that is mitotically and/or meiotically heritable changes in gene behaviour 
that are not due to changes in DNA sequence, however this definition is, itself, 
continuing to evolve (Berger et al., 2009). Epigenetics is a biochemical process that 
occurs in a number of macromolecular loci within the mammalian genome, that serves 
to chemically modify these loci, and in doing so, alters gene expression. In order to 
review the current literature focusing on epigenetics and its role in skeletal muscle, a 
narrative is given of the basic biological structure of chromatin, histones and DNA, 
the location in which epigenetic regulation predominantly occurs.  
	
1.4.1 Chromatin, histone and DNA 
All eukaryotic cells contain a nucleus that houses all the molecular blueprints required 
to create a living cellular structure. Skeletal muscle cells, like other eukaryotic cells, 
contain 23 paired chromosomes. Chromosomes are DNA and histone based molecules 
that include all of the genetic material of an organism’s genome. The chromosome 
consists of a chromatin fibre that, itself, is made up of multiple amounts of 
macromolecule complexes known as nucleosomes (Figure 1.6). The nucleosome is a 
compound of histones in an octamer like structure that allow the DNA to wrap around 
the outer side of its structure to condense the DNA strand down into tightly packed 
units. Histone tails disperse from the individual histone units and running a number 
of amino acids long which creates a site for epigenetic modification (Bannister and 
Kouzarides, 2011). The chromatin structure resides into two major functional states. 
Euchromatin translates to a more open and transcriptionally active chromatin state, in 
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which the nucleosome structures open apart from one another, allowing the binding 
of transcriptional proteins to specific strands of DNA (Allis and Jenuwein, 2016). 
Conversely, heterochromatin conveys a more closed chromatin state, in which DNA 
strands are protected from transcriptional or modifying machinery (Allis and 
Jenuwein, 2016). The process of inducing either a euchromatin or heterochromatin 
state has been identified to be a highly conserved phenomenon, in which epigenetics 
has, in part, been suggested to play an important regulatory role (Bannister and 
Kouzarides, 2011, Allis and Jenuwein, 2016).  
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Figure 1.6. Composition and Structure of Chromosome, Chromatin, Nucleosome 
and DNA Network in Mammalian Cells. Taken from Tonna et al. (2010).  
 
1.4.2  Epigenetics and DNA methylation  
Epigenetics, translated means ‘above genetics’, and by definition is the study of 
mitotically and/or meiotically heritable changes in gene behaviour that are not due to 
changes in DNA sequence (Bird, 2007, Bird, 2002, Jaenisch and Bird, 2003). These 
modifications occur on multiple sites within the cell nucleus, most important of which 
are at histone and DNA loci. The amino acid N-terminal tails that protrude from the 
core histones means they are readily available for epigenetic modifications such as 
methylation (increased methylation state; hypermethylation), demethylation 
(decreased methylation state; hypomethylation), acetylation, deacetylation, 
phosphorylation, sumoylation, ubiquitination, ADP-ribosylation and citrullination 
(Bannister and Kouzarides, 2011). Alternatively, epigenetic modifications that occur 
at the DNA level are more limited, with the most characterised and biologically 
prominent modification being DNA methylation (Bird, 1986).  
 
DNA methylation attaches a methyl molecule to the 5’ position of a cytosine 
nucleotide located at a cytosine-phosphate-guanine (CpG) dinucleotide pairing, 
creating a 5-methyl-cytosine (5mC) residue (Figure 1.7). When hypermethylation 
occurs (increased DNA methylation) in important regulatory regions of a gene 
transcript, this type of epigenetic modification commonly leads to a reduction in its 
expression, via two known methods. Attachment of a methyl-molecule co-attracts the 
addition of CpG methyl binding proteins (MBD) to the promotor region of the gene, 
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blocking the binding of RNA polymerase and subsequently attenuating the 
transcription phase of gene expression (Bogdanovic and Veenstra, 2009). The second 
process is via the incorporation of chromatin remodelling protein methyl CpG binding 
protein (MeCP1/ MeCP2) that, via binding with the transcriptional-repressor domain 
(TRD) and co-incorporation of SIN3 transcriptional regulator family member A 
(SIN3a) and histone deacetylases, leads to a heterochromatin structure (Nan et al., 
1997, Nan et al., 1998, Jones et al., 1998) supressing the expression of genes. 
Therefore, where strands of DNA are hypermethylated or hypomethylated, it would 
suggest that the genes effected by this epigenetic modification have reduced or 
enhanced expression, respectively. Other DNA methylation sites have been 
uncovered, notably, intragenic DNA methylation, however their role in modulating 
gene expression is less well understood. The process of DNA methylation is 
orchestrated via a group of enzymes called DNA methyltransferases. De-novo 
methyltransferases 3a and 3b (DNMT3a/3b, respectively) are able to methylate non-
methylated cytosine residues via the donation of a methyl group from s-adenosyl 
methionine (SAM), producing 5mC and s-adenosyl homocysteine (SAH; Figure 1.7) 
(Trasler et al., 2003). To remove the cytosine modification (Figure 1.7), the ten-eleven 
translocation methylcytosine dioxygenase 1 (TET 1) enzyme and other members of 
the TET protein family, catalyse the conversion of 5mC to 5-hydroxy-methyl-
cytoseine (5hmC) via oxidation of 5mC in an iron and alpha-ketoglutarate dependent 
reaction (Ito et al., 2010). Importantly, DNMT 3a/b are largely considered de novo by 
nature and induce an epigenetic modification that is considered to be relatively 
transient. Whereas, DNA methyltransferase 1 (DNMT 1) is considered the stabilising 
methylation modification enzyme, whereby during DNA replication DNMT1 
localises to replication foci and hemi-methylated DNA strands are synthesised. Upon 
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selective binding to specific hemi-methylated CpG (hCpG) loci, DNMT1 replicates 
the exact epigenetic modification that preceded at this site, prior to DNA replication 
(Pradhan et al., 1999, Ramsahoye et al., 2000, Leonhardt et al., 1992). Via this 
process, DNMT 3a/b are considered de novo in which they orchestrate initial DNA 
methylation, and DNTM1 is considered the enzyme that creates a stabilised 
modification sufficient to be passed onto daughter generations of cells (Probst et al., 
2009). Interestingly however, recent evidence suggests that the clear definitive role of 
the DNMT 1, 3a and 3b is somewhat ambiguous. Indeed, evidence is apparent that 
DNMT 1 may also play a role in de novo methylation of genomic DNA (Egger et al., 
2006), and that DNMT 3a may also play a role in maintaining the cytosine 
modification (Riggs and Xiong, 2004). Further work is needed to fully characterise 
the roles the enzymes play in initiating and stabilising DNA epigenetic modifications.  
	
Figure 1.7. Biochemical reactions that create hypo- or hyper-methylated DNA at CpG 
genomic loci. Briefly, DNMT3a/b attach a methyl-molecule to 5th position of the 
cytosine nucleotide, via donation from s-adenylmethionine (SAM), rendering 5-
methyl-cytosine (5mC) and therefore resulting in DNA methylation. Through the 
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Ten-Eleven-Translocase 1 enzyme (TET1), 5mC is converted in 5-hydroxymethyl-
cytosine and undergoes DNA de-methylation through base excision repair processes. 
 
DNA methylation has previously been shown to play a regulatory role in a number of 
biological and pathological processes, most prominent of which is X chromosome 
inactivation, tumorigenesis and cancer progression (Jones and Baylin, 2007, McCabe 
et al., 2009, Jin et al., 2008, Jin et al., 2009, Gopalakrishnan et al., 2008, Robertson, 
2005). However, more recently, its role in modulating muscle specific gene 
expression has become of significant interest, with findings suggesting that DNA 
methylation may play a role in regulating gene expression and is associated with 
alterations in physiological response in skeletal muscle to environmental stress.  
 
1.4.3 Alterations to DNA methylation in mammalian skeletal muscle  
The association of DNA methylation alterations in response to exercise have been 
explored in a number of biological tissues (Voisin et al., 2015). However, with respect 
to skeletal muscle, the field of epigenetics is still very much in its infancy. The 
investigative work that has been performed has focused mainly on the adaptive 
response to either acute/ chronic aerobic exercise. Indeed, following on from findings 
suggesting that hypermethylation of the peroxisome proliferator activated receptor 
gamma co-activator 1-alpha (PGC1-a) resulted in a reduced mitochondrial content in 
patients suffering from type II diabetes (T2D) (Barres et al., 2009), the same authors 
report aberrant DNA methylation patterns in the promotor regions of important 
mitochondrial related genes, following acute aerobic exercise (Barres et al., 2012). 
Indeed, acute aerobic exercise at 80% of maximal aerobic capacity, induces 
significant hypomethylated profiles of genes PGC1-a, mitochondrial transcription 
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factor A (TFAM) and pyruvate dehydrogenase lipoamide kinase isozyme 4 (PDK4) 
immediately following the termination of exercise, and a reduction in PPAR-δ DNA 
methylation 3 hrs post exercise. This reduction in DNA methylation corresponded 
with a time-dependent reduction in gene expression (Barres et al., 2012). In support 
of this work, Lane et al. (2015) report that after 120-min of steady state aerobic 
exercise (60 % VO2 peak), an increased DNA methylation profile of fatty acid-
binding protein 3 (FABP3) 4h into recovery corresponded to a reduction in gene 
expression (Lane et al., 2015). These data collectively suggested that aerobic exercise 
is sufficient to induce alterations to DNA methylation, that coincide with changes in 
gene expression, of important metabolic transcripts. Similarly, chronic exposure to 
aerobic based training stimuli have been reported to have a significant effect on DNA 
methylation patterns in the mammalian genome. A six-month training intervention, 
consisting of predominantly aerobic based exercises, 3 times a week for 1-hour per 
session, produced 134 differentially methylated genes, with 115 of these genes 
showing significantly decreased DNA methylation profiles (Nitert et al., 2012). 
Suggesting that chronic exposure to aerobic based training interventions induces 
large-scale changes in the human epigenome, preferentially favouring a 
hypomethylated modification.  
 
DNA methylation changes have also been observed at specific CpG site loci, 
independent to global methylation changes in the gene of interest. Indeed, an initial 
experiment by King-Himmelreich et al. (2016), undertook 4 weeks of aerobic based 
exercise training (5 days per week, comprising of jogging, Nordic walking and 
climbing) in humans and demonstrated significant changes in loci-specific CpG sites 
of the gene alpha 2 subunit of the AMP-activated protein kinase (AMPKa2) (King-
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Himmelreich et al., 2016). In continuation of this initial work, the same authors 
exposed male C57BL/6 mice to a bout of acute exercise (1 hour at a running speed of 
10.2m/ min to all subjects), before analysing skeletal muscle for epigenetic, transcript 
and protein profiles, 30-mins following exercise termination. Interestingly, the 
authors report that 3 out of the 7 CpG sites analysed within the first exon of the 
AMPKa2 gene presented greater DNA methylation when compared to un-exercised 
controls (King-Himmelreich et al., 2016). The increased DNA methylation of specific 
sites of the AMPKa2 exon corresponded with attenuated gene transcript expression, 
and protein abundance via qRT-PCr and Western Blot analysis, respectively (King-
Himmelreich et al., 2016). Importantly, this work identifies that changes in DNA 
methylation at a small number of CpG sites of a transcript are sufficient to produce 
alterations in gene and protein expression, findings that have also been identified 
elsewhere in rodents (Laker et al., 2014). Where, a maternally fed high fat diet (60% 
caloric intake in fat) induced a hypermethylated profile of CpG site -260 within the 
promotor region of PGC-1α, detected at birth and persisting to 12-months of age in 
offspring, that correlated with a trend for reduction in PGC-1α gene expression (Laker 
et al., 2014).  
 
In attempts to understand greater the role DNA methylation plays in modulating the 
mammalian genome, research studies have begun to utilise epigenome wide 
approaches during periods of exercise or nutrient manipulation. For example, a 6-
month aerobic exercise intervention in healthy male subjects and male subjects who 
had hereditary T2D, demonstrated that 17,975 individual CpG sites displayed a 
significantly differentially regulated methylation signature (Ronn et al., 2013), from 
DNA samples obtained from adipose tissue. The same authors report that 18 and 21 
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gene transcripts displayed significantly altered DNA methylation profiles for obesity 
and type 2 diabetes respectively, with a number of these candidate genes displaying 
inverse relationships with gene expression (Ronn et al., 2013). Further work has 
overlapped the epigenome and the transcriptome to elucidate the response to a period 
of exercise training. Following 3 months of aerobic exercise training in one leg, 
muscle samples from the vastus lateralis were analysed for their epigenomic and 
transcriptomic profiles (Lindholm et al., 2014). The authors reported a significant 
alteration in DNA methylation of intergenic regions, motifs and enhancer regions of 
gene transcripts, that inversely corresponded to gene expression and enhanced 
performance (greater average wattage compared to control limb) during a 15-min 
maximal one-legged performance cycle test (workload was modified throughout to 
keep a continued cadence of 60 rpm). Collectively, the authors suggest that following 
continuous exposure to aerobic stimulus, highly correlative modifications in the 
human epigenome and transcriptome orchestrate functional changes in skeletal 
muscle that bring about enhanced performance at a whole tissue level (Lindholm et 
al., 2014). Finally, investigative work has shown that even relatively acute periods of 
external stimuli are sufficient to produce large scale adaptions of the epigenome. 
Indeed, after only 5 days of high fat feeding (50% extra calories of which 60% came 
from fat) altered the DNA methylation profile of 6,508 genes of the 14,475 studied 
(Jacobsen et al., 2012). More interestingly, the authors demonstrated a slow return of 
DNA methylation profiles of the most differentially regulated candidate genes when 
the high fat diet was removed. Where, out of 10% of the genes previously studied 
during the high fat diet, 66% displayed a methylation pattern whose direction of 
change (i.e. hypo- or hypermethylated) reverted back towards control levels. Of these 
however, only 5% reported a significant change in methylation pattern, suggesting a 
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slow reversibility in the profile of DNA methylation during exposure to a high-fat diet 
(Jacobsen et al., 2012). Furthermore, the authors identified that following the initial 
encounter with a high fat diet (5 days overfeeding), the gene expression of the 
methyltransferase enzymes, DNMT1 and 3a (de novo and maintenance of methylation 
respectively), were significantly elevated. Together, these studies suggest that both 
acute and chronic high fat diets lead to large and significant alterations to the 
epigenome that correlate closely to alterations in gene expression. 
 
It is clear that a strong association exists for DNA methylation in modulating the 
adaptive response of mammalian skeletal muscle, in response to a number of different 
environmental stimuli. However, the field of skeletal muscle epigenetics is in its 
infancy. For example, before 2009 there has been no official publications recorded 
when searching for the terms of “skeletal muscle and epigenetics” (Figure 1.8A) in 
the National Centre for Biotechnology Information ‘PubMed’ database. Interestingly 
however, when refining the terminology to “skeletal muscle and DNA methylation” 
a slightly greater number of publications is reported (Figure 1.8B), but even here, 
prior to 2009 a total of 103 papers (in a 25-year period) had been published when 
searching for these terms, averaging just over 4 papers annually between the years of 
1984 and 2008 (Figure 1.8B). What is also interesting is that this area of research is 
rapidly expanding, with a clear exponential increase in the sheer number of 
publications (both search criteria) from 2011 onwards. Indeed, 2016 saw a ~445% 
increase in the amount of publications published when searching for skeletal muscle 
epigenetics, and a ~180% increase when searching for skeletal muscle DNA 
methylation, when compared to publications in the year 2011 (Figure 1.8A and 1.8B, 
respectively).  Nonetheless, distinct paucities exist in our current understanding of 
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skeletal muscle epigenetics and specifically the role of DNA methylation. For 
example, it has recently been hypothesised that skeletal muscle may be programmable 
or possess a ‘memory’, defined by (Sharples et al., 2016b) as: ‘The capacity of skeletal 
muscle to respond differently to environmental stimuli in an adaptive or maladaptive 
manner if the stimuli have been previously encountered.’ This concept has been 
ascribed, in part, to epigenetic modifications. Therefore, the next part of this literature 
review will focus on the potential role of epigenetic modifications in retaining the 
biological information generated from earlier periods of muscle atrophy and 
hypertrophy – in analogous to a memory effect.   
	
Figure 1.8. Research interest into skeletal muscle epigenetics (A) and skeletal muscle 
DNA methylation (B) as indicated via number of publications annually. Data acquired 
from PubMed (National Centre for Biotechnology Information) searches for terms 
‘skeletal muscle and epigenetics’ and ‘skeletal muscle and DNA methylation’. Data 
accurate as of 2017-11-09. 	
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1.5 Epidemiological Evidence That Mammalian Skeletal Muscle Possesses a 
Memory of Earlier Stimulus  
1.5.1 Early life encounters effect long term skeletal muscle phenotypes  
Epidemiological evidence suggests there is a distinct association between low-birth 
weight and deleterious outcomes in skeletal muscle functionality and morphology. 
Indeed, low birth weight in humans has regularly been associated with reductions in 
later life grip strength, as a marker for muscle functionality (Inskip et al., 2007, Sayer 
et al., 2008, Sayer et al., 2004). Grip strength itself has further been associated with 
overall health, with reductions in grip strength being linked with heart disease, type II 
diabetes and deleterious metabolic conditions (Rantanen, 2003, Rantanen et al., 2002, 
Rantanen et al., 1999). Furthermore, low-birth weight has been associated with 
significant reductions in skeletal muscle mass into later-life. Indeed, large cohort 
analysis of >900 male subjects found that a reduction of 1kg in birth weight correlated 
to a 4.1kg reduction in skeletal muscle mass, later on in life (Yliharsila et al., 2007). 
Collectively, these findings suggest that the early life phenotype, may have a long-
lasting effect on the development of the mammalian organism. In agreement with 
these conclusions, in-utero nutrient manipulation during gestation has been shown to 
alter the development of the off-spring into later life, a phenomenon termed foetal 
programming. Indeed, at the tissue level, reduction of 60% of total calorie 
consumption in adult guinea pigs resulted in significant reductions in the offspring’s 
birth weight together with a reduction of 20% myofiber number in biceps brachii 
(Dwyer and Stickland, 1992, Ward and Stickland, 1991). Similar findings were 
identified in a rat model, where 50% reductions in body and organ weight were 
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observed following a 50% reduction in gestational nutrient availability during day 7 
– 21 (Garofano et al., 1998). As well as total weight, in-utero nutrient manipulation 
has also been shown to have a large impact on the fibre type composition in skeletal 
muscle. As evident in new born rats exposed to a 30% reduction in calories during 
gestation, resulting in significantly fewer fast type muscle fibres in both the soleus 
and lumbrical muscle groups of the progeny, when compared to controls (Wilson et 
al., 1988). Interestingly, re-feeding of the mothers during lactation was unable to 
rescue the fibre composition alterations in the soleus muscle, suggesting that altered 
programming was sufficient to be retained even upon reversal of nutrient availability 
(Wilson et al., 1988). Furthermore, work in ewes has reported that a global reduction 
of 50% maternal nutrition (between days 30-70 of gestation) resulted in a fibre 
compositional alteration, favouring an increase in slow twitch fibres and a reduction 
in fast twitch fibres, 14 days after birth (Fahey, 2005 ). These data collectively suggest 
that in-utero manipulation of total calorie availability leads to altered responses in the 
skeletal muscle in the offspring. Similar conclusions have also been identified during 
protein restriction during gestation (Mallinson et al., 2007, Hales and Barker, 1992, 
Snoeck et al., 1990).  
 
1.5.2 Evidence of a cellular skeletal muscle memory  
Seminal in-vivo work from Egner and colleagues identified that skeletal muscle 
retains myonuclei following a period of earlier muscle growth (Egner et al., 2013). 
Using a mouse model, following a period of exercise induced overload they reported 
a retention of myonuclei number in mice during the ensuing period of denervation-
induced atrophy (Bruusgaard et al., 2010). The follow up work administered 
testosterone to provide a hypertrophic stimulus to increase muscle mass size, in which 
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an increased myonuclei number accompanied the increase in muscle mass. Similar to 
the previous work, a retention of this myonuclei number was observed during a 
subsequent period of muscle wasting, where removal of steroidal exposure reduced 
muscle mass back towards baseline. Importantly however, when the rodents that had 
experienced the early testosterone encountered a later period of mechanical overload, 
they were able to increase muscle mass size more efficiently and rapidly compared to 
rodents who had not experienced the earlier encounter with testosterone, thereby 
acting as relevant controls (Egner et al., 2013). Indeed, the rodents that were exposed 
to both the early (testosterone) and late (overload) anabolic stimuli, presented a 31 % 
increase in muscle fibre cross-sectional area over a period of 6 days compared to 
controls, who showed no significant increase in the same time period. Importantly, 
these studies suggest that skeletal muscle has the capability to increase myonuclei 
number following earlier hormone induced hypertrophy, and retain this number even 
during periods when muscle returns to baseline levels following stimulus withdrawal. 
Following, this adaptation at the level of the myonuclei therefore provides the 
opportunity for skeletal muscle to hypertrophy more quickly when encountering later 
muscle growth stimuli. This is suggestive, given the earlier definition of a skeletal 
muscle memory. Given that retention of epigenetic modifications can occur in skeletal 
muscle, such as 30 days after the termination of a 5 day high fat diet discussed above 
(Jacobsen et al., 2012), it is feasible that epigenetic modifications to the DNA of cell 
nuclei can be retained following earlier periods of growth, even during periods when 
muscle returns to a pre-growth amount.  
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1.5.3  Skeletal muscle cells remember the niche in which they are derived  
Together with the above work identifying a cellular retention in skeletal muscle, there 
have been important in-vitro based studies that show skeletal muscle cells retain 
information from the in-vivo niche in which they were derived, a process where 
epigenetics has begun to be elucidated as an important factor.  It was first revealed by 
members of my supervisory team, that skeletal muscle stem cells isolated from 
patients suffering from cancer exhibit inappropriate proliferation compared to age-
matched healthy control cells (Foulstone et al., 2003a). Importantly, at the cellular 
level, it was identified that the gene encoding for insulin like growth factor binding 
protein 3 (IGFBP-3) displayed impaired expression resulting in dysregulated cell 
retrieval in the cells derived from cancer patients (Foulstone et al., 2003a). Since this 
work, further studies have confirmed the findings that cells derived from different 
patients retain altered behavioural characteristics when cultured in-vitro. Indeed, 
myotubes grown from muscle-derived stem cells isolated from obese patients exhibit 
an altered relocation of the fatty acid translocase protein, resulting in a greater 
intramyocellular lipid content (Aguer et al., 2010). Further work in satellite cells 
derived from obese patients suggests that upon lipid over-supply in-vitro, these cells 
display a differential gene expression compared to those of cells isolated from healthy 
humans (Maples and Brault, 2015). Morphologically, muscle-derived cells from in- 
utero growth-restricted foetuses demonstrate weaker proliferative capabilities vs. 
controls (Yates et al., 2014). Furthermore, cells taken from nutrient-restricted prenatal 
mice or a postnatal high-fat diet (60 % of total caloric intake) exhibit a significant 
reduction in the number of derived precursor cells, with these cells displaying an 
attenuated ability to regenerate post trauma (induced via 5s dry-ice exposure to belly 
of TA muscle) (Woo et al., 2011). Collectively, these studies suggest that at a 
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morphological, behaviour and cellular level, skeletal muscle derived stem cells 
remember the niche in which they were isolated from and demonstrate altered 
responses when encountering different environmental insults in-vitro vs. relevant 
control cells. However, the precise mechanisms by which this retention of their 
environmental niche is poorly understood and require further elucidation.  
 
1.5.4  The role of DNA methylation in skeletal muscle memory 
To the author’s knowledge, only one study has investigated the hypothesis as to 
whether skeletal muscle possesses an epigenetic memory (Sharples et al., 2016a). The 
authors utilised an in-vitro model, in which murine myoblasts were cultured in the 
presence or absence of the inflammatory cytokine, TNF-a, cultured for 30 population 
doublings before experiencing a secondary stimulus of the same cytokine. 
Importantly, at the morphological and biochemical level, it was reported that cells 
exposed to both early and late TNF-a treatments displayed significantly reduced 
myotube number and reduced creatine kinase activity compared to control cells that 
only experienced the late dosage. It was further reported that epigenetic modifications 
of the myogenic regulatory factor, MyoD, that were generated following acute early 
life exposure to TNF-a, were retained even after 30 population doublings in specific 
CpG regions (Sharples et al., 2016a). Collectively, these data suggest that murine 
myoblasts retain biological information acquired from early life encounters with the 
catabolic cytokine, with this retention manifesting into a higher susceptibly to 
myofiber size reductions upon later life TNF-a exposure. It also suggests that even 
after an acute early life exposure (24-hrs) and extensive replicative aging (30 
population doublings) that DNA methylation tags are able to be retained. It is to be 
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noted that upon secondary exposure to TNF-a no further adaptations in MyoD gene 
expression nor DNA methylation were observed.  
 
Nonetheless, this work was the first to directly explore the concept of ‘epigenetic 
muscle memory’, reporting intriguing findings. As yet however, no further work has 
explored this concept in-vivo, and thus, further investigative work is warranted.   
 
1.6 Thesis Research Project 
1.6.1 Research project aims 
Given that skeletal muscle cells seem to undergo epigenetic modifications in atrophic 
conditions we first wished to identify the epigenetic modifications that occur during 
muscle atrophy in-vivo. Therefore, we aimed to:  
 
1. Investigate the role of DNA methylation in skeletal muscle atrophy using an in-
vivo tetrodotoxin nerve silencing system in rodents to model disuse atrophy over a 
period of 14 days.  
 
Furthermore, because epigenetic modifications have been shown to be retained for a 
significant period of time following atrophic exposures, we aimed to:  
 
2. elucidate whether these epigenetic modifications were retained or returned to 
normal with 7 d of full active recovery in the same animals. 
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We next wished to explore the concept of epigenetic retention in skeletal muscle of 
human participants and the role DNA methylation played in orchestrating this 
phenomenon, especially given previous work elucidating a cellular based 
phenomenon in rodents, as described above. We therefore aimed to;   
 
3.  Investigate whether an epigenetic muscle memory of hypertrophy occurs in human 
skeletal muscle in-vivo, using chronic resistance exercise (loading), followed by 
cessation of exercise (unloading), and finally a subsequent later chronic resistance 
exercise programme (reloading), thus allowing the elucidation of the underlying 
epigenetic alterations that occur after muscle hypertrophy (loading), a return of 
muscle back to baseline size (unloading) and a secondary anabolic encounter 
(reloading), respectively.   
 
 
Finally, given evidence described above that epigenetic modifications are 
dynamically altered post-acute aerobic exercise stimulus, we wished to elucidate the 
extent to which acute resistance exercise modifies the human methylome and whether 
these modifications may exist as early biological markers of later life adaptation to 
resistance exercise induced muscle hypertrophy. Therefore, we aimed to; 
 
4. Explore modifications to genome wide DNA methylation following a single bout 
of resistance exercise in previously untrained human subjects (acute RE), and 
correlate these modifications to changes in the DNA methylation and gene expression 
following chronic resistance exercise induced hypertrophy (loading) and later life 
reloading induced muscle growth (data derived in aim 3 above). 
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The overarching aim of this thesis was to produce novel data in the field of skeletal 
muscle epigenetics in order to aid in the development of our current understanding of 
the epigenetic mechanisms that govern skeletal muscle adaptations. 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Chapter 2 
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Materials and Methodologies  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1      Tetrodotoxin Exposure of the Tibialis Anterior Muscle in Rodents 
2.1.1 Wistar rats 
Wistar rats from Fisher (2012) weighing between 350 – 450 g were utilised for 
experimentation, and housed in controlled conditions of 20oC, 45% relative humidity 
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with food and water available ad libitum. Rats were grouped into five experimental 
conditions including one control group (CON), three groups were exposed to 
tetrodotoxin (TTX) administered to the peroneal nerve in one hind limb (detailed 
below) for 3, 7 and 14-days (d). A final group was exposed for 14-d to TTX followed 
by TTX removal and 7 days of habitual physical activity. The rats’ general welfare 
was routinely checked and their mobility was minimally affected during 
experimentation.  
 
2.1.2  Implantation of TTX delivery unit and common peroneal nerve block model 
In rats exposed to TTX, a mini-osmotic pump (Mini Osmotic Pump 2002, Alzet, 
Cupertino CA, USA) was implanted subcutaneously in the scapular region, as 
previously described (Jarvis and Salmons, 1991, Fisher, 2012). Delivery tubes were 
then subcutaneously channelled to a silicone rubber cuff that was carefully placed 
around the common peroneal nerve of the left hind limb of the rodent. Implantation 
was performed as an in house modification of previous work (Michel and Gardiner, 
1990). The osmotic pump efficiently delivered 0.5 µl/hr of TTX (350 µg/ml in sterile 
0.9 % saline) to the delivery cuff unit allowing the common peroneal nerve to be 
exposed to TTX at a consistent rate. TTX exposure resulted in the ankle dorsiflexor 
muscles (tibialis anterior and extensor digitorum longus) to be silenced, but normal 
voluntary plantarflexion was maintained. Following correct assembly of TTX 
delivery apparatus, rats were subjected to 3, 7 or 14 days (d) of TTX exposure, with 
a further group under-going 14d TTX exposure with a subsequent 7d of TTX 
cessation where normal habitual physical activity resumed. At the end of each 
experimental time course, all animals were humanely euthanized with increasing CO2 
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concentration and cervical dislocation, in accordance with the Animals (Scientific 
Procedures) Act 1986. 
 
2.1.3 Muscle harvesting procedure and treatment 
Following termination of the animals, the TA muscle was harvested, placed on a 
sterile petri dish and dissected into adequate sections for downstream histological, 
gene expression and DNA analysis. For histological analysis, samples were mounted 
and frozen onto cork in isopentane before being stored at -80 oC. Samples required for 
downstream molecular analysis of RNA and DNA (microarray, RT-PCR and 
pyrosequencing), were snap frozen in liquid nitrogen before being stored in -80 oC, 
ready for further analysis.  
 
2.2 Human Skeletal Muscle Resistance Training Studies 
2.2.1 Participants 
Eight healthy males gave written, informed consent to participate in the study, 
following successful completion of a readiness to exercise questionnaire and a pre-
biopsy screening as approved by a physician. Inclusion criteria for all human studies 
were: 
i. Male volunteers - to avoid changes in muscle function as a consequence 
of menstrual cycle (Sarwar et al., 1996) and the known variability between 
genders in the response to resistance exercise training (Ivey et al., 2000, 
Tracy et al., 1999) 
ii. Aged 18 – 40 
iii. Free from known medical conditions 
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iv. Having not previously taken part in any form of structured resistance 
exercise 
v. Able to successfully pass both readiness to exercise questionnaire and pre-
biopsy medical screening.  
 
One participant withdrew from the study at experimental week 17 of 21, for reasons 
unrelated to this investigation. However, consent allowed samples to be analysed prior 
to withdrawal, therefore for this participant this included all conditions excluding the 
final reloading condition (described below). Ethical approval was granted by the NHS 
West Midlands Black Country, UK, Research Ethics Committee (NREC approval no. 
16/WM/0103).  
 
2.2.2 Experimental design   
Using a within subject design eight previously untrained male participants (27.6 ± 2.4 
yr, 82.5 ± 6.0 kg, 178.1 ± 2.8 cm, means ± SEM) completed an acute bout of resistance 
exercise (acute RE), followed by 7 weeks (3d/week) of resistance exercise (training), 
7 weeks of exercise cessation (detraining) and a further period of 7 weeks (3d/week) 
resistance exercise (retraining). Graphical representation of experimental design is 
provided in Figure 2.1. Whole-body fan beam dual-energy x-ray absorptiometry 
(DEXA), strength of the quadriceps via dynamometry and muscle biopsies from the 
vastus lateralis for RNA and DNA isolation were obtained at baseline, after 7 weeks 
training (beginning of week 8), 7 weeks detraining (end of week 14) and 7 weeks 
retraining (beginning of week 22). A muscle biopsy was also obtained 30 minutes 
after acute RE prior to 7 weeks resistance exercise/training.  
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2.2.3 Resistance Exercise Protocols for Acute Loading & Chronic Loading, 
Unloading and Reloading   
Untrained male subjects initially performed an exercise familiarization week, in 
which participants performed all exercises with no/low load to become familiar with 
the exercise movements (detailed below). In the final session of the familiarization 
week, the load that participants could perform 4 sets of 8-10 repetitions for each 
exercise was assessed. Due to participants being un-customized to resistance exercise, 
assessment was made on competence of lifting technique, range of exercise motion 
and verbal feedback. Subsequently, starting load was set for each participant on an 
individualised basis.  Three to four days later, participants then undertook a single 
bout of lower limb resistance exercise (acute RE) followed by biopsies 30-mins post 
exercise. Following this single bout of acute RE they then began a chronic resistance 
exercise program (training), completing 60-min training sessions (Monday-
Wednesday-Friday), for 7 weeks, with 2 sessions/week focusing on lower limb 
muscle groups (Monday and Friday) and the third session focusing on upper body 
muscle groups (Wednesday). Lower limb exercises included, behind head barbell 
squat, leg press, leg extension, leg curl, Nordic curls, weighted lunges and calf raises. 
Upper limb exercises included, flat barbell bench press, machine shoulder press, 
latissimus dorsi pull down, bent over dumbbell row and triceps cable extension. To 
ensure progression in participants with no previous experience of resistance exercise, 
a progressive volume model was adopted (Peterson et al., 2011) in which investigators 
regularly assessed competency of sets, reps and load of all exercises. Briefly, 
exercises were performed for 4 sets of 10 reps in each set, ~90-120s in between sets 
and ~3 mins between exercises. When participants could perform 3 sets of 10 
repetitions without assistance and with the correct range of motion, load was increased 
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by ~5-10% in the subsequent set and participants continued on this new load until 
further modification was required. Where subjects failed to complete 10 full 
repetitions (usually for their final sets), they were instructed to reduce the load in order 
to complete a full repetition range for that set or the subsequent set. Total weekly 
volume load was calculated as the sum of all exercise loads;  
 
 
Equation 1. Equation to identify the total exercise volume undertaken by human 
participants during the resistance loading programmes. 
 
The acute RE session resulted in a total load of 8,223 kg (±284). Thereafter, the 
loading and reloading phases resulted in a progressive increase in in training volume 
(± SEM) of 2,257 ± 639 kg and 2,386 ± 222 kg respectively per week. Loading and 
reloading programs were conducted in an identical manner, with the same exercises, 
program layout (same exercises on same day), sets and repetition pattern, as well as 
rest between sets and exercises. During the 7 week detraining phase, participants were 
instructed to return to habitual pre-intervention exercise levels and not to perform any 
resistance training. Regular verbal communication between researcher and participant 
ensured subjects followed these instructions. A trainer was present at all resistance 
exercise sessions to enable continued monitoring, provide verbal encouragement and 
to ensure sufficient progression. No injuries were sustained throughout the exercise 
intervention. 
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Figure 2.1. Overview of resistance exercise training protocol for acute loading and 
chronic loading, unloading and reloading stimuli in human subjects. Light grey 
(loading) and white box (unloading) indicate training programme. Medium grey box 
with black outline identifies the acute RE condition, with biopsy occurring 
immediately (> 30 mins) post RE. Dark grey box with solid black outline details the 
experimental measures taken for analysis of in-vivo muscle mass and strength 
adaptations and acquisition of muscle sample for down-stream RNA/DNA analysis.  
	
2.3  Histological and Morphological Measurements of Muscle Mass Atrophy 
in Rodents 
2.3.1 Haematoxylin and eosin staining for fibre cross sectional area and tibialis 
anterior muscle mass analysis  
For morphological and histological purposes, muscle was harvested from control and 
experimental groups (n = 6 per group), weighed, and divided into pieces, and a 
transverse portion from the mid-belly of the muscle was frozen in melting isopentane, 
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cryostat sectioned (10 µm), and stained with haematoxylin and eosin, as previously 
described (Fisher, 2012). To perform staining, samples were removed from -80oC and 
left to stand at room temperature for 30 mins before being rehydrated in water. 
Sections were placed in haematoxylin solution for 3 mins, washed in warm-water for 
3 mins, placed in Eosin solution for 1-min and subsequently washed in warm water 
for 10 secs. Finally, the sections were dehydrated through incremental exposures to 
molecular grade alcohol solutions at 50, 70, 90 and 100% purity, cleared in xylene 
and mounted using Dibutyl phthalate in xylene (VWR, Lutterworth, UK). For each 
muscle sample, 5 images were obtained at random. By using ImageJ 1.45i software 
(National Institutes of Health, Bethesda, MD, USA), each photograph was overlaid 
with an 8 X 8 grid with which to make an unbiased selection of fibres. Ten fibres were 
selected for counting for each field of view at the first 10 intersections of the grid that 
fell within a fibre. Magnification of each section was calibrated from an image of a 
stage graticule. Cross-sectional area (CSA) was estimated from precise diameter 
measurements that were taken by selecting 2 points across the minimum diameter and 
assuming a circular cross-section. Mean TA mass for all control and experimental 
groups were expressed as a percentage of whole animal body mass to normalize for 
inter-individual differences in animal size (n = 6). Mean CSA of TA muscle fibre of 
the treated (left) limb was expressed as percent change from the untreated 
contralateral control (right) limb for each animal (n = 6).  
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2.4 In-Vivo Assessment of Changes in Skeletal Muscle Strength and Mass in 
Human Studies 
2.4.1 Dual energy X-Ray absorptiometry  
A whole-body fan beam dual-energy x-ray absorptiometry (DEXA; Hologic QDR 
Series, Discovery A, Bedford, MA, USA) scan was performed at baseline (control) 
and after loading, unloading and reloading conditions to assess lower limb changes in 
lean mass. All scans were performed and analysed (QDR for Windows, version 
12:4:3) by the same trained operator, according to Hologic guidelines. The DEXA 
scan was automatically analysed via the QDR software before the operator confirmed 
areas of interest including lower limb positions. Lean muscle mass (kg) was calculated 
and analysed on absolute values for each condition, and presented as a relative 
percentage change compared to baseline. Furthermore, to assess whether reloading 
induced adaptations in skeletal muscle mass compared to loading alone, absolute 
values of lean mass were normalised to appropriate conditions to account for residual 
starting mass. Where, loading condition was normalised to baseline, and reloading 
was normalised to unloading for each participant, with change in lean mass presented 
as percentage change to the normalised condition. 
 
2.4.2 Maximal isometric voluntary contraction of the quadriceps muscle  
To assess quadriceps muscle strength, in-vivo isometric knee extension maximal 
voluntary contractions (MVC) were performed using an isokinetic dynamometer 
(IKD; Biodex, New York, USA) to measure peak joint torque. Data is presented as 
percentage increase to baseline (%) using absolute values (Nm), unless otherwise 
stated. The participants were seated on the dynamometer chair with the hip flexed to 
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90°, the lateral femoral condyle of the right leg aligned with the dynamometer axis of 
rotation during contraction and the tibia strapped to the dynamometer lever arm 
proximal to the malleolus. Inextensible straps harnessed participants into the chair at 
the hip, distal end of the thigh and the chest to minimize compensatory movements. 
Following a progressive warm-up of submaximal through to maximal contractions 
(e.g. a 5-10% increasing in rate of perceived exertion of each sequential repetition, 
climaxing to performing 1-2 maximum efforts), participants performed two or three 
isometric MVCs at the ‘optimum’ knee angle for torque production. This angle was 
identified as that at which peak torque was recorded during a prior isokinetic knee 
extension at a constant speed of 30°/s (through a full range of motion). The optimum 
ranging between 70o – 90o. A rest period of 90 – 120 s was allowed between efforts. 
Verbal and visual (real-time trace of torque motion) feedback as well as verbal 
encouragement were given throughout all MVC efforts. Joint torques and angles were 
recorded and filtered with a low-pass 500 Hz filter (AcKnowledge Version 4.4) to 
omit background noise. The highest peak joint torque recorded from all isometric 
trials was taken forward for analysis. Data are presented as percentage increase to 
baseline (%) using absolute values (Nm), unless otherwise stated.  
2.5 Muscle Harvesting and Tissue Handling    
At all experimental time points, muscle biopsies were obtained from the right vastus 
lateralis (VL) muscle of human participants, using conchotome instruments. Subjects 
were asked to relax on a pre-sterilised hospital bed, whilst the biopsy area of the VL 
was prepared. Avoiding immediate areas of previous incision, the site was shaved, 
washed with an alcohol swab and washed again with Hydrex surgical scrub 
(ECOLAB Ltd. Leeds, UK), before a sterile sheet was placed around the site of 
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interest and participants were informed to avoid direct contact with the surgical area. 
A local anaesthetic (bupivacaine hydrochloride; Kays Medical Supplies, Liverpool, 
UK) was administered to the incision site, at a concentration of 5 mg.ml (~ 1.5 – 2 
ml), to anaesthetise the area. A sterile, one-use, disposable scalpel (needle size 10; 
Swann-Morton, Mu-Care Ltd., Bedfordshire, UK) was used to make an incision, 
penetrating the skin and muscle fascia. An autoclaved sterilised conchotome biopsy 
tool was used to retrieve a muscle sample from the vastus lateralis muscle of subjects. 
Surgically sterile tweezers and a scalpel were used to dissect the obtained muscle 
sample on an irradiated sterile petri-dish for preparation of down-stream analysis (see 
below). In the unlikely event of the biopsy containing any fibrous/fat tissue this was 
removed using a scalpel, leaving only lean tissue.	Post-incision treatment and follow-
up aftercare was given to all participants in alignment with our laboratories operating 
procedures.  
 
2.6  RNA Isolation, q-RT-PCR for Gene Expression Analysis 
2.6.1 Homogenisation of muscle samples for gene expression analysis  
A schematic representation of RNA isolation procedure is given in Figure 2.2 The 
following procedures were all performed on ice to attenuate the activity of 
endogenous RNases, allowing for the maintenance of RNA integrity. Samples were 
withdrawn from -80°C storage and immediately immersed in 1 ml of TRIzol (Thermo 
Fischer Scientific, UK), before being spun for 40 s at 6,000 rpm (MagNA Lyser 
Instrument, Roche Life Sciences, UK) in MagNA Lyser (Green Top) Beaded tubes 
filled with 1.4 mm ceramic beads and left to stand on ice for 5- 
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 mins. This step was performed 3 times, or until whole muscle sample was visibly 
homogenised.  
  
2.6.2 Procedures for RNA isolation 
Two hundred µl of Chloroform was added to each 1 ml working sample and shaken 
vigorously to encourage sufficient mixing indicated by a cloudy pink colour. Samples 
were left to stand for 2-3 mins at room temperature before being centrifuged at 12000 
g for 15 mins at 4oC. Following centrifugation, samples were separate into three 
distinct sections; (i) a lower red organic component that comprises TRIzol, protein 
and lipid, (ii) a thin milky interphase layer that contains DNA, and (iii) a clear aqueous 
phase that contains RNA and chloroform (Figure 2.2). The final layer, the clear RNA 
component, was carefully extracted and placed in new RNA-free tubes (Ambion® 
RNase-free, AmbionTM). These samples were then supplemented with isopropanol in 
a 1:1 ratio with the amount of original TRIzol used to lyse sample, before being 
vortexed and left to stand at room temperature for 10 mins. Centrifugation for 10 mins 
at 12,000 g and 4oC created an RNA pellet, the excess isopropanol was then removed 
via pipette as not to dislodge the RNA pellet (Figure 2.2). To clean the RNA pellet 
from any residual isopropanol, 1 ml of molecular grade ethanol (75 %: 25% molecular 
grade RNA free water) was added to the RNA pellet which was gently agitated to 
remove from the side of the tube in order to clean the entire pellet. The sample was 
then centrifuged again at 7500 g for 8 mins at 4oC. Excess ethanol was then pipetted 
off and RNA pellets were left to stand at room temperature until ethanol had 
evaporated and the pellet had dried (usually indicated by the pellet turning from 
cloudy white to translucent). As soon as the pellet turned translucent the samples were 
immediately resuspended in 20-30 µl of RNA storage solution (Ambion® RNA 
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Storage Solution, AmbionTM), thoroughly vortexed and left on a 35oC heating block 
for 10 mins. 
	
Figure 2.2. Process of RNA isolation from skeletal muscle samples and reaction tube 
setup for reverse-transcription quantitative real time polymerase chain reaction 
analysis. 
 
2.6.3 Measurement of quality and quantity of isolated RNA  
A measurement of isolated RNA concentration and purity was done via use of a 
Nanodrop spectrophotometer (Nanodrop 2000, Nanodrop, Thermo Scientific). The 
concentration of RNA was made under the assumption that nucleotides absorb a UV 
light in specific patterns. A UV light, at a wavelength of 260 nm, was emitted and 
passed through 1µl of experimental sample. A photo-detector measured the amount 
of UV light that passed through the sample, and therefore the absorbency of the 
targeted suspension. Utilising the Beer-Lambert law (modified for analysis of 
oligonucleotides; see below for equation 3) of optical density, and prior knowledge of 
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the absorbance (A), the wavelength-dependent extinction coefficient (ℇ) and the path 
length of emission (b), it is possible to identify the concentration (C) of suspension. 
Where the known wavelength-dependent extinction coefficient for RNA is 40 ng-
cm.µl-1.  
 
Equation 2. The modified Beer-Lambert Law of absorbance. The equation allows for 
detection of quantity (C) for both RNA via the identification of absorbance (A), and 
the known properties of extinction-coefficient (ℇ) and path length (b).  
 
The purity of the suspension was measured via the 260:280 ratio of absorbance, given 
that protein absorbs maximally at 280 nm, it can identify protein contamination. RNA 
is considered to be purest with a reading of around 1.9 - 2.1. To further confirm purity 
of isolated RNA suspension, absorbance of UV light emitted at wavelengths of 260 
and 230 nm (260:230 ratio) were analysed. The 260:230 of nucleic acids are often 
higher than the 260:280 counter-part for the same sample, however, readings will 
usually lie in the range of 1.8-2.2. If considerably different to these targets, it would 
indicate the presence of residual amounts of phenol, guanidine or proteins. Average ± 
standard deviation for 260:280 ratios for samples are described in the methods for 
experimental chapters, where applicable.  
 
2.6.4 Quantitative real time polymerase chain reaction experiments 
2.6.4.1 One step PCR reaction	
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To analyse gene expression for all genes in chapters 4 and 5, and Ampd3 and POLr2a 
in chapter 3, QuantiFast™ SYBR® Green RT-PCR one-step kit was utilised with 
reactions setup as follows; 9.5 µl RNA sample (7.3 ng/µl = 70 ng total RNA in the 
reaction or 5.3 ng/ µl = 50 ng total), 0.15 µl of both forward and reverse primers (100 
µM stock suspension, 0.2 µl of RT mix and 10 µl of SYBR® Green, totalling 20 µl 
reactions (Figure 2.2). For all human gene expression analysis, PCR reactions were 
set up as 50 ng reactions, and rodent work set up as 70 ng reactions. Reverse 
transcription cycles were completed before subsequent PCR performed as follows: 
hold 50°C for 10 min (reverse transcription/cDNA synthesis), followed by 95°C for 
5 min (transcriptase inactivation and initial denaturation step), before 40 - 45 PCR 
cycles of; 95 °C for 10 s (denaturation), 60 °C for 30 s (annealing and extension). 
Finally, a melt curve step was performed to identify any primer dimer formation or 
non-specific amplification. All relative mRNA expression was quantified using the 
comparative Ct (DDCt) method (Schmittgen and Livak, 2008) against a known 
reference gene. Primer sequences were designed by the current Ph.D applicant via use 
of the Primer-Blast software on National Centre of Biotechnology 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/). All primers were subsequently 
sent for manufacturing from Sigma-Aldrich, before being purchased and re-suspended 
in TE buffer (pH 8.0: TE Buffer, Ambion®, Invitrogen, California, USA). All primer 
sets for gene expression can be found in relevant experimental chapters, along with 
average Ct value, standard deviation and percentage variation of housekeeper utilised 
within each experiment.   
 
2.6.4.2 First-strand cDNA synthesis and PCR	
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Analysis of a sub-set of genes in chapter 3 (Myog, Fbxo32, Trim63, Chrna1 and 
Hdac4) was performed previously by Dr. Andrew Fisher using a cDNA and end-point 
PCR method, as described here (Fisher, 2012). One µg of RNA was taken forward 
(addition of RNAse free water to equate a 12 µl suspension), and 1 µl of oligo dT 
primer (Invitrogen, Thermo Fisher Scientific, California, United States) was added to 
the suspension before being incubated at 70°C for 10-mins. A reaction mix containing 
4 µl of 5X buffer, 2 µl of dithiothreitol (DTT) and 1 µl of deoxynucleotide 
triphosphates (dNTPs; all products Invitrogen), was added to each RNA sample and 
incubated at 42°C for 2 mins. Superscript II Reverse Transcriptase (Invitrogen) was 
added (1 µl) and suspension was incubated for a further 50 mins at the same 
temperature, before being incubated for 15 mins at 70°C to inhibit the reaction. 
Reverse-transcription PCR (HotStar Taq Master Mix; Qiagen, Crawley, UK), 
performed on a Px2 Thermocycler (ThermoFisher, Scientific), was setup as follows; 
3 µl of cDNA, 15 µl HotStar Taq Master Mix, 1.5 µl of forward and reverse primers 
(20 µM) and 9 µl of RNAse free water, to total a 30 µl reaction. PCR cycles began 
with 1 cycle of 95°C for 10 mins, before 40 cycles of denaturation (94°C for 30 s), 
annealing (55-65°C for 30 s) and extension (72°C for 1 min) were performed, and a 
final polishing hold was performed (72°C for 10 mins). For real-time qPCR using 
HotStar Taq Master Mix Kit on the iQ5 Thermocycler, reactions were as follows: 3 
µl cDNA, 15 3.96 µl of RNAse-free water, 7.5 µl 2X SYBR Green Supermix (BioRad, 
Hemel Hempstead, UK) and 0.27 µl of forward and reverse primers (20 µM). Relative 
gene expression was subsequently analysed and performed as previously described 
(section 2.6.4.1).	
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2.6.5 Microarray Analysis of Rodent Muscle 
2.6.5.1 Rodent muscle sample preparation for microarray analysis 
Frozen muscle samples were sent to AROS Applied Biotechnology for processing and 
preparation for downstream analysis, this included N=4 for all conditions of sham 
control, 3-D, 7-D, 14-D TTX exposed and 14-D TTX plus 7-D of active recovery 
conditions. AROS Applied Biotechnology performed all homogenisation, nucleic 
acid isolation, quality control and array analysis. Over 30,000 rat transcripts and 
28,000 variants were examined via Affymetrix GeneChip® Rat Genome 230 2.0 
Array (Affymetrix, High Wycombe, UK).  
 
2.6.5.2 Transcript wide analysis via transcriptome analysis control software 
Raw data files were analysed by the current Ph.D applicant for the elucidation of 
differentially regulated transcripts across experimental conditions. Raw data files 
(.CEL) were normalised via the MAS 5.0 signal method (Irizarry et al., 2003a, Irizarry 
et al., 2003b) and .CHP files were subsequently analysed for significantly differential 
gene expression from microarray data (Transcriptome Analysis Console; TAC, 
Affymetrix, High Wycombe, UK).  TAC software was used to create hierarchical 
clustering heatmaps of the most differentially expressed genes and lists of the most 
frequently differentially regulated transcripts across experimental comparisons. 
Specific heatmap details can be found in figure legends within experimental chapters. 	
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2.7  DNA Isolation, Epigenome-wide Analysis and Loci-Specific DNA 
Methylation Experiments  
2.7.1  Preparation of muscle sample for DNA isolation 
Samples were withdrawn from -80oC storage and immediately stored on ice, before 
being immersed in 200 µl of DNA homogenate buffer (180 µl of ATL buffer and 20 
µl of proteinase k; DNA Blood and Muscle Kit, Qiagen, Manchester, UK), before 
being spun for 40 s at 6,000 rpm (MagNA Lyser Instrument, Roche Life Sciences, 
UK) in MagNA Lyser (Green Top) Beaded tubes filled with 1.4 mm ceramic beads, 
and left to stand on ice for 5 mins. This step was repeated 3 times, or until whole 
muscle sample was visibly homogenised (Figure 2.3). 
 
2.7.2 Isolation of deoxyribonucleic acid 
All samples were isolated using a commercially available DNA isolation kit (DNeasy 
Blood and Tissue Kit; Qiagen, United Kingdom) in accordance with manufacturers’ 
instructions. Samples were collected from -80oC and immediately kept on ice before 
being immersed in 200 µl of DNA homogenate buffer (180 µl of ATL buffer and 20 
µl of proteinase k) and homogenised at 6,000 rpm 40 s (MagNA Lyser Instrument, 
Roche Life Sciences, UK). This step was repeated 3 times with 5 mins on ice between 
homogenisations, to ensure total disruption of muscle cells, and the release of genomic 
DNA while avoiding its degradation. Suspension was supplemented with 200 µl of 
AL buffer before being incubated at 56oC for 10 mins. Molecular grade ethanol (200 
µl of > 96 % pure) was subsequently added to the suspension before being briefly 
vortexed and aliquoted into spin columns placed in 2 ml collection tubes (DNeasy 
Mini Spin Colum, DNeasy Kit, Qiagen). Spin columns were centrifuged at 6,000 g 
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for 1 min, flow through discarded and 500 µl of buffer AW1 was added to the spin 
column and centrifuged at 6,000 g for 1 min. Buffer AW2 was then added to the spin 
column and centrifuged at 20,000 g for 3 min. All flow through was discarded and 
spin columns were placed in new RNA/DNA free tubes (RNase-free Microfuge 
Tubes, AmbionTM, ThermoFisher Scientific, United States), before 50 µl of elution 
reagent (buffer AE) was added directly to the spin column and centrifuged at 6,000 g 
for 1 min. The elution step was repeated to yield a total DNA suspension of 100 µl 
per original sample. Samples were then frozen (-20oC) in this form until further down-
stream analysis. This process is schematically represented in Figure 2.3.   
 
	
Figure 2.3. Overview of the Process for DNA Isolation from Muscle Tissue 
Samples. 
	
2.7.3 Quantification of DNA quantity and quality. 
Isolated DNA was analysed for quality and quantity via UV spectroscopy (Nanodrop 
2000, ThermoFisher Scientific, United States), in identical fashion to that described 
for RNA analysis (see section 2.6.3). However, double stranded DNA has a known 
wavelength-dependent extinction coefficient of 50 ng-cm.µl-1 and single-stranded 
DNA (that best represents bisulfite converted DNA, see below) has a coefficient of 
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33 ng-cm.µl-1. The optimum absorbency ratio for isolated DNA is 2.0 for 260/280 
wavelengths, and in the range of 1.8-2.2 for 260/230 ratio.  
 
2.7.4 Bisulfite conversion of isolated DNA 
Once isolated DNA was quantified, downstream bisulfite conversion was required in 
order to allow for detection of unmethylated and methylated loci (Frommer et al., 
1992). This methodology works on the principle of generating an artificial single 
nucleotide polymorphism (SNP) where methylated CpG sites maintain cytosine 
uniformity upon bisulfite treatment, whereas un-methylated CpG locus are modified 
into uracil and read as a thiamine upon PCR amplification. Thus, an artificial SNP is 
rendered at the site of un-methylated CpG and is detectable upon down-stream 
analysis (Figure 2.4). In all experiments, bisulfite treatment was accomplished via use 
of EZ-DNA methylation kit (Zymo Research, California, United States), or 
InnuConvert Bisulfite Basic kit (AJ Innuscreen GmbH, Berlin, Germany) and were 
performed in accordance with manufacturer’s instructions.  
 
2.7.4.1 EZ DNA methylation kit protocol 
The EZ DNA methylation bisulfite conversion protocol was performed using Zymo-
Spin™ IC Columns (pyrosequencing method of DNA methylation detection, chapter 
3) and a Silicon-ATM Binding Plate for higher throughput of conversion (DNA 
methylation BeadChip Array, chapter 4 and 5). Both protocols are performed 
identically, unless otherwise stated. Five micro-litres of M-Dilution Buffer was added 
to 500 ng of isolated DNA, and distilled water (dH20) was added where applicable, 
to yield a total suspension of 50 µl, before samples were incubated for 15 mins at 37 
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˚C. In each sample 100 µl of prepared CT Conversion Reagent was added, and 
incubated overnight (16 hrs) at 50 ˚C. CT Conversion Reagent is light sensitive and 
thus, the incubation period was performed overnight and in the dark to limit exposure, 
where possible. Following incubation, samples were moved onto ice for 10 mins. 
Four-hundred µl of M-Binding Buffer was added to a Zymo-Spin™ IC Column or a 
Silicon-ATM Binding Plate, before the experimental sample suspension was added and 
mixed via inversion. Spin columns were spun at either maximum speed for 30 s (spin 
column) or at 3,000 g for 5 mins (silicon plate) and flow through discarded. For spin 
column-based conversion, a series of wash buffer stages followed, where all steps 
included a 30 s spin at maximum speed; i. 100 µl of M-Wash Buffer, ii. 200 µl M-
Desulphonation Buffer (incubation for 15-20-mins at room temperature), iii. 200 µl 
of M-Wash Buffer, iv. 200 µl of M-Wash Buffer. Finally, 10 µl of M-Elution Buffer 
was added directly to spin column matrix and centrifuged for 30 s at maximum speed 
to elute DNA. For conversion performed on the Silicon-ATM Binding Plate, a series 
of wash buffer stages were performed. Five-hundred µl of M-Wash Buffer was added 
and centrifuged at 3,000 g for 5 mins. M-Desulphonation Buffer (200 µl) was added 
to the suspension and left to incubate at room temperature for 15-20 mins before being 
centrifuged at 3,000g for 5 mins. Two wash buffer stages were then performed, where 
500 µl of M-Wash Buffer was added to the suspension and centrifuged at 3,000 g for 
5 and 10 mins, respectively. To elute the sample, the silicon plate was placed onto an 
Elution Plate and 30 µl of M-Elution Buffer was added directly to the matrix of each 
well and spun at 3,000 g for 3 mins 
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2.7.4.2 InnuConvert bisulfite conversion kit protocol  
To generate bisulfite converted DNA for use in down-stream high resolution melt 
polymerase chain reaction (HRM-PCR; described in section 2.7.6.2), as utilised in 
chapter 3, isolated DNA was converted using the InnuConvert bisulfite conversion 
kit, as described. A bisulfite conversion suspension was created containing 70 µl of 
Conversion Reagent and 30 µl of Conversion Buffer, and was added to 50 µl of 
isolated DNA, before being vortexed and incubated at 85 ˚C for 45 min with 
suspension being vortexed every 15 mins, throughout the incubation. 700 µl of 
Binding Solution GS was added to incubated suspension, vortexed briefly and added 
to a spin column and receiver tube system and spun at 14,000 g for 1 min. A six-step 
protocol of washing and buffer reagents ensued, in which all reagents were spun at 
14,000 g for 1 min; i. 200 µl Washing Solution BS, ii. 700 µl Desulphonation Buffer 
(10 min incubation), iii. 500 µl Washing Solution C, iv. 650 µl Washing Solution BS, 
v. 650 µl ethanol absolute, vi. 650 µl ethanol absolute. The remaining substance in 
the spin filter was then incubated for 10-min to air dry, then incubated for a further 1-
min in the presence of 25 µl of Elution Buffer and spun at 8,000 g for 1 min. The 
eluted suspension was aliquoted out, and this final step was performed for a second 
time, resulting in a total yield of 50 µl of bisulfite converted DNA.  
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Figure 2.4. Schematic representation of modifications to DNA strands during bisulfite 
conversion treatment and PCR amplification. Briefly, methylated cytosine residues 
(depicted as ‘C’ with red methylation (Me) modification) maintain cytosine 
uniformity during bisulfite modification. Conversely, unmethylated cytosine residues 
(depicted as ‘C’ with a green empty modification) are modified into uracil residues 
(rounded nucleotide; U) and once amplified via PCR, are read as thymine (inverted 
nucleotide; T). Solid black arrows indicate unmodified base during bisulfite and 
amplification processes. Dashed arrow indicates modification of the base nucleotide 
during the same processes.  
 
2.7.5 Methylome-wide bead chip arrays and analysis 
2.7.5.1 Methylome Wide CpG DNA Methylation Assay  
Isolated DNA and bisulfite converted samples, as outlined previously, from all human 
in-vivo studies were sent to The Genome Centre at Barts and the London School of 
Dentistry of Queens Mary University London for analysis of the Illumina Infinium 
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MethylationEPIC array that examines over 850,000 CpG sites of the human 
epigenome (Infinium MethylationEPIC BeadChip, Illumina, California, USA). The 
EPIC array covers 99% of the reference sequence of promotors and includes targets 
of the FANTOM5 and ENCODE methylated sites previously identified (Bibikova et 
al., 2011). In a 3 stage process, the EPIC Infinium array was performed in accordance 
with Illumina standard operating procedures, as described here. 
 
2.7.5.1a Genomic DNA Bisulfite Conversion and Amplification: 
Four µl of bisulfite converted DNA (BCD; section 2.7.4.1) was transferred from the 
bisulfite conversion plate in to corresponding wells of a MSA4 plate and 20 µl of 
MA1, 4 µl of 0.1N NaOH were added before plate was vortexed (1600 rpm for 1-
min), pulse centrifuged (280 g) and left to incubate at room temperature (RT) for 10-
mins. Samples within this place then had 68 µl of RPM and 75 µl of MSM added 
before a further round of vortex and centrifugation was performed (identical to 
above). Samples were subsequently left in a 37˚C hybdrization oven overnight (20-
24 hrs) to allow for amplification.  
 
2.7.5.1b Fragmentation, Precipitation and Resuspension of Amplified DNA:  
FMS (50 µl) was added to each well of the MSA4 before being vortexed (1600 rpm 
for 1-min), centrifuged (280 g) and incubated (37˚C for 1-hr) to fragment DNA. An 
endpoint fragmentation was used to avoid over-fragmentation. Following incubation, 
100 µl of PM1 and 300 µl of 2-propanol were added to each well interspersed with 
vortexing (1600 rpm for 1-min), incubation (37˚C for 5-mins) and centrifugation (280 
g for 1-min). MSA4 plate was subsequently mixed via inversion (at least 10 times) 
incubated at 4˚C for 30-mins, centrifuged at 3000 g at 4˚C for 20-mins, supernatant 
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liquid decanted out of wells and left at room temp for 1 hour to dry pellet. Following 
precipitation, each pellet in each well was resuspended in 46 µl of RA1 incubated at 
48˚C for 1-hour, vortexed for 1-min (at 18000 rpm) and pulse centrifuged at 280 g. 
 
2.7.5.1c Hybdrization to BeadChip, Extension and Staining:  
Fragmented DNA residing on the MS4A plate was incubated at 95˚C for 20-mins to 
denature experimental samples before being left to stand at RT for 30-mins and pulse 
centrifuged at 280 g, and subsequently prepared for transfer and precisely loaded onto 
a working BeadChip. BeadChips were loaded into the Illumina Hyb Chamber and 
placed for over-night incubation at 48˚C for 16-hrs, before being washed (gentle 
agitation in 200 ml of  PB1) and readied for BeadChip staining. Assembled flow-
through chambers were loaded into a chamber rack where single based-extension 
occurred of each flow through assembly. Single base-extension was performed at 
44˚C via the addition of the following reagents: 150 µl of RA1 with incubation of 30-
secs (repeated 5 times), 450 µl of XC1, 450 µl of XC2, 200 µl of TEM and 450 µl of 
95% formamide/1 mM EDTA (repeated). Each flow-through assembly was incubated 
for 5-mins, before 450 µl of XC3 was added (repeated). Staining of assemblies was 
performed in 5 repeated cycles of the following: addition of 250 µl of STM to each 
flow-through assembly (10-mins incubation), 450 µl of XC2 incubated for 1-min 
(repeated) and left to stand for 5-mins. To wash staining reagents, BeadChips were 
gently submerged and agitated initially in PB1 (310 ml per 8 BeadChips), and then in 
XC4 (same total amount of reagent), with a 5-min delay in between the use of both 
cleaning buffers. Finally, washed BeadChips were left to dry for 50-55-mins before 
being taken for BeadChip imagery, using the Illumina iScan® System (Illumina, 
United States).  
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2.7.5.2 Computational data handling and quality control procedures 
Raw data files (.IDAT) were returned and normalised via subset-quantile within array 
normalisation (SWAN) method, as previously described (Maksimovic et al., 2012) 
within the genome package, Partek Genomics Suite V.6.6 (Partek Inc. Missouri, 
USA). Subsequent data sets represent SWAN-normalised β-values that correspond to 
the percentage of methylation at each CpG site, calculated as the ratio of methylated 
to unmethylated probes via the formula (equation 4); 
 
	
Equation 3. Calculation for Identifying the Percentage Methylation at Each Individual 
CpG Site Following Methylome Wide Bead Array Analysis. 
 
Where a β value of 1 indicates total methylation and a value of 0 represents a 
completely unmethylated CpG site (Pidsley et al., 2016). Initial quality control steps, 
Principal Component Analysis (PCA) and normalisation histograms, were undertaken 
to detect for arrays/samples that were identified as being outliers. Differential 
methylation was subsequently detected across all experimental conditions, and 
between conditions to identify statistically differentially regulated CpG sites. All 
analysis of methylation data and statistical analysis was performed using Partek 
Genomic Suite V.6.6 software (Partek Inc., Chesterfield, Missouri, USA).  
 
Quality control analysis of principal component and intensity frequency histogram 
were plotted for identification of outliers (Figure 2.5). This analysis revealed two 
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outliers, while all other samples were reported as consistent between conditions. 
Down-stream analysis was therefore performed on the remaining samples and these 
two samples disregarded for downstream analysis.  
	
Figure 2.5. Initial quality control analysis of human samples utilised for down-stream 
methylome wide bead arrays. 13A. Figure displaying the average methylation profile 
across all detected CpG loci allowing for analysis of variability using three-
dimensional principal component analysis (PCA), where each sample is represented 
by a dot and ellipses for each condition. 13B. Histogram plot representing the 
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distribution of intensity for each probe allowing for detection of aberrant samples. 
Two samples are identified as being outliers (X) from both quality control procedures 
and were subsequently removed from down-stream analysis. 
 
2.7.5.2 Partek genomic suite for hierarchical clustering dendogram, gene ontology 
and KEGG pathway analysis 
Unadjusted p-value significance (P < 0.05) was used to create a CpG site marker list 
of standardized beta-values across arrays of interest. A standardized expression 
normalisation was performed to shift CpG sites to mean of zero and scale to a standard 
deviation of one. Unsupervised hierarchical clustering was performed and a 
dendogram was constructed to represent differentially methylated CpG loci and 
statistical clustering’s of experimental samples. Heatmaps represent the modification 
of CpG loci, where regulated sites that possess reduced methylation (hypomethylated) 
are represented in green, increases in methylation (hypermethylated) in red, and 
unchanged sites are represented in black. Statistically differentially regulated CpG 
sites were analysed via Fishers exact test (FDR < 0.05) in Partek Genomic Suite and 
Gene Ontology Browser, for molecular function, cellular component and biological 
process. An enrichment score of greater then 3 indicated a significantly 
enriched/altered functional group. In similar approach, Kyoto Encyclopaedia of 
Genes and Genomes (KEGG) pathways were examined for identification of 
transcripts with associated significantly differentially regulated CpG sites (Kanehisa 
et al., 2017, Kanehisa and Goto, 2000, Kanehisa et al., 2016).  Statistically 
differentially regulated CpG sites were analysed via Fishers exact test (FDR < 0.05) 
in Partek Genomic Suite and exported to the software, Partek Pathway (Partek Inc., 
Missouri, USA). To ascertain differential methylation, configuration by fold-change 
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of conditions was applied, and represented by colour intensity, where green indicates 
hypomethylation, red hypermethylation and grey unchanged. The strength of colour 
indicates a greater fold change.  
 
2.7.6 Loci-specific DNA methylation analysis 
2.7.6.1 Loci-specific pyrosequencing for analysis of rodent muscle atrophy 
Assays for pyrosequencing were purchased from EpigenDX (Hopkinton, MA, USA). 
Following bisulfite conversion, PCR reactions were designed depending on the 
specific DNA methylated region of interest and the size of the product, as per 
manufacturer’s instructions. However, a typical reaction was performed as follows; 3 
µl of 10X PCR buffer (containing 15 mM MgCl2), 0.2 µl of 10 mM dNTPs, 1.8 µl of 
25 mM MgCl2, 0.6 µl of 10 mM dNTPs, 0.15 µl HotStar Taq Polymerase, 1 µl of 
bisulfite treated DNA and 0.2 µM of forward and reverse primer. One primer was 
biotin-labelled and HPLC purified in order to facilitate purification of the final PCR 
product using sepharose beads. Following an initial denaturation incubation at 95°C 
for 15-min, 45 cycles of denaturation at 95°C for 30 s; 63°C for 30 s (annealing), 68°C 
for 30 s (extension) were performed, with all PCR cycles followed by a final 5 minutes 
at 68°C. PCR products were then bound to Streptavidin Sepharose HP (GE Healthcare 
Life Sciences), after which the immobilized PCR products were purified, washed, 
denatured with a 0.2 µM NaOH solution and rewashed using the Pyrosequencing 
Vacuum Prep Tool (Pyrosequencing, Qiagen, Manchester, UK), as per the 
manufacturer’s instructions. Following annealing with 0.5 µM sequencing primer, the 
purified single stranded PCR products were then sequenced using the PSQ96 HS 
System (Qiagen) following the manufacturer’s instructions. The methylation status of 
each CpG site was determined individually as an artificial C/T SNP using QCpG 
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software (Qiagen). The methylation level at each CpG site was calculated as the 
percentage of the methylated alleles divided by the sum of all methylated and 
unmethylated alleles. The mean methylation level was calculated using methylation 
levels of all measured CpG sites within the targeted region of each gene. Each 
experiment included non-CpG cytosines as internal controls to detect incomplete 
bisulfite conversion of the input DNA. In addition, a series of unmethylated and 
methylated DNA strands were included as controls after each PCR. Furthermore, PCR 
bias testing was performed by mixing unmethylated control DNA with methylated 
DNA at different ratios (0%, 5%, 10%, 25%, 50%, 75%, and 100%), followed by 
bisulfite modification, PCR, and Pyrosequencing analysis.  
 
2.7.6.2 High resolution melting (HRM) polymerase chain reaction for total DNA 
methylation of rodent muscle atrophy 
HRM-PCR for CpG methylation was performed in accordance with protocols 
previously described (Sharples et al., 2016a). Briefly, 20 ng of isolated and bisulfite 
treated DNA was subjected to HRM-PCR using EpiTect HRM-PCR kits and 
Rotorgene 3000Q (Qiagen, Crawley, UK) with Rotorgene software (Hercules, CA, 
USA). All primer concentrations for gene CpG assays and EpiTect HRM master mix 
volumes were used in accordance with the manufacturer’s instructions. HDAC4 
(Qiagen) was designed to amplify a product length of 140 to 190 bp. PCR cycles were 
performed as follows; 10 s at 95 °C (denaturation), 30 s at 55 °C (annealing), 10 s at 
72 °C (extension) for a maximum of 55 cycles. Following PCR, a high-resolution melt 
(HRM) analysis was performed with 0.1 °C increments from 65 to 95 °C. 
Fluorescence versus melt temperature was used to create a standard curve using rat 
methylated DNA standards representing 100, 75, 50, 25, 10, 5 and 0 % methylation. 
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All samples were run in duplicate normalised to 0% methylated control and averaged 
to produce a single curve. The relationship between the area under the curve, 
determined via each standard curve, and the corresponding percentage methylation 
curve of specific gene loci was determined via the best fitting fourth-order polynomial 
relation. This relationship was subsequently used to quantify the % methylation from 
the integrated raw melt curves of experimental samples. The calculations were 
performed using an in-house developed Python-based program, MethylCal.  
 
2.8 Statistical Analysis 
Statistical analysis was performed via MiniTab Statistical Software (v. 17.2.1; 
MiniTab Inc, Pennsylvania, USA) or a statistical package for the social sciences 
software for Microsoft (SPSS, v. 22.0 and v 23.0; IBM Corporation, New York, 
USA). All genome-wide data sets (Rat Transcriptome and Human MethylomeEPIC 
array) were analysed for significance via the use of the genomic software 
Transcriptome Analysis Console (TAC) or Partek Genomic Suite software (version 
6.6). Statistical values were considered significant at the level of P ≤ 0.05.  
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Chapter 3: 
	
	
	
Transcriptomic and Epigenetic Regulation of Disuse 
Atrophy and the Return to Activity in Skeletal Muscle 
 
Fisher, A, G. (Primary Author), Seaborne, R. A. (Primary Author), Hughes, T. 
M., Gutteridge, A., Stewart, C., Coulson., J. M., Sharples, A. P (Corresponding 
Author) and Jarvis, J. C (Corresponding Author). 2017. Transcriptomic and 
epigenetic regulation of disuse atrophy and the return to activity in skeletal muscle. 
Official Publication of the Federation of American Societies for Experimental 
Biology. 31 (12). 5268 - 5282.  
 
Please note that this chapter extends work by Dr. A. Fisher and Professor, J. Jarvis. 
Muscle mass and cross-sectional area analysis was performed and published 
previously (Fisher, 2012), with raw data being provided to the current Ph.D applicant 
by Dr. Fisher. Muscle mass and cross-sectional area were re-analysed by the current 
applicant, with all figures produced by the current Ph.D applicant. Raw microarray 
files were donated to the current Ph.D applicant who performed all bioinformatic 
analysis for the derivation of data in this thesis. The PhD candidate also ran all of the 
HRM DNA methylation and pyrosequencing experiments and analysis, as well as 
created all graphs, figures and schematics for the epigenetic (DNA methylation) data 
presented in the current chapter.  
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3.1 Introduction  
Skeletal muscle is the most abundant tissue in the mammalian body, whose 
maintenance is pivotal for the health and life longevity. However, the precise 
molecular mechanisms that regulate skeletal muscle mass remain elusive. In chapter 
1, we identified that skeletal muscle cells in-vitro undergo significant epigenetic 
modifications during catabolic conditions (exposure to the cytokine TNF-α) (Sharples 
et al., 2016a). Despite these preliminary findings, further work examining the role of 
DNA methylation during periods of skeletal muscle atrophy in-vivo remain scarce. 
Furthermore, the findings by Sharples et al. (2016a) suggest that epigenetic 
modifications incorporated following exposure to an atrophic stimulus, may be 
retained for a substantial period of time (30 population doublings in-vitro) once the 
stimulus is removed. Again, however, the exploration of this work since these findings 
has not been performed, and thus it is unknown as to whether modifications of the 
DNA will persist following removal/reversal of the atrophying stimuli, in-vivo.  
 
In order to investigate the underlying time-course and molecular mechanisms 
responsible for skeletal muscle atrophy, molecular biologists have commonly 
implemented models such as denervation (Tang and Goldman, 2006, Batt et al., 
2006), limb suspension (de Boer et al., 2007), space flight (Nikawa et al., 2004) and 
joint immobilisation (Yasuda et al., 2005). Within these models, large alterations in 
gene regulatory networks have been identified to orchestrate the altered balance 
between protein synthesis and degradation during muscle atrophy (Bonaldo and 
Sandri, 2013). Indeed, previous investigative work has uncovered key pathways, such 
as the ubiquitin-proteasome pathway (Eddins et al., 2007, Sandri et al., 2004, Lecker 
et al., 2004), and key gene transcripts, such as Trim63 (MuRF1) and Fbxo32 (MAFbx) 
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(Bodine et al., 2001a), that converge to promote the breakdown of skeletal muscle 
proteins, as described in chapter 1. However, there are currently no studies that 
investigate the epigenetic modifications that occur during skeletal muscle atrophy in-
vivo. Furthermore, current in-vivo models are not without limitations. For example, 
during limb cast immobilisation, systemic stress response factors are released, due to 
the muscle still being able to contract but without generating any movement, that have 
the potential to interfere with down-stream molecular events, such as gene expression 
and DNA methylation (Midrio, 2006, Holecek, 2012). 
 
With this in mind, the aim of this chapter was to investigate the role of DNA 
methylation in skeletal muscle atrophy, and, for the first time, characterise DNA 
modifications that are associated with skeletal muscle mass perturbation in-vivo. To 
do so, we used an in-vivo osmotic pump and nerve cuff apparatus that would 
administer tetrodotoxin (TTX) to the peroneal nerve and silence the neural input to 
the muscles of the hind limb. Importantly, because this model also allowed for 
successful cessation of TTX administration following a specific time-course, the hind 
limb of the same animal could be recovered and normal physical activity could be 
established (Fisher, 2012). Therefore, the second aim of this chapter was to elucidate 
whether any of the epigenetic modifications identified after atrophy were retained 
following a return to normal physical activity levels in the same animals. It was 
hypothesized that TTX-induced atrophy would be coupled with an inverse 
relationship between DNA methylation and corresponding changes in gene 
expression. Where reduced (hypo)methylation of promoter regions of genes would 
lead to increases in gene expression and increased (hyper)methylation would lead to 
gene silencing.  It was also hypothesized that these DNA methylation modifications 
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would be dynamic in nature and was therefore sort to exploratively elucidate this 
behaviour.  
 
3.2 Methodology 
3.2.1 Experimental design 
As described previously (Fisher, 2012), the tibialis anterior muscle of Wister rats was 
subjected to either 3, 7 or 14 days (D) worth of tetrodotoxin (TTX) or 14D of TTX 
plus 7D worth of activity induced recovery, via an assembled osmotic pump and nerve 
cuff apparatus that would deliver treatment in a continuous manner (see sections 2.1.1 
– 2.1.2 for details). Following termination, the TA muscle group from both control 
and experimentally treated limbs of rodents were harvested and either mounted and 
frozen for histological purposes, or snap frozen for gene expression and DNA 
methylation assays (see methodology section 2.1.1 – 2.1.2). For details of 
experimental procedures see methodology section 2.1. Schematic representation of 
experimental design is given in Figure 3.1.  
	
	
99 
	
Figure 3.1. Schematic representation of TTX muscle atrophy model and subsequent 
muscle sample preparation for morphologic, transcriptomic, and epigenetic analysis. 
A. Display of physiological location of TTX administration pump. (i) Real image of 
osmotic pump location and assembly with the left hind limb of the rodent, originally 
defined in Fisher (2012). A representative overview of the osmotic pump assembly 
(ii; black lines show osmotic pump unit and delivery tube to nerve cuff unit and white 
line displays the synaptic nerve; real morphology images (Ai & ii) B. Muscle sample 
preparation for downstream analysis: treated (left) and untreated contralateral control 
(right).  
 
3.2.2 Morphological and histological analysis of muscle adaptation 
Following cessation of experimental procedures, all animals were humanely 
euthanized via increasing CO2 concentration and cervical dislocation. Muscle samples 
A B
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were harvested from both the control and experimentally treated groups (N=6), 
weighed and divided into pieces for down-stream analysis of muscle size and fibre 
cross-sectional area, as previously described (section 2.1.3). Data for muscle mass of 
the tibialis anterior (TA) for all control and experimentally treated groups was 
expressed as a percentage of whole animal body mass (428 ± 45 g) to normalise for 
inter-individual differences in animal size. Mean CSA of the tibialis anterior (TA) 
muscle fibres were expressed as a percentage change from the untreated contralateral 
control limb for each animal. All data are presented as means ± SD, unless otherwise 
stated.  
 
3.2.3 Transcriptome-wide analysis via microarray 
Microarray analysis of the rodent genome was performed to elucidate transcript 
expression changes in experimental compared to control groups. All analysis was 
performed as previously described (2.6.5). Briefly, samples were sent to AROS 
Applied Biotechnology, who performed RNA isolation (AROS Standard Operating 
Procedures) and microarray analysis via Affymetrix GeneChip Rat Genome 230 2.0 
Array (Affymetrix, High Wycombe, UK). Raw data files were subsequently analysed 
by the current Ph.D applicant utilising the freely available genomic software, 
Transcriptome Analysis Console (TAC; Affymetrix). Raw data files (.CEL) were 
normalised via the MAS 5.0 signal method (Irizarry et al., 2003b, Irizarry et al., 
2003a) and CHP files were subsequently analysed for significantly differential gene 
expression, compared to baseline and within pairwise comparisons of experimental 
groups. TAC software was utilised to create clustering heatmaps.  
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3.2.4 RNA isolation and rt-qRT-PCR 
Gene expression was performed previously by Dr Andrew Fisher and presented in his 
Ph.D thesis (Fisher, 2012), with raw data provided to, and statistically reanalysed by, 
the current Ph.D applicant. The current Ph.D applicant isolated further RNA and qRT-
PCR (as described in methodology) for the gene of interest (Ampd3) and reference 
gene (POLR2a) for analysis of their expression. RNA was isolated, and quantity and 
quality analysis was performed via protocols outlined in sections 2.6.1 – 2.6.3. All 
relative gene expression was quantified by using the ∆∆Ct method against known 
references genes of (POLR2a) and/or RN18s. Average Ct values for POLR2a and 
RN18s were 20.08 (± 0.59) and 15.80 (± 0.39), respectively, across all experimental 
conditions. Primer sets for transcripts analysed for gene expression are given in table 
3.1. All data for fold change in gene expression is presented as mean ± SD, unless 
otherwise stated (N=6).  
 
Table 3.1. Gene primer sequences for rodent muscle atrophy experiment. All primers 
were used the same cycling conditions.	
Gene 
Name Accession No.  Primer Sequence 
Primer 
Length 
Product 
Length 
Trim63 NM_080903 F GGAGGAGTTTACTGAAGAGG 20 180 
R GACACACTTCCCTATGGTGC 20 
Fbxo32 NM_133521 F CTTGTCTGACAAAGGGCAGC 20 184 R TGAAAGTGAGACGGAGCAGC 20 
Ampd3 NM_031544 F ACGCTTGCTGGTCGGTTTAG 20 96 R TGGCTTCCTTCTGTCCGATG 20 
Hdac4 XM_343629.4 F GCAGCCAAACTTCTCCAGCA 20 212 R TTGACATTGAAACCCACGCC 20 
MyoG NM_017115.2 F GCCATCCAGTACATTGAGCG 20 267 R CATATCCTCCACCGTGATGC 20 
Chrna1 NM_024485.1 F TGTCATCAACACACACCACC 20 269 R CTGCAATGTACTTCACACCC 20 
RN18s X01117 F TTGACGGAAGGGCACCACCAG 21 131 
R GCACCACCACCCACGGAATCG 21 
POLR2a XM_001079162.5 
F GCTGGACCTACTGGCATGTT 20 
102 R ACCATAGGCTGGAGTTGCAC 20 
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3.2.5 DNA isolation and methylation analysis  
DNA was isolated and subsequently analysed for quantity and quality in protocols 
described in section 2.7.1 – 2.7.3, from control and experimental conditions (N=3). 
DNA methylation of identified transcripts was detected via two methods. Bisulfite 
treatment for analysis of DNA methylation via loci-specific pyrosequencing was 
performed via the Zymo EZ Methylation Kit (Zymo Research, Irvine, CA, USA) 
using the protocol previously described (section 2.7.4.1). DNA methylation detection 
via high-resolution melt PCR (HRM-PCR) utilised a bisulfite treatment performed via 
the InnuConvert All-in-One Bisulfite Conversion Kits (AJ Innuscreen GmbH, Berlin, 
Germany) using methods previously described (2.7.4.2). The use of bisulfite treatment 
for detection for down-stream DNA methylation analysis has previously been 
described within this thesis (section 2.7.4) and previously (Frommer et al., 1992). 
Both DNA methylation analysis methods were performed as previously described 
(2.7.6). Transcript primers for loci-specific DNA methylation analysis is presented in 
Figure 3.2 and table 3.2, and via HRM-PCR given in table 3.3.  
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Figure 3.2. Gene map of CpG islands for loci-specific pyrosequencing for quantitation 
of DNA methylation for transcripts. In descending order: MyoG, Fbxo32 (MAFbx), 
Trim63 (MuRF1), Ampd3 and Chrna1. UTR untranslated region. 
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Table 3.2. Detailed description of targeted DNA methylation assays for loci-specific 
pyrosequencing analysis. Where Y and R bases indicate cytosine residues in CpG 
sites, depending on whether a reverse (Y base) or forward (R base) biotinylated primer 
is used (Delaney et al., 2015).   
Gene CpG 
Pos. 
from 
ATG  
Pos. 
from 
TSS 
Chromatin 
Location Assay Sequence 
      
MyoG 
CpG-9 -280 -247 Chr13:51126212 
AGTYGAYGGTTTTTYGATTYG
TGTATAGGAGTYGTTTGGG 
CpG-8 -277 -244 Chr13:51126215 
CpG-7 -269 -236 Chr13:51126223 
CpG-6 -264 -231 Chr13:51126228 
CpG-5 -251 -218 Chr13:51126241 
      
Trim63 
CpG-5 -64 40 Chr5:152533388 
ATTYGAGTGGGATTTTTTTTA
TTYGGTGTGAYGTAGGTGGA
AGAGATAGTYGTAGTTTYGA
AGTAATATGGATTATAAATTT
GGTTTGATTTYGGAYGGAAAT
G 
CpG-4 -44 60 Chr5:152533408 
CpG-3 -36 68 Chr5:152533416 
CpG-2 -17 87 Chr5:152533435 
CpG-1 -9 95 Chr5:152533443 
CpG1 26 129 Chr5:152533447 
CpG2 30 133 Chr5:152533481 
      
Ampd3 
CpG-10 -559 -540 Chr1:175585557 
GYGGGYGTATGGGTG CpG-9 -555 -536 Chr1:175585561 
      
Fbxo32 
CpG-49 -519 -322 Chr7:98098590 TAYGTTYGATAGGGGAGTAG
GGGAGGTGTAAGAGGTGTTA
GGGTATYGAGGGTTAGYGGG
ATATTTGG 
CpG-48 -515 -318 Chr7:98098586 
CpG-47 -475 -278 Chr7:98098546 
CpG-46 -465 -268 Chr7:98098536 
      
Chrna1 
CpG-7 -240 -179 Chr3:60460903 
TCRACTCATATTAAACRTAAA
CCRTATAAAAATCTACATAAA
TCRTAAACCAAAAAC 
CpG-6 -219 -158 Chr3:60460882 
CpG-5 -212 -151 Chr3:60460875 
CpG-4 -198 -137 Chr3:60460861 
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Table 3.3. Primer design for HDAC 4 for analysis of DNA methylation via HRM-
PCR 
Gene 
Name 
CpG 
No. 
Gene Globe 
Cat No. 
Chromatin 
Location 
Primer Sequence Length 
      
Hdac4 
1 PM00599046 
Chr9:9138915
1-91391341 
GGGCGCGCAAGAGCG
CAGACTGTGACGGGG
GCCCGGT 
190 
2 PM00599053 
Chr9:9139007
7-91391147 
GCGCCCGCGAAGCGG
GGGTGGCTGTTGGGCT
ATTGTAGGGCGGA 
138 
3 PM00599060 
Chr9:9138905
2-91391220 
GCTAGCGCCTGGAGA
GTCCTCGGTACGCCCC
GC 
168 
4 PM00599067 
Chr9:9138947
7-91391621 
GCTTTGGGTCGCCGCC
ACCGCGTCCCGGT 
144 
5 PM00599074 
Chr9:9138947
2-91391621 
CGTTGCTGTGGCGGAG
GTGTAGGCTTTGGGTC
GCCGCCACCGCGTCCC
G 
149 
 
3.2.6 Statistical analysis  
Analysis of morphologic data were performed previously (Fisher, 2012) and 
confirmed by the current Ph.D applicant in SPSS (v. 22.0; SPSS, Chicago, IL, USA). 
Gene array analysis was performed using Transcriptome Analysis Console (TAC; 
Affymetrix) described in full (section 2.6.5.2). Morphological comparisons between 
experimental and control conditions were assessed via 1-way between-groups 
ANOVA. Microarray data were analysed for statistical comparison via 1-way 
between-group ANOVA within the freely available genomic software (TAC). 
Targeted rt-qRT-PCR was analysed by using a 1-way between-group ANOVA (with 
Tukey’s post-hoc test). DNA methylation data sets were analysed via a 2-way 
between-group ANOVA (with Tukey’s post-hoc test) which allowed for comparison 
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of experimental conditions and individual CpG islands. A follow-up 1-way ANOVA 
between CpG islands at each experimental condition was used to identify significant 
differences in the DNA methylation states of each individual CpG island within the 
same experimental condition. Finally, Student’s t tests were used to identify 
significant differences in CpG methylation between experimental conditions and 
control. All statistical analyses for DNA methylation were performed on absolute 
percentage values, with figures representing the fold change (means ± SD) to relevant 
control. Differences were considered statistically significant at values of P ≤ 0.05. 
 
3.3 Results  
3.3.1 Disuse atrophy produces significant wasting of skeletal muscle 
Cross-sectional area and muscle weight were analysed and presented for thesis 
examination previously (Fisher, 2012), with raw data being given to, and statistically 
reanalysed by, the current Ph.D who subsequently modified/redrew all figures for the 
purpose of this thesis. Tetrodotoxin (TTX) produced an average of 7.0 ± 2.4% loss in 
TA muscle weight at 3D, 28.7 ± 5.1% at 7D and 50.7 ± 2.7% loss following 14D that 
resulted in statistical significance at all time points versus the untreated control TA (P 
< 0.001; Figure 3.3) and a significant difference between paired comparisons of 3 and 
7D, 3 and 14D, 7 and 14D (P < 0.001). In the experimental group that received 7D of 
recovery (habitual activity patterns) following 14D of TTX exposure, muscle 
significantly recovered by 51.7% vs. 14D of denervation (P = 0.001). Muscle weight, 
however, did not completely recover to baseline control levels as there was still a 
significant reduction in the recovery group when compared to control (P < 0.001; 
Figure 3.3). Interestingly muscle weight in the recovery group was equivalent to that 
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of the 7D TTX atrophy group, suggesting that rates of recovery of a 7D period were 
similar to rates of loss over the same period of time. Collectively, these data suggest 
a significant and progressive reduction in TA muscle weight following disuse-induced 
atrophy, that is significantly, albeit partially, recovered following disuse cessation and 
normal habitual activity is resumed.  
 
 
	
Figure 3.3. Quantification of changes in muscle mass in vivo after TTX-induced nerve 
block. Data shown for 3, 7 and 14D of treatment, and TTX nerve block for 14D plus 
7D of active recovery (14D TTX 7D recovery). Mean TA mass is expressed as a 
percentage difference of whole animal body mass (428 ± 45 g) to normalise for inter-
individual differences in animal size. All data are presented as means ± SD for N = 6. 
* Statistically significant vs. sham control (P < 0.05); # statistically significant vs. 
14D TTX (P < 0.05). Figures adapted/redrawn from raw data provided by Dr. Andrew 
Fisher (Fisher, 2012) and statistically re-analysed by the current PhD candidate. 
 
* 
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Exposure to TTX produced a progressive reduction in mean muscle fibre CSA of 
17.95 ± 12.06% at 3D, 42.09 ± 6.17% at 7D and 68.94 ± 2.97% at 14D of TTX 
exposure, with 7D and 14D TTX exposure being significantly reduced versus the 
control (P = 0.003; P < 0.001, respectively; Figure 3.4). Similarly, to TA muscle 
weight, upon TTX cessation, the 14D TTX + 7D recovery group muscle CSA 
significantly recovered compared to 14D TTX alone, with an increase of 62.6% in 
CSA compared with 14D TTX alone (p = 0.002; Figure 3.4). Therefore, there was 
significant atrophy of individual skeletal muscle fibres in the TA muscles following 
denervation and a 51.7% recovery of muscle weight and 62.6% recovery of muscle 
CSA following 7D cessation of the TTX administration and normal habitual physical 
activity (Figure 3.4). 
 
The presented morphological data reports the successful induction of severe disuse-
induced atrophy across time-course. It is also observed that 7D of normal habitual 
physical activity, where 14D of TTX had previously induced significant atrophy, was 
sufficient to induce significant, albeit partial, recovery of skeletal muscle mass. 
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Figure 3.4. Muscle fibre cross-sectional area after TTX-induced atrophy and recovery. 
A). Mean cross sectional area of the TA muscle was expressed as a percentage change 
from untreated contralateral control limb for each animal. B). Haematoxylin and 
eosin-stained sections of untreated (A) and treated (B) TA muscle of control (i), 3D 
TTX (ii), 7D TTX (iii), 14D TTX (iv) and 14D TTX plus 7D recovery (v) conditions. 
* Statistically significant vs. sham control (P < 0.05); # statistically significant vs. 
14D TTX (P < 0.05). Figures adapted/redrawn from raw data provided by Dr. Andrew 
Fisher (Fisher, 2012) and statistically re-analysed by the current Ph.D candidate. 
 
3.3.2 Microarrays identify important gene regulatory networks during rat skeletal 
muscle atrophy  
After confirming a significant reduction and subsequent recovery in muscle mass, the 
temporal transcriptome profile accompanying muscle atrophy was investigated 
(N=4). For comparison, treated TA muscle samples from sham, 3D, 7D, 14d TTX and 
14D TTX plus 7D recovery groups were sent for microarray analysis. 30,000 rat 
A B 
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transcripts and 28,000 variants were examined via Affymetrix GeneChip® Rat 
Genome 230 2.0 Array and subsequently analysed for statistically differentially 
regulated transcripts.  
 
The representative dendrogram from the hierarchical clustering analysis of probe sets 
across the genome identified 3,714 genes that were significantly differentially 
expressed (P ≤ 0.001; Figure 3.5 A). It also demonstrated that there was a strong 
clustering of data sets for the 3, 7 and 14D TTX atrophy groups, which showed a clear 
and separate differentially regulated transcriptome compared to the recovery and 
sham control groups. This suggests that disuse-induced atrophy evoked a significant 
alteration on a large number of gene sets, that, following 7D worth of recovery, 
returned to baseline levels. To explore these findings further, the top 20 most 
differentially regulated probe sets across all comparisons were investigated, 
producing an unsupervised hierarchical clustering (Figure 3.5 B). These findings 
display a similar pattern of gene expression, reporting that 3, 7 and 14D of disuse-
induced atrophy show clear differentially regulated gene activity compared to 
recovery and sham control groups.  
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Figure 3.5. Transcriptomic analysis of disuse atrophy and recovery in rats. A. 
Hierarchical clustering heatmaps of probe set expression across the rodent genome 
identified 3714 genes that were highly and significantly differentially regulated (P ≤ 
0.001) across all conditions. Clustering analysis displays conditions 3, 7 and 14D to 
be significantly differentially regulated compared to sham control and 14D TTX and 
7D recovery. B. This analysis was confirmed in the top 20 statistically differentially 
expressed genes across all conditions. Similar clustering occurred that segregated 
TTX only exposure groups to sham control and 14D TTX and 7D of recovery.  
	
3.3.3 Microarray and significance ranking identifies important regulatory genes 
during atrophy 
In order to decipher what genes were important in the regulation of skeletal muscle 
atrophy and subsequent recovery, transcriptome wide data sets were analysed to 
produce six separate pairwise comparisons (sham vs, 3D, 7D and 14D, and recovery 
vs. 3D, 7D and 14D), revealing a list of genes that were most statistically altered 
within these experimental parameters. Trim63 (MuRF1), Myogenin (MyoG) and 
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Ampd3 were identified as being the most frequently occurring highly differentially 
regulated genes across all pairwise comparisons, who all also appeared in the top 20 
most statistically differentially regulated genes across all probe set comparison (table 
3.4). Previous work has identified Ampd3 as playing a pivotal role in protein 
degradation in C2C12 murine myotubes (Davis et al., 2015). The E3 ubiquitin ligase 
Trim 63, has regularly been shown to be a key transcript in orchestrating the loss of 
skeletal muscle in a number of catabolic situations, as has its protein family members, 
Fbxo 32  (Cohen et al., 2009, Cohen et al., 2007, Tang and Goldman, 2006, Tang et 
al., 2009, Tang et al., 2015). This justification led for an extended analysis of these 
three genes for confirmation of transcript behaviour and elucidation of epigenetic 
profile during muscular atrophy and recovery. The basic helix-loop-helix myogenic 
factor, MyoG has been shown to play a crucial role in denervation-dependent skeletal 
muscle atrophy (Macpherson et al., 2011, Tang et al., 2009). Importantly, the MyoG 
upstream regulator, Hdac4, also appeared in the top 20 most statistically differentially 
regulated genes and was the most highly differentially regulated when comparing 
sham control to 3d TTX atrophy. The class II histone deacetylase has previously been 
shown to play an important role in the regulation of MyoG activity (Moresi et al., 
2010, Tang et al., 2009), and thus both genes warranted further analysis. Additional 
NMJ associated genes that were significantly altered and appeared in the top 20 most 
differentially regulated genes included the acetylcholine receptor subunit alpha 1 
(Chrna1; table 3.4). This gene also appeared in 2 out of 6 paired comparisons of most 
differentially regulated genes.  Chrna1 plays a crucial role in acetylcholine binding 
and channel gating activity, within the neuromuscular junction pathway (Yu and Hall, 
1991) and has been previously been identified via transcriptome analysis as the most 
differentially regulated gene in skeletal muscle loss observed in age-related muscle 
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loss/denervation (Ibebunjo et al., 2013). 
 
Table 3.4. Top 20 most statistically differentially regulated gene transcripts across all 
conditions of rodent disuse-induced atrophy and return to activity, identified via gene 
expression microarrays (N=4), and ranked according to significance. Transcript ID 
identifies multiple transcript variants. Two unknown transcripts were identified and 
removed from this table (ranked at positions 3 and 15, respectively). Highlighted cells 
indicate those run for further down-stream analysis. 
Gene 
Symbol 
Ranked Gene Description 
ANOVA P-
Value 
Transcript 
ID 
Runx1 1 Runt-related transcription factor 1 6.60E-10 Rn.11201.1 
Ampd3 2 
Adenosine Monophosphate Deaminase 
3 
6.60E-10 Rn.11106.1 
Atf4 4 Activating Transcription Factor 4 7.43E-9 Rn.2423.1 
Myog 5 Myogenin 1.96E-8 Rn.9465.1 
Adig 6 Adipogenin 2.59E-8 Rn.17645.1 
Gadd45a 7 
Growth Arrest and DNA-damage-
inducible alpha 2.59E
-8 Rn.17645.1 
Runx1 8 Runt-related transcription factor 1 3.17E-8 Rn.31927.1 
Trim63 9 Tripartite Motif Containing 63/ Murf1 4.10E-8 Rn.40636.1 
Sat1 10 Spermidine 4.10E-8 Rn.40636.1 
Hdac4 11 Histone Deacytelase 4 5.98E-8 Rn.23483.1 
Ankrd1 12 Ankyrin Repeat Domain 1 6.62E-8 Rn.3789.1 
Pdhx 13 
Pyruvate Dehydrogenase Complex, 
Component X 
6.62E-8 Rn.2260.1 
Reps1 14 
RALPBP1 Associated Eps Domain 
Containing 1 
1.19E-7 Rn.12867.1 
Adam19 16 ADAM Metallopeptidase Domain 19 3.01E-7 Rn.904.1 
Hdac4 17 Histone Deacytelase 4 3.72E-7 Rn.20628.1 
Ankrd1 18 Ankyrin Repeat Domain 1 3.96E-7 Rn.3789.1 
Chrna1 19 Cholinergic Receptor, Nicotinic alpha 1 4.07E-7 Rn.44633.1 
Mxra7 20 
Matrix-Remodelling Associated 1 
(uncharacterised) 
5.65E-7 Rn.12266.1 
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3.3.4 DNA methylation is inversely associated with gene expression of the 
identified genes during TTX atrophy and recovery  
Following 3D TTX exposure there was a significant reduction (0.85 ± 0.04, P = 0.011) 
in DNA methylation (hypomethylation; 3D, 40.2 % ± 2.6) in the promotor region of 
the myogenic regulatory factor, MyoG (Figure 3.6 A), compared to baseline control 
(sham control, 33.9 % ± 6.8). This reduction in DNA methylation coincided with a 
significant (P = 0.011) increase in gene expression (33.08 ± 33.71) at the same time 
point (Figure 3.6 B). Interestingly, following this time point both DNA methylation 
and gene expression profiles of this gene returned towards baseline control levels 
during TTX only exposure (i.e. 7 and 14D TTX; Figure 3.6 A and 3.6 B). The DNA 
methylation profile of the cholinergic receptor nicotinic alpha 1-subunit (Chrna1) 
portrayed a progressive hypomethylation from sham control through to 14D of TTX 
exposure, with 7D (41.5 % ± 1.5, representing a fold change of 0.93 ± 0.04) and 14D 
(39.4 % ± 2.1, representing a fold change of 0.89 ± 0.04) attaining significance 
compared to control (44.4 % ± 0.7; P = 0.035 and P < 0.001, respectively; Figure 3.6 
A). This progressive reduction in DNA methylation was met with a progressive 
increase in gene expression across the same time points (7D, 133.55 ± 38.73; 14D, 
177.52 ± 205.19; Figure 3.6 B), where it attained a significance value at 14D TTX 
exposure (P = 0.016). In similar fashion to Chrna1, Trim63 showed a significant 
reduction in DNA methylation status at both 7D (32.4 % ± 2.3) and 14D (31.7 % ± 
3.7) of TTX exposure (P = 0.035 and P < 0.001, respectively) (Figure 3.6 A), which 
coincided with a stable increase in mRNA expression at the same time points (7D, 
2.70 ± 1.73; 14D, 1.52 ± 2.14). Trim63’s protein family member, Fbxo32, showed a 
decreasing trend in DNA methylation over the 14D period which attained significance 
at 14D of exposure (0.4 % ± 0.4, representing a fold change of 0.30 ± 0.21; P = 0.021), 
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when compared to control (1.1 % ± 0.4). mRNA expression of the Fbxo32 gene 
showed significant increases compared to control at both 3D (3.03 ± 2.5; P = 0.037) 
and 7D of atrophy (3.03 ± 2.3; P = 0.038).  
 
Interestingly, in genes Fbxo32, Trim 63 and most notably Chrna1, TTX cessation and 
7D worth of recovery caused DNA methylation profiles to become methylated once 
more and return to sham control levels (P > 0.05; Figure 3.6 A). Importantly, the 
return of DNA methylation status to resemble that of sham control levels, was met 
with a concomitant return of gene expression towards baseline levels. Schematic 
representation of the correlation	 between DNA methylation and gene expression 
profiles is given in Figure 3.6 B. No statistically significant observations were noted 
in the behaviour of Ampd3 methylation following disuse-induced atrophy or return to 
activity in skeletal muscle. Furthermore, following initial screening of the gene Hdac4 
for total percentage methylation within the amplicon/ product via HRM PCR, 
methylation above that of the 0% control was undetectable and therefore loci-specific 
pyrosequencing of this gene was not performed.		
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Figure 3.6. Relative fold change in gene expression and DNA methylation displaying 
an inverse and transiently active relationship across experimental time-course, in a 
subset of identified and analysed gene transcripts. A. DNA methylation data presented 
as relative fold change compared with sham control for all genes previously reported 
(except Hdac 4). Mean data (histogram bars) are the average taken from each CpG 
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island of the respective gene transcript, analysed via loci-specific pyrosequencing. 
Individual CpG island methylation percentages are visualised as individual lines and 
annotated in graph specific indents. Data presented as means ± SD for N = 3. 
Statistically significant reductions compared with control group represented by *; 
reduction compared to 3 d TTX represented by ✢; and § represents significance 
compared to 7 and 14 d TTX atrophy. B. An overlap representative schematic of the 
relationship between changes in gene expression (thick black line; mean fold change 
to baseline ± SD) and DNA methylation (black dashed line) of key transcripts. 
  
3.4 Discussion of Findings 
The aim of this chapter was to, for the first time, investigate the role of DNA 
methylation in skeletal muscle atrophy using an in-vivo implanted osmotic pump and 
nerve cuff apparatus that would administer tetrodotoxin (TTX) to the peroneal nerve 
and silence the neural input to the muscles of the hind limb. We also wished to 
elucidate whether any epigenetic modifications identified after atrophy were retained 
or returned to normal following a return to normal physical activity levels in the same 
animals. The findings in this chapter support the first hypothesis, whereby epigenetic 
modifications to the promotor region of important genes are concomitant with 
functional changes in gene expression, during a progressive muscle atrophy model. 
Contrary to the second hypothesis however, upon cessation of the atrophic stimulus, 
we observed that promotor methylation in the majority of gene transcripts returned 
towards baseline, showing no statistical difference compared to control, suggesting 
that these genes did not retain epigenetic modifications.  
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3.4.1 DNA methylation is inversely mirrored with important changes in skeletal 
muscle gene expression after atrophy and the return to habitual activity  
The observed changes in DNA methylation profiles of muscle specific regulatory 
gene targets is inversely reflected with altered expression of a number of key target 
transcripts previously identified as playing a significant role in orchestrating muscular 
atrophy in a disuse or denervated milieu. The bHLH transcriptional factor and 
member of the MRFs, MyoG, is commonly associated with having an important role 
in the process of skeletal muscle development/myogenesis and the repair and 
regeneration process of myofibres following injury, specifically the differentiation 
and fusion process (Le Grand and Rudnicki, 2007). Counterintuitively, we observe a 
marked increase in gene expression upon disuse-induced atrophy (Figure 3.6 B), that 
may reflect a compensatory mechanism in an unsuccessful attempt by the organism 
to halt the atrophy process. However, novel data is reported here to suggest that DNA 
hypomethylation is met with increases in gene expression observed over the atrophy 
time-course.  
 
Two well categorised down-stream transcriptional targets of the MyoG protein are the 
E3 ubiquitin ligases Trim63 and Fbxo32, that have both previously been identified as 
being highly regulated during periods of muscle loss caused by denervation, 
immobilization and unloading in rodents (Bodine et al., 2001a, Bodine and Baehr, 
2014). Trim63 is an E3 ubiquitin ligase and member of the RING zinc finger family 
of proteins, and is responsible for the polyubiquitination of proteins to target them for 
proteolysis (Bodine et al., 2001a, Gomes et al., 2001). Upon catabolic stimuli, such 
as diabetes, glucocorticoid treatment, cytokine treatment, unloading and denervation, 
the expression of Trim63 has consistently been reported to increase, confirming its 
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action in atrophying skeletal muscle (Goldberg, 1969, Bodine et al., 2001a). At a 
protein level, northern blot analysis reported a significant increase of both Trim63 and 
Fbxo32 proteins at 3 and 7 days of denervation induced atrophy (Bodine et al., 2001a). 
Here, it is reported that DNA hypomethylation of these ubiquitin ligases is decreased 
at specific time points during disuse-induced atrophy time-course, that was coupled 
with time specific increases in gene expression (Figure 3.6 B). Interestingly, upon 
TTX cessation and 7 d of active recovery, DNA methylation of these two E3 ubiquitin 
ligase genes, increases back towards control levels, which coincides with a reduction 
in gene expression (Figure 3.6 B). Collectively, these data suggest a distinct role for 
DNA methylation in modulating gene expression of the two ubiquitin ligases proteins 
during progressive disuse atrophy and subsequent physical activity induced muscle 
mass recovery.  
 
Chrna 1, the major component of the muscle specific nicotinic acetyl choline receptor 
(nAchR) in adult skeletal muscle (Giniatullin et al., 2005), plays an integral role in 
initiating the opening of the nAchR channel allowing for the transfer of positively 
charged ions through the cell membrane (Beker et al., 2003). Interestingly, given its 
role in muscle contraction, we observe a progressive and significant increase in gene 
expression which is met with an equally progressive reduction in DNA methylation, 
culminating at 14 d of TTX exposure. Following 7d of active recovery, DNA 
methylation returns to sham control levels, which coincides with a significant 
reduction of gene expression, back to control levels also. The gene expression and 
DNA methylation profile of the gene Chrna1 shows interesting temporal behaviour 
through the 14 d atrophy time-course and subsequent 7 d of recovery. Chrna1 is one 
of five isoforms found in human skeletal muscle, and the most dominant in the nAchR 
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cluster. All five isoforms function to create an	acetylcholine cluster surrounding the 
neuromuscular central pore, in which they house target binding sites, predominantly 
located on the alpha subunit. Upon contact of a chemical messenger to one of the 
target binding sites, all present subunits undergo a conformational change resulting in 
the channel gate opening, and the potential passing of positively charged ions 
(Colquhoun and Sivilotti, 2004). Given the specific model of denervation in this 
chapter, in which no action potential signals reach these subunits, it is possible that 
the observed reduction in DNA methylation and concomitant progressive increase in 
gene expression is a compensatory mechanism to form new end plates and enable the 
successful opening of the nAchR channel.		
 
3.5 Summary, Conclusions and Future Chapter Directions  
Analysis of individual CpG sites within the promoter region of key target transcripts 
(Myog, Trim63, Fbxo32, Chrna1, Ampd3) during skeletal muscle atrophy and 
recovery in rodents, identified a potential relationship with gene expression. Where 
hypomethylation of DNA, especially within promotor regions as studied here, has 
been well characterised to promote increased gene expression. Overall, suggesting an 
important role for the epigenetic control of these genes during disuse atrophy. 
Furthermore, upon recovery of skeletal muscle, DNA methylation of the same genes 
were methylated once more and returned back to normal levels concomitantly with a 
reduction in gene expression back towards normal levels. This also suggested that 
epigenetic changes in these genes, via DNA methylation, were transient and reversible 
after recovery from atrophy.  
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After targeted analysis of DNA methylation of genes identified to be important during 
atrophy and recovery, demonstrating muscle size reductions are sufficient to induce 
epigenetic modifications skeletal muscle, we wished to explore whether during 
muscle mass increases (hypertrophy) we identified similar changes. Furthermore, we 
wanted to elucidate whether such epigenetic modifications, were retained or reversed 
(similar to findings in the present chapter) during a subsequent later period of skeletal 
muscle hypertrophy in order to investigate the concept of epigenetic muscle memory, 
as speculated in chapter 1.  
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Chapter 4:  
 
	
	
Human Skeletal Muscle Possesses an Epigenetic Memory of 
Hypertrophy   
 
 
 
 
 
 
 
 
 
The work contained within this chapter has recently been published; 
 
Seaborne, R. A., Strauss, J., Cocks, M., Shepherd, S., O’Brien, T. D., van Someren, 
K. A., Bell, P. G., Murgatroyd, C., Morton, J. P., Stewart, C. E. & Sharples, A. P. 
(2018). Human skeletal muscle possesses an epigenetic memory of hypertrophy. 
Scientific Reports, 8,1898.  
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4.1 Introduction  
In chapter 3, significant epigenetic modifications (in the form of DNA 
hypomethylation) in the promotor region of genes increased at the expression level 
during skeletal muscle atrophy were identified. Furthermore, via re-introduction of 
habitual physical activity, it was possible to identify a reversal of DNA methylation 
during recovery that was associated with gene expression returning to normal control 
levels. Therefore, contrary to our original hypothesis, these DNA methylation 
modifications were not retained and instead, returned back towards control levels. In 
order to explore these concepts further, we sought to elucidate the role DNA 
methylation plays in modulating skeletal muscle growth (hypertrophy) following a 
period of chronic resistance exercise in humans (RE). Further, via the implementation 
of an experimental design whereby following earlier hypertrophy, RE was completely 
cessed for a period of time retuning muscle mass to baseline levels and then re-
introduced to evoke later hypertrophy, we aimed to identify if there was an epigenetic 
retention or simply a reversal of DNA modifications that occurred during earlier 
hypertrophy. Furthermore, if a retention of epigenetic information did occur during 
cessation of RE and later RE (following a period of earlier hypertrophy), if this was 
associated with advantageous gene expression and larger muscle mass during 
subsequent hypertrophy.   
 
Indeed, there is a distinct paucity of work identifying the large-scale epigenetic 
modifications that occur following RE in the mammalian organism. In skeletal 
muscle, acute RE (3 sessions, 4 × 8-10 reps, 3 exercises, 2-days rest between sessions) 
induced significant DNA methylation changes to 474 regions of DNA isolated from 
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the vastus lateralis muscle (Laker et al., 2017). Furthermore, when exploring the 
relationship between the methylome and transcriptome, the authors identified 54 
genes as demonstrating a significant relationship between modifications in DNA 
methylation and gene expression (Laker et al., 2017). However, interpretation of these 
findings was somewhat limited given were consuming a high-fat diet in addition to 
undertaking RE (3.9 g fat/kg fat free mass, equating to 77% of total caloric intake) in 
an attempt to compare with a high fat diet alone control group, with no basal 
comparison.  Thus, it is still unknown as to the basal response of the human 
methylome following a period of RE-induced muscle hypertrophy.  There are 
currently no investigations in skeletal muscle tissue that identify the DNA methylation 
changes after chronic RE. The only data included DNA methylation changes in 
leukocytes following 8-wks of chronic RE (3 times per week, 3 × 10-12 reps at 80% 
1RM). Where  analysis of the human methylome via BeadChip array identified 57,384 
CpG sites as portraying a significantly differentially modified profile, with the same 
number of DNA sites being identified to be hypomethylated (28,987) vs. 
hypermethylated (28,397) (Denham et al., 2016).  
Therefore, the aim of this was to elucidate the response of the human methylome 
following exposure to chronic RE, and to identify whether these modifications are 
retained or reversed over a period of exercise cessation and if further modified 
following exposure to a secondary RE stimulus. In order to investigate these aims, an 
in-vivo RE model was utilised, where human subjects were exposed to an initial 7-
weeks of RE (loading), a subsequent 7-weeks of exercise cessation (unloading), and 
a final, secondary 7-week period of RE loading (reloading). Furthermore, to determine 
if there was retention or a reversal of epigenetic modifications following muscle mass 
increases, a methylome array was utilised to examine over 850,000 CpG sites of the 
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human genome after all conditions (baseline, loading, unloading and reloading). 
 
Following identification that DNA methylation plays a role in muscle mass regulation, 
in chapter 3, it was first hypothesised that large-scale modifications to the human 
methylome would occur following 7-weeks of RE induced hypertrophy in humans. 
Furthermore, it was hypothesised that a distinct number of these modifications would 
be retained during 7-weeks unloading, and would aid in generating a further enhanced 
(e.g. enhanced gene expression) response of the human methylome following 
secondary exposure to RE.  
 
4.2 Methodology 
4.2.1 Experimental design 
Using a within subject design, eight previously untrained male participants (27.6 ± 
2.4 yr, 82.5 ± 6.0 kg, 178.1 ± 2.8 cm, means ± SEM), completed a 7 week chronic and 
progressive resistance exercise training programme (3d/week; loading), 7 weeks of 
exercise cessation (unloading) and a subsequent 7 weeks (3d/week) of resistance 
exercise loading (reloading). Exercise protocol is detailed previously (section 2.2.2), 
and experimental design is schematically represented in Figure 4.1. Whole-body fan 
bean dual-energy x-ray absorptiometry (DEXA), isometric voluntary contraction to 
assess quadriceps strength and muscle biopsy samples from the vastus lateralis for 
down-stream RNA and DNA analysis were obtained at baseline and experimental 
weeks 8, 14 and 22, respectively (detailed in Figure 4.1). Genome wide DNA 
methylation analysis was performed via Illumina EPIC array for participants (N=8 
baseline, loading, unloading; N=7 reloading) across all conditions. Follow up gene 
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expression was subsequently performed on identified transcripts of interest.  
	
	
Figure 4.1. Schematic representation of experimental condition and types of analyses 
undertaken across the time-course. Muscle schematic represents data collection time, 
where analysis of muscle size (i. DEXA) and muscle strength (ii. IKD) were 
performed. Muscle samples were obtained at the same experimental time points and 
down-stream analysis of methylome wide bead array (iii) were performed on isolated 
and treated DNA. Finally, gene expression was analysed on muscle samples via rt-
qRT-PCR (iv).  
	
4.2.2 Resistance exercise-induced muscle hypertrophy: loading, unloading, 
reloading 
Complete description of resistance load induced hypertrophy programme is detailed 
in methodology section 2.2.2. Briefly, following a familiarization week which 
accustomed previously novice participants to the required lifting techniques, range of 
motions and exercise, exercise loads were set via an ability assessment and verbal 
feedback (participant). Participants performed 3 sessions (~ 60mins per session) per 
week for 7 weeks of resistance exercise training constituting of two lower limb 
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sessions and one upper body focused session (section 2.2.2). Due to participants being 
unaccustomed to exercise training modality, an overall progression model was 
utilised, similar to that previously described (Baechle et al., 2008, Peterson et al., 
2011). Full descriptive of exercises, sets, reps and progression model utilised are 
given in section 2.2.2. Following 7 weeks of resistance training, participants were 
instructed to return to habitual pre-intervention exercise levels (unloading) and not to 
perform any form of resistance training. Regular verbal communication between 
researcher and participant ensured subjects followed these instructions. Participants 
subsequently began a secondary period of 7 weeks of resistance training (reloading). 
In the first session of this training phase (reloading), participants performed sets, reps 
and load that resembled week 1 of loading training. All exercises, sets, reps and 
progression were performed and monitored in identical to fashion to that of the 
loading phase (section 2.2.2). Total weekly volume load was calculated as the sum of 
all exercise loads;  
 
This model of progression and resistance training, resulted in a progressive increase 
in training volume (± SEM) of 2,257 ± 639 kg and 2,386 ± 222 kg respectively per 
week (Figure 4.2), with the reloading phase displaying a significant (P = 0.043) 
increase in average load. 
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Figure 4.2. Weekly total volume of resistance exercise undertaken by human 
participants (N=7) during first 7 weeks of resistance exercise period (loading), 
followed by 7 weeks’ exercise cessation period (weeks 8-14), and the later secondary 
period of 7 weeks’ resistance exercise loading (reloading).  
	
4.2.3 In-vivo assessment of lean mass and strength in humans 
At experimental time points (Figure 4.1), DEXA and knee-extensor MVC measured 
were taken from participants (N=7) for analysis of changes in skeletal muscle mass of 
the lower limbs, and muscular strength changes in the quadriceps femoris of the right 
leg. Protocols for analysis of lean mass via DEXA and muscular strength via 
isokinetic dynamometer (IKD) are provided in sections 2.4.1 and 2.4.2, respectively. 
Lean mass of the combined lower limb values were analysed via QDR software, 
calculated on absolute values for each condition, and presented as percentage change 
compared to baseline. Furthermore, to assess whether later reloading altered lean 
mass, loading was normalised to baseline, and reloading was normalised to unloading 
data to account for residual starting mass in both conditions. Quadriceps femoris 
measure of strength was analysed using absolute values (Nm) as a percentage change 
to baseline (%). Furthermore, to assess whether later reloading altered quadriceps 
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femoris strength, loading was normalised to baseline, and reloading was normalised 
to unloading data to account for residual starting strength in both conditions.  
 
4.2.4 Muscle biopsy preparation 
At baseline, 7 weeks loading (beginning of week 8), 7 weeks unloading (end of week 
14) and 7 weeks reloading (beginning of week 22) (Figure 4.1), a muscle sample was 
obtained from the vastus lateralis muscle of the right leg from each participant, 
avoiding areas of immediate proximity to previous incisions, before being carefully 
dissected using a sterile scalpel on a sterile (gamma-irradiated) petri dish. Separate 
samples were immediately snap frozen in liquid nitrogen before being stored at -80oC 
for down-stream analysis.  
 
4.2.5 Isolation and analysis of DNA for methylome and CpG DNA methylation via 
epic methylome bead array 
DNA was isolated and analysed for quality and quantity from skeletal muscle biopsy 
samples as previously described (section 2.7.1 to 2.7.3). Isolation of DNA yielded 
averages quantities of 8.0 µg (± 4.2) and 260/280 quality ratio of 1.88 (± 0.09). Five 
hundred ng of prepared DNA was subsequently bisulfite converted using the EZ-96 
DNA methylation kit (as described 2.7.4.1). Illumina MethylationEPIC BeadChip 
(Infinium MethylationEPIC BeadChip, Illumina, California, United States) array was 
then used to examine over 850,000 CpG sites of the human methylome (see section 
2.7.5), and subsequent data files (.IDAT) were imported into Partek Genomic Suite 
for differential methylation analysis across all experimental conditions to identify 
differentially regulated CpG sites of experimental groups. Fold change in CpG 
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specific DNA methylation and statistical significance was performed using Partek 
Genomic Suite V.6.6 software, where statistical significance was obtained following 
ANOVA (with Bonferroni correction) analysis.  Unadjusted p-value significance (P 
< 0.05) was used to create a CpG site marker list of standardized beta-values. 
Unsupervised hierarchical clustering was performed and a dendogram was 
constructed to represent differentially methylated CpG loci and statistical clustering 
of experimental samples, and schematically represented in heatmaps (for further 
details see section 2.7.5). The same marker list was used to analyse gene ontology 
(GO) terms and KEGG signalling pathways, as previously described (section 2.7.5.2) 
 
4.2.6 Isolation and analysis of RNA for gene expression 
RNA was isolated, quantified, prepared and setup for rt-qRT-PCR as described in 
sections 2.6.1 to 2.6.4. All primer sequences for analysis of genes of interest are 
provided in table 4.1. Gene expression analysis was performed on at least n = 7 for all 
genes, unless otherwise stated. All relative gene expression was quantified using the 
comparative Ct (∆∆Ct) method (Schmittgen and Livak, 2008). Individual participants’ 
own baseline Ct values were used in ∆∆Ct equation as the calibrator using RPL13a as 
the reference gene. The average Ct value for the reference gene was consistent across 
all participants and experimental conditions; 20.48 (± 0.64, SD) with low variation of 
3.17%, and an average efficiency of 82.5 % (± 7.1, SD) and low percentage variation 
3.9. 	
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Table 4.1.	Gene primer sequences for human muscle memory experiment. All primers 
used the same cycling conditions.	
Gene Accession No.  Primer Sequence 
Primer 
Length 
Prod. 
Length 
      
RPL13a NM_012423 
F – 
R – 
GGCTAAACAGGTACTGCTGGG 
AGGAAAGCCAGGTACTTCAACTT 
21 
23 105 
ERICH1-
AS1 
NM_00134
6810.1 
F – 
R – 
AATGGGCAATTCGAGTCCGT 
GCTGTGACTCCTTGTTCGGA 
20 
20 105 
CACNA1H NM_001005407.1 
F – 
R – 
AGCGCCGGCCCTACT 
CATGGTGATGACGTTGACACAG 
15 
22 119 
GAS7 NM_201432.1 
F – 
R – 
GAACCTGGGATCCTCATCGC 
GTGAGGGAACGTCACACAGT 
 
20 
20 79 
FBXL17 NM_001163315.2 
F – 
R – 
TTGCACAGAGCAGCAAGTCT 
TGTTCCACCGTCACTTCGTT 
20 
20 76 
CPT1A NM_001031847.2 
F – 
R – 
CAGGCCGAAAACCCATGTTG 
AGGCCTCACCGACTGTAGAT 
20 
20 104 
STAG1 NM_005862.2 
F – 
R – 
GCATTTTTAGCAACTTCTACCAGC 
AACTTGAATTTGGCAGGGCA 
24 
20 115 
AFF3 NM_002285.2 
F – 
R – 
AACGGGAGCTGAGAGCTGAT 
GGGTGTCGACTTCAAACTTGC 
20 
21 70 
STIM1 NM_001277962.1 
F – 
R – 
TGGACGATGATGCCAATGGT 
CTCACCATGGAAGGTGCTGT 
20 
20 110 
AXIN1 NM_003502.3 
F – 
R – 
AAGGTCCCGAGGCTACTCAG 
GCATTTCTTTTGCACGCCAC 
20 
20 112 
MTFR1L NM_001099625.1 
F – 
R – 
CAACCTACCCTTGAAGCCGT 
TGGGGGCACATCTCTCAAAC 
20 
20 89 
ODF2 NM_153436.1 
F – 
R – 
TTGTGGCGCACCCAGTGTAA 
GCACATTCACAGTGTCCCCT 
20 
20 71 
GRIK2 NM_001166247.1 
F – 
R – 
CACATACAGACCCGCTGGAA 
GGTCTAAAATGGCACGGCTG 
20 
20 110 
CAMK4 NM_001323377.1 
F – 
R – 
AGCTCTGCTGTGGGTTTTGA 
AAATGCCGGTGTTTGGCTTC 
20 
20 91 
CPED1 NM_024913.4 
F – 
R – 
GCCGAAGGGCCATACTCTAC 
TCTTCAGCGATGACAACCGT 
20 
20 106 
NUB1 NM_001243351.1 
F – 
R – 
GGATCATGCGGCCACTCATA 
AACCTGATGTTCTCGAGGCG 
20 
20 102 
APLP1 NM_001024807.2 
F – 
R – 
CATCTGGGACAGCAGTTGGT 
CCTCCTCTTCCTCGTCCTCA 
20 
20 87 
PAPD7 NM_001171805.1 
F – 
R – 
CATGAAAGCCATGACCAGCG 
TCGAAGACCTGCTTCACCTG 
20 
20 120 
IL19 XM_011509450.2 
F – 
R – 
CCATCGGCCTCCTGATATGG 
TGGGAGAGGTTCTCCACAGT 
20 
20 84 
UNC45A NM_001039675.1 
F – 
R – 
GAGATGTTGGGGTTCCCAGG 
AGCTGAAGAGCAGCAGTAGC 
20 
20 118 
CNTNAP2 NM_014141.5 
F – 
R – 
CACTTGGTGGGTTGGCAAAG 
GGATCTGTGCAGTTGCGTTC 
20 
20 105 
MYO10 NM_012334.2 
F – 
R – 
CACTGAGTGTGACTTCAAGAAAGC 
TTTGGGGCTGACATAGGGGA 
24 
20 110 
TM6SF1 NM_001144903.1 
F – 
R – 
CCATCCCGGTCACCTATGTC 
CAGCAGTGCTACCAGGAACA 
20 
20 101 
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NUP205 NM_001329434.1 
F – 
R – 
CTGGAGAGCATCAACAGCCA 
ATGCATCGCTTTCCATCCCA 
20 
20 85 
HOXB1 NM_002144.3 
F – 
R – 
TACCCACTCTGTAACCGGGG 
ATAGCTGTCAACCGCCTGAG  
20 
20 100 
C8B NM_001278544.1 
F – 
R – 
TGCCAAGGAAATGGAGTCCC 
AGGAGACCTCACAGGCTAGG 
20 
20 91 
KLHDC1 NM_172193.2 
F – 
R – 
TGGTGGGAGCAAAGATGACT 
TCAAGGCATGACCTGAGTAGTG 
20 
22 102 
MYO16 NM_015011.2 
F – 
R – 
AGTCTCAGGACAGCATCCCT 
TTTGGGGCAGGAGGCATTAG 
20 
20 85 
C11orf24 NM_001300913.1 
F – 
R – 
CCAGCTCACCCACAAGATGT 
AGTTGCGTGGATCGTTGGAT 
20 
20 98 
FREM2 NM_207361.5 
F – 
R – 
GAGAAGGGGCTAATGCCACA 
TCCATGCCCAATTCAGACGA 
20 
20 102 
ADSSL1 NM_152328.4 
F – 
R – 
ACTTCATCCAACTGCACCGT 
ACGTCACCTATGTTCTGCGG 
20 
20 71 
RPL35A NM_000996.2 
F – 
R – 
TAACTCGGGCCCATGGAAAC 
TGTCCAATGGCCTTAGCAGG 
20 
20 76 
SETD3 NM_032233.2 
F – 
R – 
GACCCATCCTCATGCCAACA 
CAGAAGAGACTGCCCACCTG 
20 
20 77 
TRAF1 NM_001190947.1 
F – 
R – 
GGAAGCTGCGTGTGTTTGAG 
AGCTGGCTCTGGTGGATAGA 
20 
20 97 
ART3 NM_001130017.2 
F – 
R – 
AGGAGGTTATACCCGGAGGT 
GATCAGCACTGGCAGCAAAC 
20 
20 80 
NR2F6 NM_005234.3 
F – 
R – 
TCCAGGATGGAGGGTCCAAT 
CCCACCATCCCACAAGTTCA 
20 
20 74 
C12orf50 NM_152289.1 
F – 
R – 
GCAACCACTTTCAGCGTTTCT 
GCCTCTTCACAGTGTCGGAA 
21 
20 71 
BICC1 NM_001080512.2 
F – 
R – 
GGCCATGTTACAAGCTGCTG 
TGGCCAAGCAATCTGCGTAT 
20 
20 97 
ZFP2 NM_030613.3 
F – 
R – 
TTCCACAGCCAGCATCTCAC 
TCAGTAATACCCGGCTTCGG 
20 
20 99 
FKBPL2 NM_022110.3 
F – 
R – 
CTCCTGTCAGGCTCACACTG 
GGGCTTCCTTCTCGCTAGTC 
20 
20 78 
RSU1 NM_012425.3 
F – 
R – 
TGCCGCCAGATATTGGGAAG 
CCTTAGGCAGCGAGATCAGG 
20 
20 78 
IGF2BP3 NM_006547.2 
F – 
R – 
ACTCGGTCCCAAAAAGGCAA 
CCAGCACCTCCCACTGTAAAT 
20 
21 107 
UBR5 NM_001282873.1 
F – 
R – 
AGGCAACACCTTAGGAAGCC 
GCTCCAGCTGATGACCTACC 
20 
20 81 
LTB NM_002341.1 
F – 
R – 
TCACCCCGATATGGTGGACT 
TCGCACCACGCACTCATATT 
20 
20 87 
PTH1R NM_000316.2 
F – 
R – 
CAAGGGATGGACATCTGCGT 
GTCCTCCTCAGACTCAGGGT 
20 
20 85 
HEG1 NM_020733.1 
F – 
R – 
AACGTTCGATCGCTGGGATT 
TGGTCGCTGGAAGTCCTTTG 
20 
20 73 
HSPD1 NM_002156.4 
F – 
R – 
GGTGGTGCAGTGTTTGGAGA 
TGGCATCGTCTTTGGTCACA 
20 
20 
118 
 
ZNF562 NM_001120021.1 
F – 
R – 
GTGTGCACAAGGAAGCCTCT 
CACAGCAAGGCCTGGAGTTA 
20 
20 89 
PLA2G16 NM_001128203.1 
F – 
R – 
GATGACAAGTACTCGCCGCT 
CTTGTAGAGCACCTCCTGCC 
20 
20 81 
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4.2.7 Statistical analysis  
Analysis of in-vivo data (N=7) was performed via a one-way repeated measures 
ANOVA in SPSS (v.23.0), with follow up analysis of change in mass and strength as 
a result of loading or reloading (when normalized to relevant baseline or unloading 
control to account for residual starting mass or strength) performed via a pairwise T-
test in SPSS. In MiniTab Statistical Software (MiniTab v.17.2.1), MANOVA analysis 
was used for gene expression of relevant transcript clusters to detect for significance 
across time with a follow up ANOVA performed for analysis of time, within each 
transcript cluster. Correlation analysis of gene expression to percentage change in leg 
lean mass was performed via a Pearson correlation coefficient with significance 
ascertained via two-tailed test (SPSS). All methylome-wide and CpG loci specific 
statistical analysis was performed in Partek Genomic Suite (v.6.6), as described in 
section 2.5. Statistical values were considered significant at the level of P ≤ 0.05. All 
data represented as mean ± SEM, unless otherwise stated.	 
 
4.3  Results 
4.3.1 Lean leg mass and muscle strength is increased after loading, returns toward 
baseline during unloading and is further increased after reloading 
Analysis of lower limb lean mass via DEXA, identified a significant increase of 6.5% 
(± 1.0%; P = 0.013) in lean mass after 7-wks of chronic loading compared to baseline 
(20.74 ± 1.11 kg loading vs. 19.47 ± 1.01 kg baseline). Following 7-wks of unloading, 
lean mass significantly reduced by 4.6% ± 0.6% (P = 0.02) vs. the 7 weeks loading, 
back towards baseline levels (unloading, 19.83 ± 1.06 kg), confirmed by no significant 
	
	
134 
difference between unloading and baseline. Subsequently, a significant increase in 
lean mass of the lower limbs was accrued after the reloading phase of 12.4 ± 1.3%, 
compared to baseline (reloading, 21.85 ± 2.78 kg, P = 0.001, Figure 4.3), resulting in 
an increase of 5.9 ± 1.0% compared to the earlier period of loading (P = 0.005). 
Pairwise t-test analysis that corrected for any lean mass that was maintained during 
unloading demonstrated a significant increase in lean muscle mass in the reloading 
phase (unloading to reloading), compared to the loading phase (baseline to loading) 
(P = 0.022; Figure 4.3).  
 
Analysis of muscle strength suggested a similar trend. Isometric peak torque increased 
by 9.3 ± 3.5% from 296.2 ± 22.1 Nm at baseline to 324.5 Nm ± 27.3 Nm after 7-wks 
of loading, not attaining statistical significance (P > 0.05; Figure 4.4). Upon 7-wks of 
unloading, peak torque reduced by 8.3 ± 2.8% vs. loading, back towards baseline 
levels displaying no significant difference to baseline (P > 0.05). Upon subsequent 
reloading, a significant 18 ± 3.6% increase in isometric peak torque production (349.6 
± 27.7 Nm) was observed compared to baseline (P = 0.015; Figure 4.4). Pairwise t-
test analysis that corrected for any residual quadriceps’ strength maintained from 
unloading displayed no significant difference in strength of reloading phase 
(unloading to reloading), compared to the loading phase (baseline to loading) (Figure 
4.4). 
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Figure 4.3. Skeletal muscle mass changes in human participants across resistance 
exercise and exercise cessation time-course. A. Lean mass changes in human subjects 
(N=7) after a period of 7 weeks resistance exercise (loading), exercise cessation 
(unloading) and a subsequent second period of 7 weeks resistance (reloading). Total 
limb lean mass was normalised to baseline and presented as a percentage change. 
Significant change compared to baseline represented by * and significant to all other 
conditions represented by **. B. Total lean mass percentage change when loading is 
normalised to baseline, and reloading normalised to unloading to account for starting 
lean mass in both conditions. Pairwise t-test of significance indicated by *. All data 
represented as mean ± SEM.  
 
	
Figure 4.4. Skeletal muscle strength changes in human participants across resistance 
exercise and exercise cessation time-course. 4.4A. Isometric quadriceps peak torque 
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in participants (N=7) after a period of 7 weeks resistance exercise (loading), exercise 
cessation (unloading) and a subsequent second period of 7 weeks resistance exercise 
(reloading). Data was normalised back to baseline and represented as a percentage to 
the same. Significant change compared to baseline represented by *. 4.4B. Isometric 
peak force change when loading is normalised to baseline, and reloading normalised 
to unloading to account for starting lean mass in both conditions. Pairwise t-test of 
significance indicated by *. All data presented as mean ± SEM (N=7). 
 
4.3.2 Exposure to reloading stimulus evokes the largest DNA hypomethylated state 
across the genome in human muscle 
The frequency of statistically (P < 0.05) differentially regulated CpGs in each 
condition was analysed (Figure 4.5), reporting 17,365 CpG sites as significantly (P < 
0.05) differentially epigenetically modified following loading induced hypertrophy 
compared to baseline, with a larger number being hypomethylated (9,153) compared 
to hypermethylated (8,212 CpG sites; Figure 4.5). Interestingly, the frequency of 
hypomethylated epigenetic modifications was similar to loading after unloading 
(8,891) (Figure 4.5), where it was previously reported that lean muscle mass returned 
back towards baseline. Importantly, following reloading induced muscle growth, an 
increased number of epigenetically modified CpG sites (27,155) and an enhanced 
number of hypomethylated DNA sites (18,816; Figure 4.5) was observed. This 
increase in hypomethylation coincided with the largest increase in skeletal muscle 
mass in reloading, as previously described (Figure 4.3). By contrast, hypermethylation 
remained stable across conditions of loading, (8,212) unloading (8,638) and 
subsequent reloading (8,339 CpG sites).  
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To further analyse the reported increased frequency of hypomethylated genes across 
the genome following reloading, gene ontologies and KEGG signalling pathways 
were analysed for the frequency of hypo and hypermethylated CpG sites. In 
agreement with our above frequency analysis, the most statistically significant 
enriched GO terms identified an increased number of hypomethylated CpG sites 
following reloading, compared to baseline (Figure 4.6). Indeed, the most statistically 
significantly (FDR < 0.05) enriched GO terms were: 1) molecular function 
GO:0005488 encoding for genes related to ‘binding’, that displayed 9,577 (68.71%) 
CpG sites that were hypomethylated following reloading and 4,361 (31.29%) sites as 
hypermethylated compared to baseline (Figure 4.6 A), and: 2) Biological process 
GO:0044699 encoding for genes related to ‘single-organism processes’ that displayed 
7,586 (68.57%) hypomethylated CpG sites compared to 3,493 (31.43%) sites profiled 
as hypermethylated after reloading compared to baseline (Figure 4.6 B). Finally, 3) 
cellular component, GO:004326 encoding for genes related to ‘organelle’ reported 
7,301 hypomethylated CpG sites following reloading and 3,311 hypermethylated 
sites, compared to baseline, therefore favouring a majority 68.88% hypomethylated 
profile (Figure 4.6 C).  Following confirmation that the largest alteration in CpG DNA 
methylation occurred upon reloading, we sought to elucidate how the serine/threonine 
AKT signalling pathway, a critical pathway involved in mammalian growth, 
proliferation and protein synthesis (Egerman and Glass, 2014, Schiaffino and 
Mammucari, 2011), was differentially regulated across experimental conditions. 
Intuitively, the PI3K/AKT signalling pathway was significantly enriched upon all 
pairwise comparisons of base vs. load, unload and reload, respectively (P < 0.022; 
figures 4.7 A-C), suggesting that the pathway was significantly epigenetically 
modified following periods of skeletal muscle perturbation. Importantly, frequency 
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analysis of statistically differentially regulated transcripts (Figure 4.7 D) attributed to 
this pathway, reported an enhanced number of differentially regulated CpG sites (444 
CpG sites) following reloading (Figure 4.7 D), compared to loading and unloading 
alone (Figure 4.7 D). Furthermore, and in accordance with the previous findings from 
the genome-wide and GO analysis, the enhanced number of statistically differentially 
regulated CpG sites in this pathway upon reloading condition is attributed to an 
enriched number of hypomethylated (299 CpG sites, 67.3 %) compared to 
hypermethylated (145 sites, 32.7 %) CpG sites (Figure 4.7 E).  
	 	
Figure 4.5. Frequency analysis of statistically differentially regulated CpG (P < 0.05) 
sites identified via Infinium MethylationEPIC Bead Chip array (850K CpG sites) of 
the human methylome during 7 weeks of chronic resistance exercise (loading), 7 
weeks’ exercise cessation (unloading) and a secondary period of 7 weeks of resistance 
training (reloading). Frequency analysis revealed large adaptations of the human 
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methylome upon initial exposure to resistance loading, with equal number of CpG 
sites being up- and down-regulated. This response was maintained following 7 weeks 
of exercise cessation. Upon secondary exposure of later reloading, a larger number of 
CpG sites were hypomethylated compared to hypermethylated within the reloading 
condition, but also compared to all other conditions. 	
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Figure 4.6. Gene ontology analysis generated from Infinium MethylationEPIC 
BeadChip array of 850,000 CpG sites of the human methylome. Analysis confirms an 
enhanced hypomethylated profile after reloading compared to baseline, as previously 
indicated via frequency analysis. Forest plot schematics represent the number of CpG 
sites hypo- or hyper-methylated in reloading versus control conditions across various 
functional groups in A). molecular function, B) biological processes and C) cellular 
components. Functional with a fold enrichment > 3 (as indicated via shaded blue 
region) represents statistically modified (termed overexpressed for visual purposes) 
KEGG pathways, FDR < 0.05.  
	
	
141 
 
 
	
A.
 L
oa
di
ng
 C
on
di
tio
n 
- P
I3
K/
AK
T 
Si
gn
al
lin
g 
Pa
th
wa
y
A. Loading – PI3/AKT Signalling Pathway 
	
	
142 
	
 
	
B.
 U
nl
oa
di
ng
 C
on
di
tio
n 
- P
I3
K/
AK
T 
Si
gn
al
lin
g 
Pa
th
wa
y
B. Unloading – PI3/AKT Signalling Pathway 
	
	
143 
	
	
	
	
C
. R
el
oa
di
ng
 C
on
di
tio
n 
- P
I3
K/
AK
T 
Si
gn
al
lin
g 
Pa
th
w
ay
C. Reloading – PI3/AKT Signalling Pathway 
	
	
144 
 
Figure 4.7. Representation of the DNA methylation modifications that occurred 
within the PI3K/AKT KEGG signalling pathway following 7 weeks of loading (A), 
unloading (B) and reloading (C) in human subjects. Signalling analysis performed on 
statistically differentially regulated CpG sites compared to baseline, with green 
indicating a hypomethylated fold change and red indicating a hypermethylated 
change, with strength of colour representing the intensity of fold change  (Kanehisa 
and Goto, 2000, Kanehisa et al., 2017, Kanehisa et al., 2016). figure D. Venn diagram 
analysis of the statistically differentially regulated CpG sites attributed to the 
PI3K/AKT signalling pathway following loading, unloading and reloading, compared 
to be baseline. Ellipses reports number of commonly statistically differentially 
regulated CpG sites across each condition. Analysis confirms an enhanced number of 
differentially regulated CpG sites upon reloading condition. figure E. Analysis of 
hypo vs. hypermethylated profile of statistically differentially regulated CpG sites 
associated to the PI3K/AKT signalling pathway, 
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4.3.3 Genome-wide analysis identified two distinct temporal clusters of altered 
DNA methylation that provides initial evidence of an epigenetic induced muscle 
memory 
Changes in genome-wide DNA methylation were analysed following loading, 
unloading and reloading induced muscle adaptation. A dendrogram of the top 500 
most statistically epigenetically modified CpG sites across of each experimental 
condition compared to baseline, identified large alterations in DNA methylation 
profiles (Figure 4.8). A ranked unsupervised hierarchical clustering analysis 
demonstrated significant differences between the initial loading (weeks 1-7) vs. all 
other conditions (Figure 4.8). Closer analysis of the top 500 CpG sites across 
experimental conditions highlighted a clear temporal trend occurring within different 
gene clusters. The first cluster (named Cluster, A) displayed enhanced 
hypomethylation with earlier loading-induced hypertrophy. This cluster was 
methylated at baseline and became hypomethylated after loading, re-methylated with 
unloading (Figure 4.8), and, subsequently, hypomethylated after reloading. The 
second temporal trend (named Cluster B) also displayed an enhanced hypomethylated 
state across the top 500 CpG sites as a result of load induced hypertrophy. As with 
Cluster A, Cluster B genes were methylated at baseline and became hypomethylated 
after initial loading. In contrast to Cluster A however, Cluster B remained 
hypomethylated with unloading even when muscle mass and CSA returned to baseline 
levels and this hypomethylation was also maintained/ ‘remembered’ after reload 
induced hypertrophy (Cluster B, Figure 4.8). The third temporal trend, named Cluster 
C, revealed genes as hypomethylated at both baseline and after initial loading, 
suggesting no epigenetic modifications were retained or remembered after the first 
period of hypertrophy in these genes (Cluster C, Figure 4.8). During unloading, genes 
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were hypermethylated and remained in this state during reloading. The final cluster 
(Cluster D) of genes, were hypomethylated at baseline, became hypermethylated after 
loading (Cluster D, Figure 4.8), reverted back to a hypomethylated state with 
unloading and then maintained the hypomethylated state after reloading, reflecting 
the profile of the baseline targets in the same cluster (Cluster D, Figure 4.8). These 
two clusters (C&D) did report a maintenance of the DNA methylation profile from 
unloading to reloading conditions. Cluster C also reported a hypermethylated profile 
after unloading following a period of loading, that may therefore identify important 
CpG sites that are hypermethylated when muscle mass is reduced. Collectively, both 
clusters A and B identify a retention of modified epigenetic patterns following the 
initial resistance exercise loading period, where in contrast, both Cluster C&D suggest 
no retention of epigenetic modifications following the same stimulus.	 
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Figure 4.8. Heat map depicting unsupervised hierarchical clustering of the top 500 
statistically differentially regulated CpG loci (columns; P < 0.05) and conditions 
(baseline, loading, unloading and reloading) in previously untrained male participants 
(N=8). The heat-map colours correspond to standardised expression normalised β-
values with green representing hypomethylation, red representing hypomethylation 
and unchanged sites are represented in black. The temporal pattern of DNA 
methylation in each individually identified cluster is schematically represented 
beneath the heatmap for clarity.  
 
4.3.4 Identification of gene expression clusters inversely associated with CpG DNA 
methylation  
To assess whether the changes in DNA methylation affected gene expression, the 100 
most significantly differentially modified CpG sites across all conditions were 
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identified and cross referenced with the most frequently occurring CpG modifications 
in pairwise comparisons of all conditions. Importantly, forty-six percent of the top 
100 CpG sites were within gene promotor regions with 18% resided in intergenic 
regions, suggesting high biological relevance of the CpG sites of this candidate list 
(Figure 4.9). In total, 48 genes were analysed by rt-qRT-PCR to assess gene 
expression. Interestingly, gene expression analysis identified two distinct clusters of 
genes that had different transcript profiles, inversely mirroring the temporal patterns 
in DNA methylation of clusters already described. 
 
	
Figure 4.9. Genomic location of the top 100 statistically differentially regulated CpG 
sites across conditions, in the human methylome as identified via Infinium 
MethylationEPIC Bead Array. Coding DNA sequence (CDS), Untranslated region 
(UTR).  
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4.3.4.1 Cluster A: increased expression after loading, return to baseline after 
unloading and enhanced expression upon reloading, mirrored by inverse changes in 
DNA methylation 
This first cluster (A) included RPL35a, C12orf50, BICC1, ZFP2, UBR5, HEG1, 
PLA2G16, SETD3 and ODF2 genes that displayed a significant main effect for time 
(P < 0.0001) after MANOVA analysis (Figure 4.10 A). Importantly, this first cluster 
displayed a mirrored (inverse) temporal pattern to those identified previously in 
Cluster A above for CpG methylation (in the top 500 differentially regulated CpG 
sites, Figure 4.8). Where, upon 7-wks of loading, gene expression of this cluster 
significantly increased (1.22 ± 0.09, P = 0.004) and CpG methylation of the same 
genes was non-significantly reduced (hypomethylated) (0.95 ± 0.04 Figure 4.10 B). 
During unloading, methylation returned to baseline (1.03 ± 0.07), which was met by 
a return to baseline in gene expression (0.93 ± 0.05), as indicated by both CpG 
methylation and gene expression displaying no significant difference compared to 
baseline (Figure 4.10 A and B). Importantly, upon reloading, both CpG methylation 
and gene expression displayed an enhanced response compared to the baseline and 
loading time point, respectively. Indeed, upon reloading, this cluster became 
hypomethylated (0.91 ± 0.03, P = 0.05, Figure 4.10 B). This was met with a significant 
enhancement (1.61 ± 0.06) in gene expression of the same cluster compared to 
baseline and loading (P < 0.001, Figure 4.10 A). 
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4.3.4.2 Cluster B: Initial and progressive increase in gene expression from loading 
through unloading and reloading, met with an inverse profile of DNA methylation  
A second separate gene cluster was identified and included: AXIN1, GRIK2, 
CAMK4, TRAF1, NR2F6 and RSU1. Although together there was no significant 
effect of time via MANOVA analysis. ANOVA analysis reported that this cluster 
displayed increased gene expression after loading (1.19 ± 0.08) that then further 
increased during unloading (1.58 ± 0.13) resulting in statistical significance (P = 
0.001) compared to baseline alone. Gene expression was then even further enhanced 
(1.79 ± 0.09) upon reload induced hypertrophy (P < 0.0001; Figure 4.11 A). This 
temporal gene expression pattern was inversely associated to CpG methylation 
observed in Cluster B (identified previously in the top 500 differentially regulated 
CpG sites, Figure 4.8). Closer fold-change analysis of CpG DNA methylation of this 
gene cluster, identified a potential association between methylation and gene 
expression of 4 out of 6 of the targets (AXIN1, GRIK2, CAMK4, TRAF1; Figure 4.11 
B). Where, upon loading, these genes became significantly hypomethylated (0.78 ± 
0.09; P = 0.036) compared to baseline, with this profile being maintained during 
unloading (0.84 ± 0.09) and reloading (0.83 ± 0.05) conditions, albeit non-
significantly (Figure 4.11 B). Collectively, we report that a sustained hypomethylated 
state in 4 out of 6 of the genes in this cluster that were met with an increased transcript 
expression of the same genes (Figure 4.11 B). 
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Figure 4.10. Relative changes in gene expression (A) and representative schematic of 
CpG DNA methylation and gene expression relationship (B) for genes in cluster A. 
A). Expression of genes that displayed significant increased compared to baseline (*) 
upon earlier loading, that returned to baseline during unloading, displayed enhanced 
expression after reloading (**). MANOVA analysis reported a significant effect over 
entire time course (P < 0.0001). B). Representative schematic displaying a potential 
relationship between gene expression (solid black lines) and CpG DNA methylation 
(dashed black lines) of grouped transcripts (RPL35a, C12orf50, BICC1, ZFP2, UBR5, 
HEG1, PLA2G16, SETD3 and ODF2). All data represented as mean ± SEM for gene 
expression (N=7 for UBR5, PLA2G16, N=8 for all others) and CpG DNA 
methylation (N=8 for baseline, loading and unloading; N=7 for reloading).  
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Figure 4.11. Relative changes in gene expression (A) and representative schematic of 
CpG DNA methylation and gene expression relationship (B) for genes in cluster B. 
A). Gene expression analysis of genes that portrayed an accumulative increase in 
expression after loading, unloading and reloading. With the largest increase in gene 
expression observed after reloading, compared to control. Culminating in significance 
in the unloading (compared to baseline, *) and reloading (compared to baseline, **). 
B) Representative schematic displaying a potential relationship between mean gene 
expression (solid black lines) and CpG DNA methylation (dashed black lines) of 
grouped transcripts (AXIN1, TRAF1, GRIK2 and CAMK4). All data represented as 
mean ± SEM for gene expression (N=7 for AXIN1, GRIK2, N=8 for all others) and 
CpG DNA methylation (N=8 for baseline, loading and unloading; N=7 for reloading).  
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4.3.5 Identification of a number of novel genes at the expression level correlates 
with adaptations in skeletal muscle mass 
To ascertain the importance and relationship of the identified transcripts, fold change 
in gene expression was plotted against percentage changes (to baseline) in leg lean 
mass. Interestingly, in the first cluster of genes identified above (RPL35a, C12orf50, 
BICC1, ZFP2, UBR5, HEG1, PLA2G16, SETD3 and ODF2), a significant correlation 
between gene expression and lean mass was observed for genes RPL35a, UBR5, 
SETD3, PLA2G16 and HEG1 (Figure 4.11 B). Following exposure to 7-wks of load 
induced hypertrophy, RPL35a gene expression displayed a non-significant increase 
compared to baseline (1.13 ± 0.23; Figure 4.11 Ai), that upon unloading returned back 
to the baseline levels (1.01 ± 0.21). Upon reloading, the expression of RPL35a 
increased to 1.7 (± 0.44; Figure 4.11 Ai) compared to baseline (P = 0.05). This 
expression pattern across loading, unloading and reloading conditions corresponded 
to a significant correlation with percentage changes in skeletal muscle mass (R = 0.6, 
P = 0.014; Figure 4.11 Bi) with RPL35a accounting for 36% of the variation in muscle 
mass (assessed via DEXA) across experimental conditions. Both UBR5 and SETD3 
displayed similar percentage accountability for the change in skeletal muscle mass 
across conditions. Indeed, UBR5 and SETD3 accounted for 33.64% and 32.49% of 
the variability in skeletal muscle mass, respectively, both portraying statistically 
significant correlation between their gene expression and the percentage change in 
lean leg mass (UBR5, R = 0.58, P = 0.018, Figure 4.11 Bii; SETD3, R = 0.57, P = 
0.013, Figure 4.11 Biii, respectively). Additionally, UBR5 (1.65 ± 0.4; Figure 4.11 
Aii) and SETD3 (1.16 ± 0.2; Figure 4.11 Aiii) both demonstrated non-significant 
increases in gene expression after 7-wks of loading (P > 0.05), with the expression of 
both genes, UBR5 (0.82 ± 0.27) and SETD3 (0.90 ± 0.15), returning to baseline levels 
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upon 7-wks of unloading (figures 4.11 Aii & Aiii, respectively). Furthermore, upon 
reloading UBR5 displayed its greatest increase in expression (1.84 ± 0.5; Figure 4.11 
Aii), approaching significance when compared to baseline condition (P = 0.07), and 
a significant increase compared to unloading (P = 0.035). Whereas, SETD3 
demonstrated a fold increase of 1.48 (± 0.25; Figure 4.11 Aiii), again, approaching 
significance compared to baseline (P = 0.072) and achieving significance compared 
to unloading (P = 0.036). PLA2G16 also demonstrated a significant correlation 
between its fold change in gene expression and the percentage change in skeletal 
muscle mass (R = 0.55; P = 0.027; Figure 4.11 Biv), with PLA2G16 accounting for 
30.25% of the change in skeletal muscle. Interestingly, across conditions, PLA2G16 
demonstrated the greatest significant changes in gene expression. Indeed, loading 
induced hypertrophy, PLA2G16 displayed a non-significant increase compared to 
baseline in expression (1.09 ± 0.17; Figure 4.11 Aiv), that upon unloading returned 
back to the baseline levels (1.04 ± 0.25). Importantly, upon reloading, the expression 
of PLA2G16 significantly increased (1.60 ± 0.18; Figure 4.11 Aiv) compared to 
baseline (P = 0.026) and unloading conditions (P = 0.046), as well as approaching a 
significant increase compared to the initial loading stimulus (P = 0.067 compared to 
load; Figure 4.11 Aiv). HEG 1 gene expression exhibited a significant correlation with 
skeletal muscle mass (R = 0.53, P = 0.05) with HEG 1 accounting for 28.09% of the 
changes in muscle mass. However, HEG1 did not demonstrate any significant fold 
changes in gene expression across the experimental conditions (Figure 4.11 Av). 
Furthermore, no significant correlation was observed for the other identified cluster 
of genes (AXIN1, GRIK2, CAMK4, TRAF1, NR2F6 and RSU1; P > 0.05). 
Collectively, these data suggest that RPL35a, UBR5, SETD3 and PLA2G16 all 
display a significantly enhanced gene expression upon reloading induced 
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hypertrophy. This suggests, that these genes have the ability to recall information 
generated from earlier load-induced hypertrophy, by displaying the largest fold 
increases in gene expression after reload-induced growth. Out of these identified 4 
genes, UBR5 visually displayed temporal patterns in CpG methylation and gene 
expression of particular (Figure 4.12), after all experimental conditions.  
 
	
Figure 4.12. Relative fold changes in gene expression (A), correlation between gene 
expression and skeletal muscle mass across experimental conditions (B) and a 
schematic representation (C) of relationship between mRNA expression (solid black 
line) and CpG DNA methylation (dashed black line) for identified genes: RPL35a (I), 
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UBR5 (II), SETD3 (III), PLA2G16 (IV) and HEG1 (V). Statistical significance 
compared to baseline and unloading represented by* and** respectively. All 
significance taken as P ≤ 0.05 unless otherwise stated on graph. All data presented as 
mean ± SEM (n=7/8). 
 
	
4.3.6 The E3 ubiquitin ligase, UBR5, has enhanced hypomethylation and largest 
increase in gene expression upon secondary exposure to load induced stimulus 
The HECT E3 ubiquitin ligase gene, UBR5 (also known as EDD1; represented in its 
signalling pathway in Figure 4.14), for which the CpG identified is located on 
chromosome 8 (start 103424372) in the promoter region 546bp from the transcription 
start site, was identified as being within the top 100 most statistically differentially 
regulated CpG sites across all pair-wise conditions (load, unload and reload); but also 
the transcript that visually displayed the most distinctive temporal patterns in DNA 
methylation and gene expression (Figure 4.11), after every condition. Following the 
initial period of 7-weeks of load induced hypertrophy, there was a non-significant 
increase in UBR5 gene expression (1.65 ± 0.4) versus baseline, which was met with 
a concomitant (albeit non-significant) reduction in CpG DNA methylation (0.87 ± 
0.03). Gene expression returned to baseline control levels after unloading (0.82 ± 
0.27) demonstrated by a significant reduction vs. loading (P = 0.05) and non-
significance versus baseline (P = N.S; Figure 4.13). After the same unloading 
condition, we observed a significant increase in CpG DNA methylation compared to 
baseline (1.27 ± 0.02; P = 0.013; Figure 4.13). Importantly, upon reloading, UBR5 
displayed its largest increase in transcript expression, significantly greater compared 
to unloading (1.84 ± 0.5 vs. 0.82 ± 0.27, P = 0.035) and versus baseline levels 
(approaching significance, P = 0.07). Concomitantly, after the reloading condition, 
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we observed the largest statistically significant reduction in CpG DNA methylation 
(0.78 ± 0.02) compared to baseline (P = 0.039), and unloading (P ≤ 0.05; figure 4.13 
and 4.14).  
	
Figure 4.13. Schematic representation of changes in gene expression and CpG DNA 
methylation in the E3 ubiquitin ligase gene, UBR5. Representation demonstrates the 
inverse relationship between significant changes in gene expression (black lines; 
change compared to baseline, P=0.07; significant to unloading, **), and CpG DNA 
methylation (dashed lines; significantly different to baseline, §; to unloading, §§). All 
data presented as mean ± SEM (N=7/8), with arbitrary units displayed in the y-axis.  
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Figure 4.14. Representation and characterisation of the DNA methylation 
modifications that occurred along the ubiquitin mediated proteolysis signalling 
pathway across all conditions of loading, unloading and reloading compared to 
baseline (ANOVA). Signalling analysis performed on statistically differentially 
regulated CpG sites compared to baseline, with green indicating a hypomethylated 
fold change and red indicating a hypermethylated change, with strength of colour 
representing the intensity of fold change (Kanehisa and Goto, 2000, Kanehisa et al., 
2017, Kanehisa et al., 2016). Importantly, the novel HECT-type E3 ubiquitin ligase, 
UBR5, displays a significantly hypomethylated state within this pathway following 
reloading.   
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4.4 Discussion of findings 
We aimed to investigate the adaptive response of the human methylome following 
load induced skeletal muscle hypertrophy (loading and reloading) and the 
epigenetically induced retentive potential of human skeletal muscle in-vivo.  As a 
continuation of the findings in chapter 3, we hypothesised that a chronic period of RE 
induced muscular hypertrophy would be met with large modifications in the human 
methylome. In this regard, our hypothesis was met as we identified large-scale 
remodelling of the human methylome following both the initial 7 weeks of loading 
(17,365 differentially regulated CpG sites) and a secondary period of loading 
(reloading; 27,165 CpG sites). 	
	
4.4.1 Secondary exposure to resistance load stimulus induces largest 
hypomethylated profile met with largest increase in skeletal muscle hypertrophy 
We first confirmed that we were able to elicit an increase in lean mass of the lower 
limbs after 7 weeks loading, that returned back to baseline levels after 7 weeks 
unloading, with 7 weeks reloading evoking the largest increase in lean mass. 
Following DNA methylation analysis of over 850,000 CpG sites of the human 
methylome, we identified the largest frequency of hypomethylation (18,816 CpG 
sites) occurred after reloading where the largest lean mass occurred. Previous studies 
have suggested that hypermethylation of over 6,500 genes is retained, after a more 
acute stress of high fat intake (for 5 days) 8 weeks later despite removal of the high 
fat diet (Jacobsen et al., 2012), and hypermethylation occurs following early life 
inflammatory stress in muscle cells and is maintained for over 30 cellular divisions 
(Sharples et al., 2016a). The present study therefore also suggested hypomethylation 
was maintained during unloading (8,891 CpG sites) where muscle mass returned to 
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baseline having being subjected to an earlier period of load induced muscle growth 
(9,153 CpG sites), then upon reloading the frequency of hypomethylation was 
enhanced in association with the largest increases in lean mass. Furthermore, 
bioinformatic analysis of the PI3K/AKT signalling pathway across loading, unloading 
and reloading conditions, supports the findings of an enhanced hypomethylated state 
upon secondary exposure to resistance stimulus. Importantly, this pathway is 
identified as critical for cell proliferation/differentiation, muscle protein synthesis and 
therefore muscle hypertrophy (Schiaffino and Mammucari, 2011), and therefore, it is 
plausible that the enhanced hypomethylated state of the genes in this pathways would 
lead to enhanced gene expression and protein levels. However, further analysis is 
required to investigate the total protein or activity of these pathways in this model. 
Nonetheless, collectively, these results provide initial evidence for a maintenance of 
universal hypomethylation. The only other study to demonstrate a retention of prior 
hypertrophy in skeletal muscle was in rodents following earlier encounters with 
testosterone administration, where a preservation of myonuclei occurred even during 
testosterone withdrawal and a return of muscle to baseline levels (Bruusgaard et al., 
2010), suggesting a memory phenomenon at the cellular level. However, these are the 
first studies to demonstrate that a memory occurs at the epigenetic level within skeletal 
muscle tissue. Collectively, these findings provide initial evidence for a potential 
maintenance/memory of universal hypomethylation.  
 
4.4.2 Hypomethylation is maintained from earlier load induced hypertrophy even 
during unloading where muscle mass returns back towards baseline and is inversely 
associated with gene expression 
Following the frequency analysis above, closer analysis of the top 500 most 
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significantly differentially modified CpG sites across all conditions, we identified two 
epigenetically modified clusters of interest (named Cluster A&B). Cluster B 
supported the frequency analysis above and demonstrated hypomethylation after load 
induced hypertrophy that was then maintained following unloading where muscle 
returned to baseline levels and this hypomethylation was then also maintained after 
reload induced hypertrophy. This maintenance of hypomethylation during unloading, 
suggested that the muscle retained biological information that occurred after an earlier 
period of load induced muscle hypertrophy, with this finding being an agreement with 
our original hypothesis. As reduced DNA methylation of genes generally leads to 
enhanced gene expression due to the removal of methylation allowing improved 
access of the transcriptional machinery and RNA polymerase that enable 
transcription, and also creating permissive euchromatin (Bogdanovic and Veenstra, 
2009, Fuks et al., 2003, Lunyak et al., 2002, Rountree and Selker, 1997), this would 
be suggestive that the earlier period of hypertrophy leads to increased gene expression 
of this cluster of genes that is then retained during unloading to enable enhanced 
muscle growth in the later reloading period. To confirm this, in a separate analysis we 
identified the top 100 most significantly differentially modified CpG sites across all 
conditions and cross referenced these with the most frequently occurring CpG 
modifications in all pairwise comparisons of experimental conditions. From this we 
identified 48 genes that were frequently occurring in all pairwise comparisons and 
examined gene expression by rt-qRT-PCR. Interestingly, we identified two clusters 
of genes with distinct temporal expression after loading, unloading and reloading. One 
of the clusters included AXIN1, GRIK2, CAMK4, TRAF1, NR2F6 and RSU1. 
Importantly, the majority of these genes demonstrated a mirror/inverse relationship 
with DNA methylation of the CpG sites within the same genes. Where DNA 
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methylation reduced after loading and remained low into unloading and reloading, 
gene expression accumulated, demonstrating the highest expression after reloading 
where the largest increase in lean mass was also demonstrated. Overall, this suggested 
that these genes were increased after the earlier period of load induced hypertrophy, 
maintained during unloading due to methylation of these genes remaining low, and 
then upon exposure to a later period of reload induced hypertrophy, these genes were 
switched on to an even greater extent. Indeed, when analysing CpG methylation fold 
changes, significance was demonstrated across all pairwise comparisons for 4 out of 
6 genes within this cluster (AXIN1, GRIK 2, CAMK4, TRAF1). Overall, this 
demonstrates that the methylation and collective responsiveness of these genes are 
important epigenetic regulators in allowing skeletal muscle to retain biological 
information.   
 
Interestingly, AXIN1 is a component of the beta-catenin destruction complex, where 
in skeletal muscle cells AXIN1 has been shown to inhibit WNT/β-catenin signalling 
and enable differentiation (Figeac and Zammit, 2015), where treatment with the 
canonical WNT ligand suppresses differentiation (Huraskin et al., 2016). Other 
studies suggested that AXIN2 not AXIN1 is increased after differentiation, however 
confirmed that the absence of AXIN1 reduced proliferation and myotube formation 
(Huraskin et al., 2016). Therefore, together with the present data, it suggests an 
important epigenetic regulation of AXIN1 involved in human skeletal muscle memory 
and hypertrophy, with this characteristic perhaps due to inhibition of WNT/ WNT/β-
catenin signalling. GRIK2 (glutamate ionotropic receptor kainate type subunit 2, 
a.k.a. GluK2) belongs to the kainate family of glutamate receptors, which are 
composed of four subunits and function as ligand-activated ion channels (Han et al., 
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2010). Although reportedly expressed in skeletal muscle, its role in muscle growth or 
cellular function has not been determined. CAMK4 is calcium/calmodulin-dependent 
protein kinase that via phosphorylation triggers the CaMKK-CaMK4 signalling 
cascade and activates several transcription factors, such as MEF2 (Blaeser et al., 
2000). MEF2 has been previously associated with a switch to slow fibre types after 
exercise (Wu et al., 2000). While resistance exercise has been shown to preferentially 
increase the size of type II faster fibres, chronic innervation even at higher loads can 
lead to an overall slowing in phenotype (reviewed in (Fry, 2004) and therefore this 
epigenetically regulated gene, although not studied during hypertrophy maybe 
important in fibre type changes in the present study. However, it is unknown how 
DNA methylation affects the protein levels of CAMK4, and with its role in 
phosphorylation, would be important to ascertain in the future. Furthermore, fibre type 
properties were not analysed in the present study and require further investigation. 
TRAF1 is the TNF receptor-associated factor 1 and together with TRAF2 form the 
heterodimeric complex required for TNF-a activation of MAPKs, JNK and NFkB 
(Pomerantz and Baltimore, 1999). In skeletal muscle, acute TNF exposure activates 
proliferation via activation of MAPKs such as ERK (Stewart et al., 2004, Sharples et 
al., 2010, Foulstone et al., 2004, Li, 2003, Al-Shanti et al., 2008, Serrano et al., 2008). 
Therefore, acutely elevated systemic TNF-α following damaging exercise such as 
resistance exercise correlates positively with satellite cell activation in-vivo after 
damaging exercise (Mackey et al., 2007, Mikkelsen et al., 2009, van de Vyver and 
Myburgh, 2012), yet chronic administration in-vitro inhibits differentiation, promotes 
myotube atrophy and evokes apoptosis (Meadows et al., 2000, Foulstone et al., 2001, 
Stewart et al., 2004, Al-Shanti et al., 2008, Saini et al., 2008, Sharples et al., 2010, 
Saini et al., 2012, Saini et al., 2010, Grohmann et al., 2005b, Foulstone et al., 2004, 
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Foulstone et al., 2003b, Grohmann et al., 2005a, Li et al., 2005, Li et al., 2003, Li and 
Reid, 2000, Jejurikar et al., 2006, Girven et al., 2016) and muscle wasting in-vivo (Li 
et al., 2005, Li and Reid, 2000). Indeed, exposure to early life TNF-a during an early 
proliferative age in mouse C2C12s results in maintenance of hypermethylation in the 
MyoD promoter after 30 divisions and an increased susceptibility to reduced 
differentiation and myotube atrophy when muscle cells encounter TNF-a in later 
proliferative life (Sharples et al., 2016a). This explorative in-vitro work suggests a 
role for DNA methylation in retention of earlier periods of high inflammation, where 
the association between RE and an increase in systemic circulation of TNF-a, as well 
as an increase at the protein level in muscle, is well documented (Mackey et al., 2007, 
Mikkelsen et al., 2009, van de Vyver and Myburgh, 2012). These data collectively 
suggest an interesting epigenetic role for TNF and TRAF1 in the epigenetic memory 
of earlier load induced muscle hypertrophy.  
 
4.4.3 Identification of novel genes with the largest hypomethylated profile after 
secondary exposure to load stimulus, that are associated with enhanced gene 
expression 
The second DNA methylation cluster determined in the top 500 differentially 
modified CpG sites across all conditions, identified a cluster of genes (named Cluster 
A) that was methylated at baseline and also became hypomethylated after loading 
(similar to Cluster B above), then, upon unloading, genes reverted back to a 
methylated state and after reloading switched back to hypomethylated. Therefore, 
while not demonstrating an epigenetic retention per se, if hypomethylation was further 
enhanced and was associated with enhanced gene expression in reloading versus 
loading would also support an epigenetic induced retention characteristic. Further 
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gene expression analysis identified a cluster of genes that demonstrated a 
mirror/inverse temporal pattern of gene expression versus their DNA methylation 
pattern. These genes included RPL35a, C12orf50, BICC1, ZFP2, UBR5, HEG1, 
PLA2G16, SETD3 and ODF2 and demonstrated hypomethylation of DNA after load 
induced growth and an increase in gene expression. Subsequently, then both DNA 
methylation and gene expression returned back to baseline levels (in opposite 
directions) and after reload induced muscle growth DNA was hypomethylated again 
with an associated increase in gene expression. Importantly, during reloading, gene 
expression was further enhanced versus loading, suggesting that an earlier period of 
load induced growth was enough to produce a larger gene expression when reload 
induced muscle growth was encountered later, again suggesting a skeletal muscle 
memory at both the epigenetic and transcript level. Statistical analysis identified a 
number of genes (RPL35a, UBR5, SETD3 and PLA2G16) as having significantly 
enhanced expression upon reloading. Importantly, these four genes, plus HEG1, 
displayed significant correlations between their gene expression and the percentage 
change in skeletal muscle mass, suggesting for the first time, an association for these 
four genes in regulating adult human load induced skeletal muscle growth. 
Interestingly, SET Domain Containing 3 (SETD3) is a H3K4/ H3K36 
methyltransferase, is abundant in skeletal muscle, and has been shown to be recruited 
to the MyoG promoter, with MyoD, to promote its expression (Eom et al., 2011). 
Furthermore, overexpression of SETD3 in C2C12 murine myoblasts, evokes 
increases in MyoG, muscle creatine kinase, and Myf6 (or MRF4) gene expression. 
Inhibition via shRNA in myoblasts also impairs muscle cell differentiation (Eom et 
al., 2011), suggesting a role for SETD3 in regulating skeletal muscle regeneration. 
However, less is known regarding the role of PLA2G16 in skeletal muscle. PLA2G16 
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is a member of the superfamily of phospholipase A enzymes, whose predominant 
localization is in adipose tissue. PLA2G16 is known to regulate adipocyte lipolysis in 
an autocrine/paracrine manner, via interactions with prostaglandin and EP3 in a G-
protein-mediated pathway (Jaworski et al., 2009). Indeed, ablation of PLA2G16 
(referred to as Adpla), prevents obesity during periods of high fat feeding in mouse 
models, indicated via significantly less adipose tissue and triglyceride content, 
compared to relevant controls (Jaworski et al., 2009). However, to date no known 
research has elucidated the role of PLA2G16 in skeletal muscle and therefore, this 
requires future experimentation. Finally, HEG homology 1 (HEG1), initially reported 
as the heart of glass gene, is recognised for its role in regulating the zebrafish heart 
growth. HEG1 is a transmembrane receptor that has been reported to be fundamental 
in the development of both the heart and blood vessels (Gingras et al., 2012, Mably 
et al., 2003) (Kleaveland et al., 2009). However, a recent study reported a distinct 
role for HEG1 in regulating malignant cell growth (Tsuji et al., 2017). Tsuji et al. 
(2017) and colleagues reported that gene silencing of HEG1 in human MPM cell line, 
a cell linage that develop mesothelioma tumours (Martarelli et al., 2006), significantly 
reduced the survival and proliferation of mesothelioma cells, suggesting a role for 
HEG1 in regulating cellular growth. However, no known research has examined the 
role of HEG1 in regulating adult skeletal muscle growth. In the present study, UBR5 
visually displayed the most suggestive relationship between DNA hypomethylation 
and increased gene expression following loading and reloading conditions (Figure 
4.13). With the largest increase in hypomethylation and gene expression after 
reloading where the largest increase in lean mass was also observed. UBR5 is a highly 
conserved homologue of the drosophila tumour suppressor hyperplastic discs (HYD), 
and in the mammalian genome refers to a protein that is a member of the E3 ubiquitin-
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ligase family (Callaghan et al., 1998, Mansfield et al., 1994). E3 ubiquitin ligases play 
an integral role in the ubiquitin - proteasome pathway, providing the majority of 
substrate recognition for the attachment of ubiquitin molecules onto targeted proteins, 
preferentially modifying them for targeted autophagy/breakdown (Deshaies and 
Joazeiro, 2009, Buetow and Huang, 2016, Kuang et al., 2013). Indeed, extensive work 
has identified a distinct role of a number of E3 ubiquitin ligases such as MuRF1, 
MAFbx and MUSA1 in muscle atrophy (Baehr et al., 2011, Bodine, 2013, Bodine and 
Baehr, 2014, Bodine et al., 2001a, Fisher et al., 2017, Sartori et al., 2013). 
Furthermore, we have recently demonstrated that reduced DNA methylation and 
increased gene expression of MuRF1 and MAFbx are associated with disuse atrophy 
in rats following nerve silencing of the hind limbs via tetrodotoxin exposure (Fisher 
et al., 2017). A process that is reversed upon a return to habitual physical activity and 
a partial recovery of skeletal muscle mass (Fisher et al., 2017), suggesting a role for 
DNA methylation in regulating the transcript behaviour of a number of E3 ligases 
during periods of skeletal muscle atrophy and recovery. However, there have been no 
studies that the authors are aware of for UBR5 in skeletal muscle atrophy or growth. 
Given the role of ubiquitin ligases in skeletal muscle, counterintuitively, we report 
that the expression of the E3 ubiquitin ligase, UBR5, is increased during earlier 
periods of skeletal muscle hypertrophy and are even further enhanced in later reload 
induced muscle growth. We further report that the methylation profile of this E3 
ubiquitin ligase portrays an inversed relationship with gene expression, supporting a 
role for DNA epigenetic modifications in regulating its expression, as previously 
suggested (Fisher et al., 2017).  However, in support of its role in positively impacting 
on muscle, UBR5 has also been shown to promote smooth muscle differentiation 
through its ability to stabilize myocardin proteins (Hu et al., 2010). In confirmation, 
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silencing of UBR5 using siRNA in fibroblasts reduced myocardin-induced smooth 
muscle-specific gene expression and knockdown of UBR5 in smooth muscle cells 
also reduced smooth muscle-specific genes (Hu et al., 2010). Interestingly, when 
UBR5 was present myocardin protein degradation was reduced, resulting in increased 
total protein levels without changes in gene expression (Hu et al., 2010). While 
myocardin is only expressed in smooth and cardiac muscle, it is considered the master 
regulator of smooth muscle gene expression (Wang et al., 2003) and a known 
transcription factor that upregulates smooth muscle myosin heavy chains (MYHCs), 
actin and desmin. It therefore possesses a similar role to the myogenic regulatory 
factors Mrf5, MyoD and Myogenin in skeletal muscle. These genes enable the 
upregulation of slow and fast adult MYHCs, actin, desmin and titin and are expressed 
in a temporal fashion during early differentiation (Mrf5 and MyoD), during fusion 
(MyoG) and during myotube hypertrophy (adult MYHC’s). Interestingly, it has 
previously been observed that myocardin-related transcription factors (MRTF) 
interact with the myogenic regulatory factor, MyoD, to activate skeletal muscle 
specific gene expression (Meadows et al., 2008), suggesting a cross-talk between 
muscle specific regulatory factors, enabling skeletal muscle adaptations (Meadows et 
al., 2008). However, reports suggest a complex bi-functional characteristic of 
myocardin as a transcriptional repressor of skeletal muscle differentiation in favour 
of smooth muscle differentiation (Long et al., 2007). Therefore, UBR5’s expression 
throughout the time course of skeletal muscle cell differentiation and its role in 
myotube hypertrophy requires future attention. Finally, and confirming a role for 
UBR5 in growth, whole-exon sequencing identified strong gene amplifications of 
UBR5 in triple negative breast cancers that was confirmed via targeted mRNA and 
protein studies (Liao et al., 2017). Further, silencing of UBR5 via CRISPR/Cas9-
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deletion in an in-vivo murine mammary carcinoma model of triple negative breast 
cancer reduced tumour growth and metastasis via reductions in blood vessel formation 
that was associated with tumour apoptosis, necrosis and growth arrest (Liao et al., 
2017). Overall, this suggests that UBR5 is important in angiogenesis, blocking 
apoptosis and enabling growth in other cell types. Therefore, UBR5 may play a 
distinct role in skeletal muscle growth, however to determine this, future models of 
mammalian overexpression and knock-out of UBR5 are required to confirm its 
important function. Further work is needed to characterize UBR5, as well as other 
HECT-domain E3 ubiquitin ligase protein members identified in this work via 
signalling pathway analysis of the ubiquitin mediated proteolysis pathway, in the 
development of muscle growth to better understand its role in facilitating skeletal 
muscle hypertrophy. 
 
4.5 Summary, Conclusion and Future Chapter Directions 
This work furthers the claim that DNA methylation plays an important role in the 
regulation of human skeletal muscle during periods of muscle mass adaptation. These 
data also suggest that through retention of epigenetic modifications after earlier 
muscle hypertrophy, even following cessation of structured exercise interventions and 
muscle mass returning to baseline level, DNA methylation patterns are associated 
with a memory of earlier hypertrophy.   
 
Here we identify an epigenetic retention of hypertrophy via retention of DNA 
methylation in this chapter and given the dynamic and sensitive nature of DNA 
methylation identified to muscle atrophy in chapter 3.  We wished to ascertain how 
quickly and dynamically the human methylome was regulated after a single bout of 
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resistance exercise and therefore, and by comparing with data derived in chapter 4, if 
the epigenetics of target genes could be used as sensitive DNA methylation 
biomarkers that would be associated with enhanced gene expression and muscle 
hypertrophy when more chronically repeated. This would potentially identify genes 
that could be measured acutely in human skeletal muscle and predict future 
adaptation.  
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Chapter 5:  
	
	
 
DNA is Hypomethylated After a Single Bout of Exercise 
That is Retained After Continuous Periods of Loading and 
Reloading: Case for Sensitive DNA Methylation as a 
Biomarker for Adaptation 
 
	
 
 
 
 
 
 
The work contained within this chapter has recently published: 
 
Seaborne, R. A., Strauss, J., Cocks, M., Shepherd, S., O’Brien, T. D., van Someren, 
K. A., Bell, P. G., Murgatroyd, C., Morton, J. P., Stewart, C. E. & Sharples, A. P. 
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(2018). Human skeletal muscle possesses an epigenetic memory of hypertrophy. 
Scientific Reports, 8, 1898. 
5.1 Introduction  
After identifying that skeletal muscle retained hypomethylation signatures after 
earlier loading induced hypertrophy through to later reloading induced hypertrophy, 
it was next sought to ascertain how dynamic and transient DNA methylation of these 
identified genes was, after a single acute bout of resistance exercise (acute RE). It 
was aimed to identify methylation sensitive genes (to single acute 
resistance loading stimuli) that were still affected at the DNA methylation and gene 
expression levels after later chronic load and reload induced 
hypertrophy conditions. This would potentially identify important DNA methylation 
biomarkers after a single bout of exercise that would suggest if an individual was 
going to adapt advantageously (in terms of muscle size increases) to a more chronic 
exercise regime.  
 
Following previous work suggesting that a single bout of exercise creates changes in 
promotor DNA methylation (Barres et al., 2012), and that short-term exposure to RE 
(3 sessions over 9 days) generates large modifications in the number of differentially 
methylated regions (DMRs) (Laker et al., 2017), we first hypothesized that the human 
methylome would undergo large-scale remodelling following a single bout of RE. We 
further hypothesised that modifications observed following acute RE may resemble 
those observed following continuous exposure to RE (i.e. chronic loading and 
reloading stimuli), and would therefore be acute DNA methylate biomarkers for 
skeletal muscle adaptation at later time points.   
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5.2 Methodology 
5.2.1 Experimental design 
All male subjects (N = 8; 27.6 ± 2.4 yr, 82.5 ± 6.0 kg, 178.1 ± 2.8 cm, means ± SEM) 
enrolled in muscle memory study (chapter 4), performed an acute resistance exercise 
(acute RE) training session prior to loading, unloading and reloading. Skeletal muscle 
biopsies were obtained from the right vastus lateralis muscle, and down-stream 
analysis of RNA and DNA were compared to baseline biopsies (detailed in section 
4.2). Genome wide DNA methylation analysis was performed via Illumina EPIC array 
to compare the human methylome immediately following single exposure to 
resistance load. Cross-comparison of differentially regulated CpG sites was 
performed with chapter 4 data to allude to CpG sites that were differentially regulated 
at both acute and chronic time-points. Follow-up gene expression was subsequently 
performed on identified transcripts of interest.  
 
5.2.2 Acute exposure to resistance exercise stimulus 
The resistance exercise protocol was performed in identical fashion to that previously 
explained (section 4.2.2), where a familiarization week was initially performed at 
no/low loads and a competency of lifting load assessment was performed. Three to 
four days following the familiarization week, subjects performed their first training 
session of their resistance exercise programme (section 4.2.2) that was used as the 
acute resistance exercise stimulus for analysis within this experiment. Exercise load 
was set and progression was applied in accordance with that previously described 
(section 4.2.2). Exercises for this acute resistance exercise session included over-head 
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squat, leg press, Nordic curls, leg press, leg extension and dumbbell weighted calf 
raises, with all exercises being performed bilaterally and in single or in a superset. 
Total session load for the acute training stimulus was calculated as; 𝑇𝑜𝑡𝑎𝑙	𝑆𝑒𝑠𝑠𝑖𝑜𝑛	𝐿𝑜𝑎𝑑	(𝑘𝑔) = 𝑁𝑜. 𝑜𝑓	𝑅𝑒𝑝𝑠 ∗ 𝐸𝑥𝑒𝑟𝑐𝑖𝑠𝑒	𝐿𝑜𝑎𝑑	(𝑘𝑔) ∗ 𝑆𝑒𝑡𝑠) 
This model evoked an average acute session load of 8223 kg (± 284).  
 
5.2.3 Muscle biopsy preparation 
Immediately following acute resistance exercise cessation (30mins), all participants 
gave a muscle biopsy sample from the vastus lateralis muscle of the right quadriceps, 
via conchotome method (section 2.5). Muscle samples were dissected on a sterile, 
gamma-irradiated petri-dish using sterile scalpels and immediately snap-frozen in 
liquid nitrogen before being stored at -80oC for RNA and DNA analysis.  
 
5.2.4 Isolation of DNA and analysis for DNA methylome and CpG methylation  
DNA was isolated and analysed for quality and quantity in methods as previously 
described (section 2.7). Isolation of acute muscle biopsies yielded an average quantity 
of 8.1 µg (± 0.03) and a 260/280 quality ratio of 1.86 (± 0.03). Five hundred ng of 
prepared DNA was bisulfite converted using EZ-96 DNA methylation kit (Zymo 
Research corp., CA, USA) (section 2.7 for details).  Illumina MethylationEPIC 
BeadChip (Infinium MethylationEPIC BeadChip, Illumina, California, United States) 
and subsequently sent to The Genome Centre and Barts and The London School of 
Medicine and Dentistry where Illumina MethylationEPIC BeadChip (Infinium 
MethylationEPIC BeadChip, Illumina, California, United States) arrays were 
performed was then used to examine over 850,000 CpG sites of the human 
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methylome, and subsequent data files (.IDAT) were imported into Partek Genomic 
Suite for detection of differentially methylated CpG sites compared to baseline 
biopsy. Fold change in CpG specific DNA methylation and statistical significance 
was performed using Partek Genomic Suite V.6.6 software, where statistical 
significance was obtained following ANOVA (with Bonferroni correction) analysis.  
Unadjusted p-value significance (P < 0.05) was used to create a CpG site marker list 
of standardized beta-values. Unsupervised hierarchical clustering was performed and 
a dendrogram was constructed to represent differentially methylated CpG loci and 
statistical clustering of experimental samples, and schematically represented in 
heatmaps.  
 
5.2.5 Isolation of RNA and down-stream rt-qRT-PCR 
RNA was isolated, quantified, prepared and setup for rt-qRT-PCR as described in 
sections 2.6.1 – 2.6.3. All primer sequences for analysis of genes of interest are 
provided in table 5.1. Gene expression analysis was performed on at least n = 7 for all 
genes, unless otherwise stated. All relative gene expression was quantified using the 
comparative Ct (∆∆Ct) method (Schmittgen and Livak, 2008). Individual participants 
own baseline Ct values were used in ∆∆Ct equation as the calibrator using RPL13a as 
the reference gene. The average Ct value for the reference gene was consistent across 
all participants and experimental conditions 20.48 (± 0.53, SDEV) with low variation 
of 2.60 %, and an average efficiency of 81.5 % (± 8.9, SD) with low percentage 
variation of 4.9 %.	
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Table 5.1. Gene primer sequences for acute human RE experiment. All primers used 
the same cycling conditions. 
Gene Accession No.  Primer Sequence 
Primer 
Length 
Prod. 
Length 
      
FBXL17 NM_001163315.2 
F – 
R – 
TTGCACAGAGCAGCAAGTCT 
TGTTCCACCGTCACTTCGTT 
20 
20 76 
STAG1 NM_005862.2 
F – 
R – 
GCATTTTTAGCAACTTCTACCAGC 
AACTTGAATTTGGCAGGGCA 
24 
20 115 
AFF3 NM_002285.2 
F – 
R – 
AACGGGAGCTGAGAGCTGAT 
GGGTGTCGACTTCAAACTTGC 
20 
21 70 
STIM1 NM_001277962.1 
F – 
R – 
TGGACGATGATGCCAATGGT 
CTCACCATGGAAGGTGCTGT 
20 
20 110 
AXIN1 NM_003502.3 
F – 
R – 
AAGGTCCCGAGGCTACTCAG 
GCATTTCTTTTGCACGCCAC 
20 
20 112 
ODF2 NM_153436.1 
F – 
R – 
TTGTGGCGCACCCAGTGTAA 
GCACATTCACAGTGTCCCCT 
20 
20 71 
GRIK2 NM_001166247.1 
F – 
R – 
CACATACAGACCCGCTGGAA 
GGTCTAAAATGGCACGGCTG 
20 
20 110 
NUB1 NM_001243351.1 
F – 
R – 
GGATCATGCGGCCACTCATA 
AACCTGATGTTCTCGAGGCG 
20 
20 102 
KLHDC1 NM_172193.2 
F – 
R – 
TGGTGGGAGCAAAGATGACT 
TCAAGGCATGACCTGAGTAGTG 
20 
22 102 
C11orf24 NM_001300913.1 
F – 
R – 
CCAGCTCACCCACAAGATGT 
AGTTGCGTGGATCGTTGGAT 
20 
20 98 
ADSSL1 NM_152328.4 
F – 
R – 
ACTTCATCCAACTGCACCGT 
ACGTCACCTATGTTCTGCGG 
20 
20 71 
TRAF1 NM_001190947.1 
F – 
R – 
GGAAGCTGCGTGTGTTTGAG 
AGCTGGCTCTGGTGGATAGA 
20 
20 97 
BICC1 NM_001080512.2 
F – 
R – 
GGCCATGTTACAAGCTGCTG 
TGGCCAAGCAATCTGCGTAT 
20 
20 97 
	
5.2.6 Statistical analysis  
All methylome and CpG DNA methylation statistical analysis was performed in 
Partek Genomic Suite via use of an in-software ANOVA. In SPSS (SPSS, version 
23.0, SPSS Inc, Chicago, IL), a pairwise t-test was used to analyse gene expression 
following acute resistance exercise to baseline. For correlation analysis comparing 
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CpG DNA methylation values from acute, loading and reloading (data taken from 
chapter 4) of transcripts of interest, a Pearson correlation coefficient was calculated 
and significance ascertained via two-tailed test. Statistical values were considered 
significant at the level of P ≤ 0.05. All data represented as mean ± SEM unless 
otherwise stated. 
 
5.3 Results 
5.3.1 Acute resistance exercise rapidly remodels the human methylome and 
preferentially favours a hypomethylated response  
We first sought to identify if CpG sites were globally hypo or hypermethylated across 
the human methylome following a single bout of RE. Herein, it was identified that 
17,884 CpG sites of the human methylome display statistically differentially (P < 
0.05) regulated DNA methylation profiles compared to baseline (Figure 5.1). 
Hierarchical clustering analysis confirmed a distinct differential regulation between 
all participant arrays (acute stimulus; Figure 5.1) compared to baseline. Further 
analysis revealed that exposure to acute RE preferentially modulates the human 
methylome into a greater hypomethylated state, where it was reported that 57.5% 
(10,284 sites) of the altered CpG sites were hypomethylated compared to 42.5% 
(7,600 sites) as hypermethylated.  
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Figure 5.1. Response of the methylome after acute resistance exercise (acute RE) 
compared to baseline (N=8). Hierarchical cluster of significantly differentially 
regulated CpG sites (rows; P ≤ 0.05) demonstrates an increased number of 
hypomethylated sites compared to hypermethylated. The heat-map colours 
correspond to standardised expression normalised β-values with green representing 
hypomethylation, red representing hypermethylation and unchanged sites are 
represented in black.  
 
To further analyse the preferentially hypomethylated methylome following acute 
resistance exercise, GO terms were analysed to detect for most significantly enriched 
functional groups and frequency of hyper and hypomethylated CpG sites of these were 
compared. In agreement with the previous findings, the most statistically significantly 
enriched functional groups displayed a preferentially hypomethylated state following 
acute exposure to a resistance exercise stimulus. Indeed, the most significantly 
enriched functional group relating to biological processes was GO:0044699 encoding 
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for genes related to ‘single-organism processes’ that displayed 3491 CpG sites (56.8 
%) as being hypomethylated compared to 2609 (43.2 %) as being hypermethylated, 
compared to baseline control (Figure 5.2 A). A similar pattern was observed for the 
most significantly enriched groups for molecular function and cellular component. 
Where the terms, GO:0005488 (binding; Figure 5.2 B) and GO:0044422 (organelle 
part; Figure 5.2 C), displayed 56.6 % (5267 CpG sites) and 57.2 % (3491 CpG sites) 
of their differentially regulated CpG sites as being hypomethylated. Collectively 
suggesting that, acutely, following exposure to a single resistance exercise stimulus a 
large adaptive response of the human methylome is exhibited in previously untrained 
subjects, that preferentially favours a greater hypomethylated response.  
 
	
	
180 
	
Figure 5.2. Gene ontology analysis generated from Infinium MethylationEPIC 
BeadChip array of 850,000 CpG sites of the human methylome. Analysis confirms an 
enhanced hypomethylated profile immediately following exposure to a single bout of 
resistance exercise training in previously untrained subjects. Forest plot schematics 
represent the number of CpG sites hypo- or hyper-methylated in reloading versus 
control conditions across various functional groups in A). molecular function, B) 
biological processes and C) cellular components. A fold enrichment > 3 (as indicated 
B 
C 
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via shaded blue region) represents statistically over expressed KEGG pathways, FDR 
< 0.05. 
	 
5.3.2 Cross-comparison analysis reveals 27 differentially regulated CpG sites 
following acute, loading and reloading resistance exercise  
In order to identify if methylation sensitive genes (to single acute resistance loading 
stimuli) were still affected at the DNA methylation and gene expression levels after 
later chronic load and reload induced hypertrophy conditions, we undertook 
comparative DNA methylation analysis of acute RE conditions compared to chronic 
loading and reloading from chapter 4. Analysis of the top 100 differentially regulated 
CpG sites from chapter 4 and the significantly differentially regulated CpG sites from 
acute RE methylome analysis, revealed 27 CpG sites that were commonly 
differentially regulated (Figure 5.3) across all conditions. Location analysis of the 
identified 27 CpG sites reported that 9 CpG sites lie within regions that did not code 
for known genes. Of the 18 remaining CpG sites, 88% of sites were located within 
promotor or intron regions of the relevant gene transcript (Figure 5.3).  
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Figure 5.3. Cross-comparison analysis of acute RE methylome data and methylome 
data derived following chronic loading and reloading. Venn diagram depicts the 
number of CpG sites analysed for gene expression across acute, RE 7 weeks loading 
and 7 weeks reloading, respectively. Pie chart details the location of the top 18 gene 
transcripts identified in cross-comparison analysis of the human methylome. Coding 
DNA sequence (CDS). 
 
	
5.3.3 Altered CpG DNA methylation profiles following acute resistance exercise 
are retained after loading and reloading  
The fold change in CpG DNA methylation of the remaining 18 sites (table 5.2) 
displayed virtually identical regulation across conditions of acute RE, loading (7 
weeks’ resistance loading) and reloading (7 weeks loading, unloading and reloading, 
respectively; Figure 5.4). The majority of genes demonstrating a hypomethylated 
profile, demonstrated on Figure 5.4, (genes with a fold change less than 0), confirming 
earlier analysis that acute resistance exercise evokes a largely hypomethylated profile. 
Correlation analysis of CpG DNA methylation fold change confirmed these findings 
with acute RE compared to loading and reloading conditions reporting a strong 
positive and significant relationship (R = 0.94, P < 0.0001; Figure 5.5). Collectively 
suggesting that even after a single bout of acute resistance exercise, DNA methylation 
of the identified CpG sites remained hypomethylated even through loading, and 
reloading. Suggesting that these DNA methylation sites were extremely sensitive to 
acute exercise induced hypomethylation and associated with increases in lean muscle 
mass in loading and reloading conditions (identified in chapter 4).    
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Figure 5.4. Modifications of DNA methylation following acute RE are maintained 
following loading and reloading. Temporal pattern of fold changes in CpG DNA 
methylation of the identified overlapping CpG sites that mapped to relevant gene 
transcripts as generated via cross-comparison analysis, figure 5.3. All data represented 
as mean ± SEM (N=7/8).  
	
	
Figure 5.5. Analysis of CpG DNA methylation changes following acute RE correlated 
with changes in CpG DNA methylation evoked following loading and reloading, 
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respectively. DNA methylation reported as mean (N=7/8) methylation change to 
baseline, of identified transcripts generated via cross-comparison analysis, figure 5.3. 	
	
Table 5.2. Genomic location of 18 CpG sites that overlap in comparisons between 
acute RE, chronic load and chronic reload methylome data sets. 
Gene CpG ID Chromosome Site Transcript ID 
ADSSL1 cg10797850 14: 105213611 NM_152328 
AFF3 cg07349094 2: 100759014 NM_002285 
AXIN1 cg04808813 16: 343299 NM_003502 
BICC1 cg22557725 10: 60368369 NM_001080512 
C11orf24 cg14870456 11: 68039143 NM_001300913 
FBXL17 cg05426509 5: 107382801 NM_001163315 
GMIP cg16175206 19: 19744627 NM_001288998 
GRIK2 cg14974622 6: 101886381 NM_001166247 
ITPK1 cg09257735 14: 93581049 NM_001142594 
KLHDC1 cg04707327 14: 50159532 NM_172193 
KSR2 cg16953186 12: 118112000 NM_173598 
NUB1 cg17067889 7: 151038703 NM_001243351 
ODF2 cg21792562 9: 131218455 NM_153436 
OPA1 cg01640444 3: 193311744 NM_015560 
PBK cg21734487 8: 27695307 NM_001278945 
RBM20 cg18594033 10: 112524504 NM_001134363 
STAG1 cg09094119 3: 136469223 NM_005862 
TRAF1 cg20015583 9: 123681613 NM_001190945 
 
5.3.4 Dynamic and sensitive changes in DNA methylation after acute RE, precede 
observed changes in gene expression after loading and reloading  
In order to elucidate whether changes in CpG DNA methylation of the candidate gene 
list was met with altered expression of these genes, a sub-set of transcripts were 
analysed for fold-change following acute resistance exercise and compared with 
loading and reloading.  Firstly, in this analysis, it was identified that significant 
changes in CpG DNA methylation following acute resistance exercise stimulus was 
not met with significant changes in gene mRNA expression. Indeed, all 12 CpG sites 
associated with genes ADSSL1, AFF3, AXIN1, BICC1, C11orf24, FBXL17, GRIK2, 
KLHDC1, NUB1, ODF2, STAG1 and TRAF1 all displayed significant alterations in 
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fold change of CpG DNA methylation compared to baseline (Figure 5.6 B; P < 0.05). 
This was met with no significant change in these gene transcript expression levels 
(Figure 5.6 A; P > 0.05), following acute load stimulus. However, upon continued 
loading (loading and reloading), significant changes in CpG DNA methylation were 
met with significant changes in a number of gene transcripts. Adenylosuccinate 
synthase like 1 (ADSSL1) displayed a significant increase in CpG DNA methylation 
at following acute stimulus (1.15 ± 0.16; P = 0.009) that was retained after 7-weeks 
of loading (1.21 ± 0.002; P = 0.001; Figure 5.6 B), compared to baseline. However, 
at the expression level, acute resistance exercise stimulus failed to evoke a significant 
change in mRNA expression (P > 0.05; Figure 5.6 A). However, upon continuous 
exposure to resistance load (loading), gene expression showed an inverse relationship 
with DNA methylation, displaying a reduction in expression compared to baseline 
control (0.75 ± 0.14; P = 0.013). Comparably, chromosome 11 open reading frame 24 
(C11orf24) displayed a similar inverse, time-dependent relationship between DNA 
methylation and gene expression. Indeed, following acute resistance exercise 
stimulus, C11orf24 displayed a significant reduction in CpG DNA methylation (0.77 
± 0.01; P = 0.022) that was not met with a significant change in mRNA expression 
levels (1.16 ± 0.026; P > 0.05; Figure 5.6 A) compared to baseline. However, upon 
repeated exposure, relative CpG DNA methylation remained significantly reduced 
(0.82 ± 0.01; P = 0.018; Figure 5.6 B), compared to baseline, and was met with an 
increase in mRNA expression that approached significance, at the same condition 
(loading 1.62 ± 0.35; P value = 0.08; Figure 5.6 B and A, respectively).  
 
More interestingly, both cohesin subunit SA-1 (STAG1) and TNF receptor associated 
factor 1 (TRAF1) display significant reductions in CpG-specific DNA methylation 
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following acute exposure to resistance stimulus (0.87 ± 0.03, P = 0.008, and 0.91 ± 
0.02, P = 0.003, respectively; Figure 5.7) that remains significantly low following 
repeated chronic exposure to resistance load stimulus. Indeed, during loading, both 
genes maintained this significant reduction in CpG DNA methylation (0.87 ± 0.01l; P 
= 0.0002 and 0.88 ± 0.01, P = 0.0004; Figure 5.7) in STAG1 and TRAF1, respectively, 
and the subsequent re-encounter with chronic resistance exercise (reloading) 
continued this hypomethylated state (0.88 ± 0.04; P = 0.0007 and 0.95 ± 0.03; P = 
0.0003, respectively; Figure 5.7). Importantly, the observed significant reduction in 
DNA methylation following acute exposure to resistance stimulus produces no 
significant change (P > 0.05 for both transcripts) in STAG1 gene expression (1.05 ± 
0.25) and TRAF1 (1.06 ± 0.14), following the same acute resistance exercise stimulus 
(Figure 5.7). However, in the reloading condition, gene expression in both STAG1 
(1.93 ± 0.64; P = 0.007) and TRAF1 (1.48 ± 0.15; P = 0.007; Figure 5.7) was 
significantly increased, where previously reported is a significant reduction in DNA 
methylation, suggesting an inverse relationship between expression and methylation. 
Collectively, these data suggest that changes in CpG specific DNA methylation of 
transcripts ADSSL1, C11orf24, STAG1 and TRAF1 precede any functional changes 
in gene expression levels upon exposure to resistance exercise stimulus. A similar, 
but less significant, relationship is observed between changes in CpG methylation 
following acute RE, and a delayed functional change in gene expression following 
exposure to reloading for genes GRIK2 and BICC1. Indeed, GRIK2 displayed no 
significant change in gene expression following acute RE (1.30 ± 0.29) despite 
displaying a significant reduction (P = 0.002) in CpG DNA methylation (0.85 ± 0.05) 
at the same time point. This hypomethylated profile is maintained through to 
reloading (0.91 ± 0.04; P = 0.005), where it is met with the largest increase in GRIK2 
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gene expression compared to baseline control (1.93 ± 0.5; Figure 5.7). Similarly, 
BICC1 shows a significantly hypomethylated CpG DNA methylation profile 
following acute RE (0.97 ± 0.002; P = 0.002) and loading and reloading (0.96 ± 0.004, 
P = 0.002; 0.94 ± 0.01, P < 0.0001), where after acute RE gene expression does not 
significantly change (1.17 ± 0.37), but shows its largest increase following continuous 
reloading exposure (1.58 ± 0.63; Figure 5.7).  
 
Collectively, these data suggest that acute RE rapidly modifies CpG DNA methylation 
of these identified transcripts, even after 30 minutes’ post exercise. However, 30 
minutes’ post exercise is insufficient to induce functional changes in gene expression. 
Importantly however, genes that were hypomethylated after a single bout of acute 
resistance exercise were maintained as hypomethylated during loading (ADSSL1 
and C11orf24) and reloading (STAG1, TRAF1, BICC1 and GRIK2) and 
demonstrated an enhanced gene expression after later reloading where the largest 
increase in lean mass was observed.  
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Figure 5.6. Relative fold changes in; A) gene expression, and, B) CpG DNA 
methylation in all 12 gene transcripts identified from comparison of methylome data 
from acute RE vs. 7 weeks loading and reloading analysis. Data represented as means 
± SEM (N=7/8), with significance compared to baseline (red line) indicated by *. 
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Figure 5.7. Representative schematic identifying early epigenetically modified (DNA 
methylation, dashed black line) genes after acute RE, that are associated with 
enhanced gene expression (solid black lines) following reloading. Significance 
indicated in gene expression (*) and in CpG DNA methylation (§) when compared to 
baseline. 	
	
5.4 Discussion of Findings 
5.4.1 Summary  
The aim of this chapter was to, for the first time, identify the modifications that occur 
in the human methylome following exposure to an acute bout of RE, in previously 
untrained subjects. Further, it was sought to elucidate whether these epigenetic 
modifications were similar in profile, and in association to changes in gene 
expression, to those observed following chronic periods of loading and reloading, 
respectively. In support of the first hypothesis, it was observed that upon exposure to 
a single bout of resistance exercise, the human methylome is rapidly remodelled to 
favour a preferential hypomethylated state, a known permissive state for enhanced 
gene expression (Long et al., 2017). In further support of our hypothesis, and via 
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comparative bioinformatic analysis, we identify a very strong and significant 
correlation between epigenetic modifications that occur following acute RE and those 
associated with chronic loading and reloading time points. Interestingly, the work 
presented in this chapter also suggested that DNA methylation modifications may 
precede functional changes in gene expression. Indeed, a number of transcripts 
displayed significant changes in CpG methylation without significant changes in gene 
expression following acute RE. However, upon chronic loading and/or reloading 
exposures, we identified genes GRIK2, TRAF1 BICC1 and STAG1 were 
hypomethylated after a single bout of acute resistance exercise that were 
maintained as hypomethylated and had enhanced gene expression after later 
reloading. Suggesting that these are epigenetically sensitive genes after a single 
bout of resistance exercise and associated with enhanced gene expression and 
muscle hypertrophy 22 weeks later. 
.  
 
5.4.2 The human methylome is rapidly altered following single exposure to RE to a 
preferentially hypomethylated state 
Until relatively recently, aberrances in DNA methylation via environmental 
influences were thought unlikely to occur, due to DNA methylation being believed to 
be mitotically stable (Reik et al., 2001). However, in direct contrast to this hypothesis, 
the work presented in this chapter demonstrates that immediately following a single 
stimulus of resistance exercise, mature human skeletal muscle is rapidly and grossly 
altered at the epigenetic level. Furthermore, it is also reported that not only is the 
human methylome highly differentially regulated, it also favours a hypomethylated 
state that may suggest a transcriptionally permissive status (Long et al., 2017). 
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Recently published work utilising a combination of high fat feeding and resistance 
exercise to examine the potential benefits of resistance exercise during high fat 
feeding periods, Laker et al. (2017) identified that high fat diet alone induced a 
significant hypermethylation effect, with the concomitant exposure to resistance 
exercise resulting in a shift towards a preferential hypomethylated state. However, the 
authors did not examine the beneficial effects of resistance exercise alone, and thus, 
the findings here are not directly translational given that large epigenetic perturbations 
have been shown previously following short-term high fat feeding (Jacobsen et al., 
2012). Furthermore, the authors acknowledged that muscle samples obtained in their 
experiment were obtained 48-hrs post the final resistance exercise stimulus, and thus 
transcriptional behaviour may be low with the authors suggesting that analysis 
immediately following a resistance exercise stimulus is warranted, given the more 
dynamic period of transcriptional activity (Barres and Zierath, 2016, Laker et al., 
2017). In this regard, the data presented here offers novel findings to support the work 
presented by Laker et al. (2017), reporting for the first time, the enhanced 
hypomethylated response of the human methylome immediately following acute 
resistance exercise alone.  
 
In further support of these findings, a series of intricate studies by Barres et al. (2012) 
who reported, via use of a number of mammalian exercise models, a significant 
hypomethylation response of targeted transcripts in the prevailing period following 
aerobic exercise stimulus. In the first experiment, the authors report that exposure to 
a single bout of aerobic exercise (80 % VO2 max maintained until 1674 kJ was 
expended) induced global hypomethylation of the human genome, that, upon follow 
up targeted analysis, reported significant reductions in PGC-1a, TFAM, PDK4 and 
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PPAR δ immediately or 3-h post exercise cessation (Barres et al., 2012). In the second 
experiment by the same authors, 60-mins of ex-vivo contraction in an isolated soleus 
muscle of rodents, produced a hypomethylated response of PGC-1a, PPAR δ, MEF2a, 
MyoD1 and PDK4 as rapidly as 45-mins post exercise cessation (Barres et al., 2012). 
Finally, in the last experiment, the authors incubated rodent L6 myotubes in growth 
media with or without 5mM of supplemented caffeine. Following a time course 
differentiation experiment, it was observed that expansion in the presence of caffeine 
induced hypomethylation in genes PGC-1a, TFAM, MEF2a, citrate synthase and 
PDK4, as rapidly as 60 mins post differentiation (Barres et al., 2012).  
 
Collectively, the novel data demonstrated in this chapter, suggests that acute RE 
experienced by mature mammalian skeletal muscle evokes large adaptations in DNA 
methylation, that prefer a hypomethylated response, and thus would preferentially 
favour a permissive transcriptional genome. 
 
5.4.3 DNA methylation profiles following acute RE are identical to those observed 
following loading and reloading: highlighting potential DNA methylation biomarkers 
for later adaptation 
Following identification that the human methylome is readily remodelled following 
acute RE, it was identified that the degree to which these modifications occurred were 
similar in nature to those observed following 7-weeks loading (Chapter 4). Indeed, 
the number of statistically differentially regulated CpG sites following acute RE 
(17,884) was almost identical in number to those modified following 7-weeks loading 
(17,365). It was therefore sought to investigate how closely regulated these epigenetic 
modifications between acute and chronic loading (acute RE vs 7-weeks loading and 
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reloading) were. In support of our hypothesis, it was identified that modifications of 
a sub-set of differentially regulated CpG sites following acute RE, are almost identical 
in directional change (i.e. hypo or hypermethylated) to those observed following 
chronic loading and reloading. Indeed, via comparative bioinformatic analysis of 
these data sets, it was observed that 26 % of analysed CpG sites following acute RE, 
portray significantly differentially regulated profiles following loading and reloading 
(Figure 5.4). More so, a significant correlation is observed (R = 0.94, P < 0.0001) for 
the hypo/hypermethylated profile of these CpG sites, when compared to loading and 
reloading modifications (Figure 5.5). To the authors knowledge, these are the first 
data to study the acute (acute RE) and long-term (loading and reloading) effects of 
exposure to same exercise stimulus on DNA methylation modifications in humans.  
 
Through qPCR analysis, we sought to elucidate how functionality relevant the 
epigenetic modifications following acute RE were, and whether these regulatory 
alterations were indistinguishable to those observed following more chronic RE 
periods (loading and reloading). Most interestingly here, it was found that, despite 
significant changes in CpG DNA methylation following acute RE, there was no 
observed significant changes in gene expression for any of the analysed transcripts 
(see Figure 5.6 A and B), collectively suggesting, that DNA methylation 
modifications may precede detectable changes in gene expression. In further support 
of this theory, it was observed that where acute RE modifications in CpG DNA 
methylation orchestrated no significant change in gene expression, but where 
methylation modifications were retained following continuous loading or reloading, 
changes in gene expression were observed. Indeed, in genes ADSSL1 and C11orf24, 
there was a significant and retained reduction in CpG DNA methylation following 
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acute RE through 7-weeks loading. At the same time points, acute RE produced no 
significant changes in gene expression, however, upon 7-weeks loading a significant 
(ADSSL1) and trend for significance (C11orf24) was observed in these transcripts in 
an inverse manner to changes in methylation (Figure 5.6 A and B). Finally, we 
identified genes BICC1, STAG1, GRIK2 and TRAF1 that were hypomethylated after 
a single bout of acute RE that were maintained as hypomethylated during loading and 
reloading and demonstrated an enhanced gene expression after later reloading (Figure 
5.7). The identification of these genes, and their relation to skeletal muscle 
hypertrophy, is relatively novel. Indeed, BICC1 is an RNA binding protein that has 
an undermined role in adult skeletal muscle. It has been identified as differentially 
expressed during prenatal muscle development between two different pig breeds 
(Murani et al., 2007). RNA binding proteins in general are important in post-
transcriptional modifications, suggesting that perhaps reduced DNA methylation and 
increased gene expression may indicate an increase in post-transcriptional 
modification after reloading, however this requires further investigation to confirm. 
STAG1 is fundamental in cell division and part of the cohesin complex, which is 
required for the cohesion of sister chromatids after DNA replication (Kong et al., 
2014). However, to the authors’ knowledge there is no specific role for STAG1 
identified in adult skeletal muscle hypertrophy. Similarly, GRIK2’s role in skeletal 
muscle is not well defined. On the contrary however, TRAF1 has been widely 
implicated in skeletal muscle proliferation and differentiation. Indeed, TRAF1 is the 
TNF receptor-associated factor 1 and together with TRAF2, form the heterodimeric 
complex required for TNF-α activation of MAPKs, JNK and NFκB (Pomerantz and 
Baltimore, 1999). The role of TNF-α in acutely activating satellite cells and cellular 
proliferation post damaging exercise, is well observed (Foulstone et al., 2004, Li, 
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2003, Mackey et al., 2007, van de Vyver and Myburgh, 2012). This identification that 
acute RE induces hypomethylated CpG sites on this transcript, that, following regular 
RE loading (reloading) induces a significant increase in gene expression is interesting 
and requires further investigation (Foulstone et al., 2004, Li, 2003). Irrespective of 
their documented role in skeletal muscle, data presented here suggest that these 
epigenetically regulated genes (BICC1, GRIK2, TRAF1 and STAG1) were acutely 
sensitive to hypomethylation after a single bout of resistance exercise, that enhanced 
gene expression 22 weeks after a period of load-induced hypertrophy, a return of 
muscle to baseline and later reloading induced hypertrophy. Therefore, the epigenetic 
regulation of these genes seems to be an early, acute exercise biomarker for later 
exercise induced adaptation.  
 
In partial support of these findings, comprehensive examination of exercise-induced 
promoter methylation modifications, and the functional role this plays in regulating 
gene expression, identified a time-dependent relationship between methylation and 
gene expression changes (Barres et al., 2012). Indeed, aerobic exercise at 80 % 
VO2max (until 1,674 kJ of energy were expended), authors identified a significant 
hypomethylated promoter region of genes PGC-1α and PDK4 immediately following 
exercise cessation, that was related to enhanced gene expression of the same 
transcripts 3hrs post exercise cessation (Barres et al., 2012). The same authors identify 
a similar finding in genes PGC-1α, PDK4 and PPAR-δ following ex-vivo stimulation 
of rodent soleus muscle (0.3s trains; 25Hz, 0.1ms impulse repeated every 1s for 5-
mins, repeated for 4 sets over a 60-min period). Where 45-mins post exercise stimulus, 
the authors identify significant reduction in promoter methylation of these transcripts, 
that only purport significant increases in gene expression 180-mins post ex-vivo 
contraction.  
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5.5 Summary and Concluding Remarks 
The findings in this chapter, firstly, suggest that the human methylome is rapidly 
remodelled following acute RE that preferentially favours a hypomethylated profile. 
Furthermore, the data presented here, suggest that a rapid modification in DNA 
methylation of specific genes may act as an early (30 mins) sensitive DNA 
methylation biomarker to acute exercise for later adaptive responses to chronic 
exercise.  
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6.1 Aims of Thesis  
Skeletal muscle mass and plasticity are fundamental for functional performance, 
maintenance of metabolic health, longevity and quality of life into old age. With this 
in mind, a large body of biological research has sought to elucidate the molecular 
mechanisms that regulate muscle mass. Despite recent advances in this field, a 
complete working understanding of the molecular processes that converge upon 
skeletal muscle to orchestrate both muscular hypertrophy, and atrophy remain poorly 
described and inadequately understood.  
 
In this regard, there is a dearth of data and experimental work examining the role of 
epigenetics in regulating skeletal muscle mass and the adaptive response of 
mammalian muscle, to both atrophic and hypertrophic encounters. With this in mind, 
this thesis aimed to elucidate this concept by investigating the DNA methylation 
response and the functional relevance on gene expression of these modification during 
periods of atrophy and hypertrophy in mammalian skeletal muscle. The overarching 
aims of this thesis were therefore to: 
 
1. Investigate the role of DNA methylation in skeletal muscle atrophy using an 
in-vivo tetrodotoxin nerve silencing system in rats to model disuse atrophy 
over a period of 14 days.  
2. elucidate whether these epigenetic modifications were retained or returned to 
normal with 7 d of full active recovery in the same animals. 
3. Investigate whether an epigenetic muscle memory of hypertrophy occurs in 
human skeletal muscle in-vivo, using chronic resistance exercise (loading), 
followed by cessation of exercise (unloading), and finally a subsequent later 
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chronic resistance exercise programme (reloading), thus allowing the 
elucidation of the underlying epigenetic alterations that occur after muscle 
hypertrophy (loading), a return of muscle back to baseline size (unloading) 
and memory (reloading) respectively.   
4. And finally, explore modifications to genome wide DNA methylation 
following a single bout of resistance exercise in previously untrained human 
subjects (acute RE), and correlate these modifications to changes in the DNA 
methylation and gene expression following chronic resistance exercise 
induced hypertrophy (loading) and subsequent reloading induced muscle 
growth (data derived in aim 3 above). Identifying whether these DNA 
modifications may exist as early acute biological markers of subsequent 
adaptation to resistance exercise induced muscle hypertrophy.  
 
To realise these aims, in chapter 3 we employed a transcriptome-wide approach in 
Wistar rats that were subject to atrophy by nerve silencing of the peroneal nerve using 
tetrodotoxin (TTX) to the hind limb (TTX exposure over 3, 7 and 14D time periods). 
Furthermore, this model allowed reversal of TTX exposure and the return of normal 
physical activity to the rodent hind limb, culminating in the partial recovery of skeletal 
muscle mass over a subsequent 7D period (14D TTX and 7D recovery). The 
transcriptome-wide analysis allowed for identification of significantly differentially 
regulated gene transcripts, which were subsequently targeted for DNA methylation 
analysis. In the second experimental study (chapter 4), an epigenome-wide approach 
was utilised to examine the human methylome following a 7-week period of resistance 
exercise (RE) (loading), a subsequent period of exercise cessation (unloading) and a 
final secondary period of chronic RE loading (reloading). In studying the human 
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methylome, we were able to investigate over 850,000 DNA CpG sites that were 
differentially methylated and associated with skeletal muscle loading, unloading and 
reloading. The most significantly and frequently modified genes between conditions 
were then followed up for target gene expression analysis at the single gene level. A 
similar analysis model was utilised in the final experimental study (chapter 5), where 
previously untrained human subjects underwent a single bout of RE (acute RE) to 
identify the immediate response of the human methylome following RE. Cross-
comparative bioinformatic analysis was performed to understand the relationship 
between acute and chronic exposures to RE, before specific genes were targeted for 
further gene expression analysis. With the view to establish whether these DNA 
modifications may exist as early acute biological markers of later life adaptation to 
resistance exercise induced muscle hypertrophy.  
 
6.2 DNA methylation is modified following catabolic and anabolic exposure: 
acute and chronic response of mammalian DNA methylation 
It was identified that following both atrophy (aim 1 above; data chapter 3) and loading 
(aims 3 and 4 above; data chapters 4 and 5), mammalian skeletal muscle demonstrated 
significant modifications in DNA methylation. Indeed, in chapter 3, the peroneal 
nerve of rat hind limbs were exposed to treatment of the toxin, tetrodotoxin (TTX), 
that induced a progressive wasting of the hind limb up to a 14D time point. Following 
gene arrays (skeletal muscle RNA; 31,000 probe sets, covering over 30,000 transcripts 
and variants of 28,000 known sequencing gene regions) and the identification of the 
most statistically differentially regulated genes between conditions, loci-specific 
pyrosequencing of bisulfite converted DNA from the same animals identified 
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significant modifications to the promotor methylation profile of important gene 
transcripts (Myog, Fbxo32, Trim63, Chrna1 and Ampd3) across 3, 7 and 14D 
exposure. Previously, it was thought that DNA methylation was mitotically stable, 
and thus environmental factors where not considered a significant vehicle to drive 
modifications in differentiated adult tissue (Reik et al., 2001). Conversely to this 
consensus, recent findings have suggested that acute exercise, through mechanisms 
that currently remain unknown, is able to modify DNA methylation in important 
regions of gene coding DNA. Indeed, in a series of investigative studies, Barres et al. 
(2012) utilised aerobic regimen (80% VO2max until 1674 KJ of energy was expended 
in humans; 0.3 s trains of 25 Hz, 0.1 ms impulses, repeated every second for 5 mins 
for 4 sets in ex-vivo rodent soleus muscle) in both human and rodent skeletal muscle 
to examine the effects of exercise on promoter methylation. The authors concluded 
that acute aerobic exercise is sufficient to rapidly remodel promoter DNA methylation 
of important metabolic related genes (PGC-1α, PDK4 and PPAR-δ). Collectively, the 
findings presented here suggest that exercise is sufficient to modify promoter DNA 
methylation of important gene transcripts, during relatively acute time periods. 
Similarly, in chapter 5 of this thesis, we present global regulatory evidence to suggest 
that the human methylome is rapidly remodelled following just a single bout of 
resistance exercise (RE) (acute RE). Indeed, in previously untrained human subjects, 
immediately following (< 30 mins) acute RE, we report 17,884 CpG sites as 
displaying a significantly differentially regulated methylation profile, with a 
preferential hypomethylated response in the human methylome (chapter 5). 
Conclusively, this work suggests that acute exposure to both catabolic (3-14D TTX 
atrophy remodels promotor methylation of important regulatory genes) and 
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hypertrophic (acute RE) conditions is sufficient to induce significant modifications to 
the mammalian DNA methylation.  
 
We also sought to elucidate (aim 3) what large-scale epigenetic modifications are 
apparent following continuous load induced skeletal muscle hypertrophy after chronic 
RE (chapter 4) in previously untrained human participants. Indeed, in chapter 4 we 
identified that, following a 7-week period of load induced hypertrophy, 17,365 CpG 
sites of the human methylome displayed significantly modified DNA methylation 
profiles. Furthermore, following a period of exercise cessation (7-weeks unloading), 
a secondary period of resistance exercise (7-weeks reloading) induced further 
modifications to the human methylome, where 27,155 CpG sites portrayed 
statistically differentially methylated profiles. To the authors’ knowledge, these data 
are the first to elucidate the effects that chronic RE exposure has on human skeletal 
muscle methylome. Similarly, previous work has also suggested that RE induced 
large-scale modifications to DNA methylation in leukocytes (Denham et al., 2016). 
Indeed, 8-weeks of RE training (3/week of 3 sets, 8-12 reps at 80 % 1RM) induced 
over 57,000 differentially methylated CpG sites with an even split between hypo/ 
(28,987) hypermethylated (28,397) modifications (Denham et al., 2016). 
Interestingly, following 7-weeks of RE loading, we have shown a similar pattern of 
change in CpG DNA methylation, where an even distribution of both hypo and 
hypermethylated sites were observed (9,153 and 8,212, respectively). However, upon 
exposure to secondary stimulus (reloading), we observed an enhanced 
hypomethylated profile, where 18,816 CpG sites were hypomethylated compared to 
8,339 as hypermethylated (chapter 4; discussed below).  
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To date however, the precise mechanisms that orchestrate modifications in DNA 
methylation in mature skeletal muscle, remain elusive. In their work, Barres et al., 
(2012) initially speculated, and subsequently investigated the role of intracellular 
calcium (Ca2+) ions in orchestrating the cascade of reactions that demonstrate an 
addition or removal of a methyl molecular onto promoter DNA sequences (Barres et 
al., 2012). Nonetheless, these in-vitro experiments failed to confirm this hypothesis, 
and to date, the mechanisms that induce DNA methylation remain unknown and thus, 
warrant further investigation.  
 
Collectively, the data presented in this thesis, as well as evidence described above, 
suggests that both anabolic and catabolic environmental encounters, in both an acute 
and chronic manner, are sufficient to drive significant modifications to mammalian 
DNA methylation in skeletal muscle. Here, we present novel data that demonstrates 
this concept in mature mammalian skeletal muscle following both atrophic and 
hypertrophic stimuli.  
 
6.3 DNA Methylation Displays an Inverse Mirrored Relationship with 
Changes in Gene Expression During Loss and Growth in Mammalian Skeletal 
Muscle 
Following identification that atrophic and hypertrophic environmental encounters 
were a driving force for both acute and chronic modifications to mammalian skeletal 
muscle DNA methylation, we next aimed to understand the functional relevance (in 
terms of whether the epigenetics lead to changes in the genes being turned on/off) of 
these modifications (aims 1 and 4, as outlined above). Importantly, in chapters 3 and 
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4, we identified that where significant modifications to DNA methylation (promoter 
region and CpG-specific) occurred, these were met with functional changes in gene 
expression, suggesting a significant role for DNA methylation in regulating the 
adaptive response of mammalian skeletal muscle during periods of perturbation.  
 
Indeed, in chapter 3 (experimental study 1), we report that following 3D of TTX 
exposure in rat TA muscle, significant reductions in promoter methylation of the 
muscle specific basic helix-loop-helix transcription factor Myogenin, was associated 
with a significant increase in gene expression at the same time point (chapter 3). 
Furthermore, where 7 and 14D of TTX exposure induced a significant reduction of 
DNA methylation in the promoter region of Chrna1, we also reported an increase in 
gene expression that attained significance at 14D of TTX exposure (chapter 3). 
Temporal pattern analysis of the fold-changes in both DNA methylation and gene 
expression (Figure 3.6 B) during 14D of TTX exposure, further identified an inverse 
relationship between methylation and gene expression of studied genes. Further work 
in this model, where TTX cessation induced recovery of ~51 % of skeletal muscle 
wasting from 14D TTX exposure only, identified a similar relationship between DNA 
methylation and gene expression. Indeed, in the identified transcripts Trim63 and 
most prominently in Fbxo32 and Chrna1, cessation of TTX induced muscle wasting 
and return to activity in skeletal muscle induced increased DNA methylation that 
returned back to baseline levels. Importantly, where this increase in methylation was 
observed, we also observed a reduction in gene expression of these transcripts which 
was associated, as previously discussed, with the partial recovery of skeletal muscle 
mass.  
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This relationship between methylation and gene expression was further identified in 
chapter 4, where CpG-specific DNA methylation and gene expression of a cluster of 
identified transcripts displayed an inverse relationship during 7-weeks loading, 
unloading and reloading, respectively. Indeed, methylome-wide bead array analysis 
identified the gene cluster consisting of UBR5, BICC1, ODF2, RPL35a, SETD3, 
C12orf50, PLA2G16, HEG1 and ZFP2, that collectively displayed reduction 
(hypomethylation) in DNA methylation following loading, that returned to baseline 
upon exercise cessation (unloading), and displayed a significant (P = 0.05) reduction 
in DNA methylation upon reloading (Figure 4.10B). Importantly, this profile was 
mirrored by significant changes in gene expression of the same transcripts, across the 
same conditions (loading, unloading, reloading; Figure 4.10B). More so, in a second 
cluster of genes including AXIN1, TRAF1, GRIK2 and CAMK4, a similar inverse 
relationship was observed, whereby initial and maintained hypomethylation was met 
with an initial and sustained increase in gene expression (Figure 4.11B).  
 
Collectively, these data suggest that there was a strong association between changes 
in promoter and/or CpG-specific DNA methylation and changes in gene expression 
during periods of skeletal muscle perturbation. As previously highlighted, such 
findings have been identified in aerobic exercise models (described above (Barres et 
al., 2012)) but more recently in a model of RE and high-fat feeding (Laker et al., 
2017). Indeed, following short-term RE (3 × 8-10 reps, 3 exercises, 2-days rest 
between sessions) and high-fat feeding (3.9 g fat/kg fat free mass, equating to 77% of 
total caloric intake) intervention (total of 9 days), authors reported a total of 54 genes 
that showed a relationship between DNA methylation modifications (analysed via 
reduced representative bisulfite sequencing, RBBS) and altered gene expression 
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(RNA sequencing) (Laker et al., 2017). Despite a strong association between DNA 
methylation and gene expression being evident, the work described and presented 
above has characterised the observation of this relationship following skeletal muscle 
adaptation, thus it shows an association/correlation but not a direct causation. In order 
to show this causation, experimental models (both in-vitro and in-vivo) utilising over-
expression/knockdown of site specific DNA methylation, and analysing the effect on 
gene functionality and tissue adaptation, must be undertaken.  
 
Nevertheless, there is now a growing number of findings that associate changes in 
DNA methylation with functional changes in gene expression in mammalian skeletal 
muscle, suggesting a role for methylation in modulating the adaptive response of this 
tissue (described above). In this manner, the data presented here adds novel data that 
supports and extends this field as it is the first to show this relationship during periods 
of skeletal muscle atrophy, recovery from atrophy and long-term RE induced 
muscular hypertrophy. The studies are the first to identify a retention of epigenetic 
information after hypertrophy, even when exercise ceases (discussed directly below). 
 
6.4 Retention and Memory of DNA Methylation in Mammalian Skeletal 
Muscle 
One of the most exciting findings from this research thesis was the identification that, 
through retention of a hypomethylated profile, human skeletal muscle possesses an 
epigenetic muscle memory of earlier hypertrophy (chapter 4). After an initial period 
of RE, where skeletal muscle significantly increased and was met with a similar 
number of hypo/hypermethylated CpG sites, the global modification of the human 
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methylome was retained even when skeletal muscle mass returned towards baseline 
levels.  Most importantly however, we identify an enhanced hypomethylated response 
of the human methylome following secondary exposure to RE loading (reloading; 
chapter 4), that was associated with the greatest increase of skeletal muscle mass at 
the whole tissue level. Collectively suggesting that a retention of hypomethylated 
modifications following RE, that were maintained even during reversal in skeletal 
muscle mass, allowed for an enhanced hypomethylated profile following a secondary 
encounter with RE. This enhanced hypomethylated profile was prominent in a cluster 
of genes targeted for closer analysis. Indeed, genes UBR5, BICC1, ODF2, RPL35a, 
SETD3, C12orf50, PLA2G16, HEG1 and ZFP2 collectively portrayed an enhanced 
hypomethylated response following reloading exposure, that was met with the largest 
increase in gene expression of the same cluster (as described above; Figure 4.10). 
Correlation analysis identified a significant positive relationship between changes in 
gene expression and skeletal muscle mass for genes, RPL35a, UBR5, SETD3, 
PLA2G16 and HEG1, suggesting that these genes, whose behaviour is relatively 
unstudied in skeletal muscle, may play an important role in skeletal muscle mass 
regulation. Collectively, these findings imply that, due to a hypomethylated 
maintenance of previous loading stimulus, secondary exposure to RE evoked an 
enhanced hypomethylated response that was met with the largest increase in gene 
expression in transcripts that were identified as highly important for muscle mass 
adaptation. We concluded that human skeletal muscle possesses an epigenetic 
‘memory’ of previous 7 weeks’ load induced hypertrophy. These findings are the first 
to elucidate such a phenomenon in mature skeletal muscle, however, previous work 
has insinuated a similar attribute within skeletal muscle cells. Indeed, cells isolated 
from obese patients and cultured under the influence of an over-supply of lipids, 
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displayed a significant reduction in the expression of the important fatty acid oxidative 
(FAO) gene PPAR-δ (Maples and Brault, 2015). Importantly, the authors further 
identified a distinct dysregulation in multiple CpG sites within close proximity to the 
transcriptional start site (TSS) of the PPAR-δ gene, of which CpG site 6 (-71 bp from 
TSS) correlated significantly with mRNA expression (Maples and Brault, 2015). This 
study implied that epigenetic modifications of the FAO gene, PPAR-δ, acquired 
during an in-vivo encounter (obesity) were remembered and retained in-vitro, with 
these epigenetic modifications being an important mediator in the inability for obese 
skeletal muscle cells to handle a secondary and similar encounter with stress (lipid 
over supply). The ability for skeletal muscle cells to retain modified epigenetic 
signatures has also been shown by our group, as previously discussed (Sharples et al., 
2016a). Indeed, it was shown that murine myoblasts, once acutely exposed to the 
catabolic cytokine TNF-α at an early-life time-point acquired an altered DNA 
methylation profile of the myogenic regulatory factor, MyoD. Interestingly, this study 
reported that, following 30 population doublings in the previously exposed cells 
(TNF-α), the modified DNA methylation profile of MyoD was retained (Sharples et 
al., 2016a). 
 
Importantly, the study by Sharples et al. (2016a) reported that skeletal muscle cells 
retained differential DNA methylation profiles following exposure to a catabolic 
encounter, that maintained a modified pattern for a sustained period of time, following 
the withdrawal of the stimulus. This retentive attribute of DNA methylation was 
examined in this thesis, following in-vivo exposure to a catabolic stimulus (chapter 
3). Indeed, Wistar rats underwent a period of TTX exposure (3, 7 and 14D) that 
induced progressively increased muscle wasting across this time-course. Importantly, 
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we identified significant modifications to promoter DNA methylation of genes MyoG, 
Fbxo32, Trim63 and Chrna1 across this time-course, that were associated with an 
inverse change in gene expression (as described above). However, the correct 
assembly of this model allowed for precise cessation of TTX nerve toxin and the 
return to habitual physical activity for 7D following 14D of muscle wasting (recovery 
group; chapter 3). This model induced a significant recovery of muscle mass by 51.7% 
compared to 14D alone, albeit muscle mass not fully returning to baseline control 
levels. Intriguingly, and contrary to our hypothesis, DNA methylation of the promoter 
region of the genes (Fbxo32, Trim63 and Chrna1) were not significantly retained 
following the withdrawal of TTX exposure, and instead, returned to baseline control 
levels in symmetry to changes in both gene expression and skeletal muscle mass 
(chapter 3). The reasoning behind this lack of retentive methylation is unclear and was 
not followed up in this thesis. However, it is plausible that the rodent epigenome may 
have retained a significant number of differentially methylated CpG sites following 
14D TTX induced muscle wasting, but these were over-looked given the specific 
pyrosequencing analysis utilised within this chapter. Thus, further work of this model, 
utilising a genome-wide DNA methylation approach (similar to that in chapters 4 and 
5), may elucidate a retention of differentially regulated CpG sites.  
 
Collectively, however, work presented from chapters 3 and 4 are interesting, 
suggesting that DNA methylation may act in both a transient and stable manner during 
periods of skeletal muscle perturbation. Further explorative work is now needed to 
understand the mechanisms and functional relevance of these modifications.  
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6.5 DNA Methylation May Act as an Early Biological Marker for Later 
Adaptation 
Seminal work by Barres et al., (2012) identified that changes in promoter DNA 
methylation of important metabolic related transcripts in human skeletal muscle, 
precede those observed in gene expression, partially suggesting that DNA methylation 
may act as an early marker of later exercise-induced cellular response.  In chapter 5, 
we report similar findings, whereby acute DNA methylation modifications were not 
directly associated with acute gene expression changes, rather, upon continued 
loading and reloading (that retained the same modifications to CpG DNA 
methylation), associated changes in DNA methylation and gene expression were 
identified. Indeed, following acute RE, ADSLL1 displayed a hypermethylated profile 
that was identical to that associated following 7-weeks loading, yet, at the gene 
expression level, acute RE did not generate a significant change. However, upon 7-
weeks of repetitive loading, where the hypermethylated profile of ADSLL1 was 
retained, gene expression was significantly reduced. The opposite (in terms of 
directionality of change) was observed in C11orf24, whereby acute RE induced a 
significant hypomethylated response but with no change in gene expression. Upon 
continued loading however, the maintained hypomethylated response was met with a 
significant increase in gene expression (Figure 5.6). In continuation of these findings, 
genes BICC1, STAG1, GRIK2 and TRAF1 displayed significant reductions in DNA 
methylation (hypomethylation) following acute RE that were not met with detectable 
changes in gene expression at the same acute time point. However, following 
reloading (7-weeks reloading), where hypomethylated CpG DNA methylation was 
significantly retained, these genes displayed their largest increase in gene expression.  
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It is currently unclear as to the mechanisms that orchestrated this observed response. 
However, similar findings, that associate significant changes in DNA methylation 
with a time-dependent and significant change in gene expression in mature skeletal 
muscle, have previously been acknowledged (Barres et al., 2012). These data raise the 
tantalising potential for future experimental work to identify this relationship further, 
with the hypothesis that changes in DNA methylation may precede changes in gene 
expression, and therefore may act as an early and acutely sensitive bio-marker for 
later adaptations at a cellular and potentially whole tissue level.  
 
6.6 Future Directions 
The work presented in this thesis has uncovered a number of important and interesting 
findings in the field of skeletal muscle epigenetics. Nonetheless, there still remains a 
lot of fundamental work that needs to be performed in order for the scientific 
community to gain a greater understanding as to the importance of epigenetics in 
regulating skeletal muscle adaptation. With this in mind, and as an artefact to the data 
derived here, there are a number of future directions stemming from this thesis. 
 
6.6.1 Elucidating whether DNA methylation modifications precede those observed 
in gene expression during skeletal muscle adaptation  
There is a clear association between DNA methylation modifications and changes in 
the expression of the associated gene, as identified in this thesis. Furthermore, it has 
been shown that changes in DNA methylation may precede those associated changes 
in gene expression, in skeletal muscle (Barres et al., 2012). Nonetheless, to the authors 
knowledge, no data/studies exist that have directly investigated this relationship in a 
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time-course manner, following changes in skeletal muscle mass. At a molecular level, 
the mechanistic link between changes in gene expression, protein quantity and 
enzyme activity are well examined (Perry et al., 2010), resulting in a functional 
remodelling of the tissue and a progressive skeletal muscle adaptation. However, this 
model of muscular adaptation bypasses the potential influence of skeletal muscle 
epigenetics in regulating gene expression, and thus, the down-stream quantity of 
functional proteins. More so, as previously identified in this thesis (chapter 5), skeletal 
muscle epigenetics may act as a potential early and sensitive biomarker for later 
adaptive responses to exercise. Therefore, an investigation to identify if a particular 
gene, or cluster of genes, is hypo/hypermethylated after acute exercise across differing 
ranges of exercise intensity in both exercise responders and non-responders for a 
measurable physiological adaptation to chronic exercise (e.g. muscle size or aerobic 
capacity). We could perhaps be able to predict, based on an acute DNA methylation 
assay, if someone would adapt to a chronic exercise program or not.  
 
6.6.2 Do repeated exposures to a catabolic event induce an epigenetic muscle 
memory   
For the first time, this thesis identified that DNA methylation may orchestrate a 
skeletal muscle memory characteristic in mature tissue, whereby enhanced adaptive 
responses are observed upon a later encounter with muscle hypertrophy (chapter 4). 
These findings now need to be further explored to characterise this phenomenon in a 
number of different environmental approaches. For example, during hospitalisation, 
humans may experience repeated episodic bouts of acute muscle wasting caused via 
bed-rest, surgery or their underlying disease state (English and Paddon-Jones, 2010). 
It is plausible, given the evidence in this thesis, that acute bouts of muscle atrophy 
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encountered during this period may alter the epigenetic blue-print of crucial muscle 
mass relating transcripts, and therefore results in a greater reduction in muscle mass 
upon secondary or even tertiary exposure to a similar stimulus. It is therefore of great 
clinical importance to elucidate this response in order to further our understanding of 
this catabolic cyclic paradigm.  
 
A human in-vivo model that induces a period of severe muscle wasting, followed by 
a similar period of muscular recovery, and a final period of skeletal muscle wasting 
raises a number of ethical and logistical issues however, and thus an extrapolated 
experimental model would need to be utilised. To over-come such difficulties, a 
possibility would be to extend the work undertaken in chapter 3 of this thesis. Indeed, 
Wistar rodents implanted with an osmotic nerve-cuff apparatus could undergo a 
significant period of disuse-induced atrophy, identical to the model utilised in this 
chapter (14D TTX exposure). Following correct assembly of the apparatus, where 
TTX is ceased, 14D of normal habitual activity would commence where it would be 
expected that skeletal muscle would return to near baseline levels, given that recovery 
of skeletal muscle in tibialis anterior of rodents in chapter 3 recovered by ~50 % after 
only 7D (Figure 3.3; chapter 3). Through a secondary minor surgery and a refilling of 
the assembled osmotic pump in the rats, the nerve cuff would begin to infuse the hind 
limb with TTX again, thus inducing a secondary period of skeletal muscle wasting 
(14D). This experiment would create an opposite model of that used in chapter 4 of 
loading, unloading, reloading in humans by undertaking unloading, loading, 
unloading in rat skeletal muscle. 
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6.6.3 Elucidating the role of the newly identified E3 ubiquitin ligase gene, UBR5, 
in skeletal muscle 
Finally, multiple novel and previously unstudied (in mammalian skeletal muscle) 
transcripts have been identified in the presented work, that, at the expression level, 
positively correlate with adaptations in skeletal muscle mass (chapters 4 and 5). Our 
molecular understanding of skeletal muscle targets that generate positive anabolic 
adaptive responses, is continually advancing and expanding. The novel transcripts 
identified within this thesis, therefore, may possess a currently un-characterised role 
in human skeletal muscle size increases after resistance exercise, and thus warrant 
further investigation. In order to do so, fundamental work needs to be performed to 
characterise the role of these genes in mature mammalian skeletal muscle. 
Intriguingly, the E3 ubiquitin ligase protein family member UBR5, whose expression 
is identified as displaying a positive correlation with increases in muscle mass, also 
displayed a distinct susceptibility to being modulated by DNA methylation. Typically, 
E3 ubiquitin ligases, such as those of Murf1/Trim63 and MAFbx/Fbxo32, are 
associated with increased gene expression during periods of skeletal muscle atrophy 
(Bodine et al., 2001a), where, in chapter 3, we have also shown that they are also 
epigenetically regulated. Thus, the identified positive correlation between gene 
expression of UBR5 and adaptations in skeletal muscle, is counterintuitive, and 
therefore highly interesting. Evidence provided here, suggests that not only is the 
expression of UBR5 a novel transcript that correlates positively with skeletal muscle 
mass development, it is also highly susceptible to aberrancies in DNA methylation. A 
plethora of future work is required to firstly characterise UBR5’s presence in skeletal 
muscle, but also its role in regulating cellular growth, and to further identify the 
epigenetic regulation of this transcript.  
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6.7 Experimental Limitations 
It is important to note that despite interesting findings being alluded to throughout this 
thesis, the explorative work described here is not without limitations. First and 
foremost, in chapter 3 we utilised a rodent model to characterise the promotor 
methylation changes in identified important transcripts during a prolonged atrophy 
and subsequent muscular recovery model. The strain of rat utilised (Wister more 
details) is an in-bred genetically identical strain of rodent, commonly utilised for in-
vivo experimental work. The loci-specific pyrosequencing and high-resolution melt 
assays utilised within this chapter to elucidate the methylation changes in these 
transcripts were performed on a small, albeit genetically identical, sample size (N=3). 
The small sample size used for this section of work may therefore impact the observed 
data and thus, the biological interpretation of these findings. Future investigations 
should therefore utilise the data here as a catalyst to further explore these findings in 
an experimental model utilising greater sample size.  
 
Equally, in chapter 4 and 5, we utilise an in-vivo human model, where voluntary 
human participants were utilised for both acute and chronic training sessions to 
explore the aims of these chapters. In these sets of experiments, eight human 
participants were originally utilised with a high retention rate, where only one 
participant withdrew in the final stage of chronic training (for reasons unrelated to 
testing/experimental protocols). Nonetheless, given the high diversity in the human 
genome (Levy et al., 2007, Venter et al., 2001), this relatively low sample size must 
be acknowledged as a limitation of the study. Indeed, low sample size in human 
research adversely effects the likelihood of identifying true statistically significant 
findings (Dumas-Mallet et al., 2017), and may increase the risk of presenting false 
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positives (Dumas-Mallet et al., 2017). Furthermore, and with greater specificity to the 
in-vivo methodologies utilised within these experiments, it has previously been shown 
that human subjects respond (strength assessment via isometric MVC) to a high inter-
individual variability following 9-weeks of progressive RE training (Erskine et al., 
2010a). It is therefore plausible that inter-individual differences in the ability for 
subjects to respond to the RE training prescribed in this thesis may underlie some of 
the observed findings. However, elucidation of such findings either requires a 
substantially larger sample size, or a unique demographic of the human population 
(i.e. monozygotic twin studies) in order to understand the extent to which this is true. 
Nonetheless, the work offered here is explorative in nature and should therefore be 
utilised as a catalyst to explore these concepts further, given the interesting findings 
presented.   
 
The human work presented in chapter 4 utilised two in-vivo methodologies to assesses 
adaptations in muscle strength and mass over time. Both of these methods, isometric 
MVC assessed via an isokinetic dynamometer and dual-energy X-ray absorptiometry 
for muscle mass adaptations, are not without limitations. For example, pre-scan 
nutrient and hydration status has been shown to substantially alter the total and 
regional lean mass as well as the associated total body mass in individuals, in a 
repeated measures study (Nana et al., 2012). For isometric MVC tests, diurnal 
variation is associated with alterations in the torque production of human participants 
when repeatedly tested, with subjects performing better in the evening compared to 
morning (Sedliak et al., 2007). The test-retest reliability of the knee extensor 
isokinetic dynamometry and dual-energy X-ray absorptiometry have both previously 
been analysed in separate laboratories and been shown to be highly reliable for the 
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assessment of knee extensor strength and lean mass, respectively (Adsuar et al., 2011, 
Sole et al., 2007, Bilsborough et al., 2014). However, such a test-retest reliability 
experiment could have been performed for chapter 4 in order to provide greater 
confidence that the findings presented are true.  
 
However, given the difficulties in performing these types of studies, the data presented 
is still of great value to the scientific community and should be utilised as a catalyst 
to reliably validate and replicate these findings.  
 
 
6.8 Final Conclusion  
This thesis has generated novel findings as to the role DNA methylation plays in 
regulating skeletal muscle disuse atrophy, acute anabolism, chronic resistance 
exercise induced hypertrophy and muscle memory.  
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